id	sid	tid	token	lemma	pos
dpc-3672	1	1	dermatology	dermatology	NOUN
dpc-3672	1	2	:	:	PUNCT
dpc-3672	1	3	practical	practical	ADJ
dpc-3672	1	4	and	and	CCONJ
dpc-3672	1	5	conceptual	conceptual	ADJ
dpc-3672	1	6	original	original	ADJ
dpc-3672	1	7	article	article	NOUN
dpc-3672	1	8	|	|	ADV
dpc-3672	1	9	dermatol	dermatol	ADJ
dpc-3672	1	10	pract	pract	NOUN
dpc-3672	1	11	concept	concept	NOUN
dpc-3672	1	12	.	.	PUNCT
dpc-3672	2	1	2024;14(2):e2024069	2024;14(2):e2024069	NUM
dpc-3672	2	2	1	1	NUM
dpc-3672	2	3	serum	serum	NOUN
dpc-3672	2	4	levels	level	NOUN
dpc-3672	2	5	of	of	ADP
dpc-3672	2	6	il-35	il-35	ADP
dpc-3672	2	7	,	,	PUNCT
dpc-3672	2	8	one	one	NUM
dpc-3672	2	9	of	of	ADP
dpc-3672	2	10	the	the	DET
dpc-3672	2	11	newest	new	ADJ
dpc-3672	2	12	members	member	NOUN
dpc-3672	2	13	of	of	ADP
dpc-3672	2	14	interleukin-12	interleukin-12	PROPN
dpc-3672	2	15	family	family	NOUN
dpc-3672	2	16	of	of	ADP
dpc-3672	2	17	cytokines	cytokine	NOUN
dpc-3672	2	18	,	,	PUNCT
dpc-3672	2	19	in	in	ADP
dpc-3672	2	20	patients	patient	NOUN
dpc-3672	2	21	with	with	ADP
dpc-3672	2	22	vitiligo	vitiligo	PROPN
dpc-3672	2	23	yıldız	yıldız	PROPN
dpc-3672	2	24	hayran1	hayran1	PROPN
dpc-3672	2	25	,	,	PUNCT
dpc-3672	2	26	çiğdem	çiğdem	PROPN
dpc-3672	2	27	yücel2	yücel2	PROPN
dpc-3672	2	28	,	,	PUNCT
dpc-3672	2	29	esra	esra	PROPN
dpc-3672	2	30	fırat	fırat	PROPN
dpc-3672	2	31	oğuz3	oğuz3	PROPN
dpc-3672	2	32	,	,	PUNCT
dpc-3672	2	33	funda	funda	PROPN
dpc-3672	2	34	eren3	eren3	PROPN
dpc-3672	2	35	,	,	PUNCT
dpc-3672	2	36	turan	turan	PROPN
dpc-3672	2	37	turhan3	turhan3	PROPN
dpc-3672	2	38	,	,	PUNCT
dpc-3672	2	39	başak	başak	NOUN
dpc-3672	2	40	yalçın4	yalçın4	NOUN
dpc-3672	2	41	1	1	NUM
dpc-3672	2	42	department	department	PROPN
dpc-3672	2	43	of	of	ADP
dpc-3672	2	44	dermatology	dermatology	NOUN
dpc-3672	2	45	,	,	PUNCT
dpc-3672	2	46	ankara	ankara	PROPN
dpc-3672	2	47	city	city	PROPN
dpc-3672	2	48	hospital	hospital	PROPN
dpc-3672	2	49	,	,	PUNCT
dpc-3672	2	50	ankara	ankara	PROPN
dpc-3672	2	51	,	,	PUNCT
dpc-3672	2	52	turkey	turkey	PROPN
dpc-3672	2	53	2	2	NUM
dpc-3672	2	54	department	department	NOUN
dpc-3672	2	55	of	of	ADP
dpc-3672	2	56	medical	medical	ADJ
dpc-3672	2	57	biochemistry	biochemistry	NOUN
dpc-3672	2	58	,	,	PUNCT
dpc-3672	2	59	university	university	NOUN
dpc-3672	2	60	of	of	ADP
dpc-3672	2	61	health	health	PROPN
dpc-3672	2	62	sciences	sciences	PROPN
dpc-3672	2	63	,	,	PUNCT
dpc-3672	2	64	gulhane	gulhane	NOUN
dpc-3672	2	65	teaching	teaching	NOUN
dpc-3672	2	66	and	and	CCONJ
dpc-3672	2	67	research	research	NOUN
dpc-3672	2	68	hospital	hospital	NOUN
dpc-3672	2	69	,	,	PUNCT
dpc-3672	2	70	ankara	ankara	PROPN
dpc-3672	2	71	,	,	PUNCT
dpc-3672	2	72	turkey	turkey	PROPN
dpc-3672	2	73	3	3	NUM
dpc-3672	2	74	department	department	NOUN
dpc-3672	2	75	of	of	ADP
dpc-3672	2	76	medical	medical	ADJ
dpc-3672	2	77	biochemistry	biochemistry	NOUN
dpc-3672	2	78	,	,	PUNCT
dpc-3672	2	79	ankara	ankara	PROPN
dpc-3672	2	80	city	city	PROPN
dpc-3672	2	81	hospital	hospital	PROPN
dpc-3672	2	82	,	,	PUNCT
dpc-3672	2	83	ankara	ankara	PROPN
dpc-3672	2	84	,	,	PUNCT
dpc-3672	2	85	turkey	turkey	NOUN
dpc-3672	2	86	4	4	NUM
dpc-3672	2	87	dermatology	dermatology	NOUN
dpc-3672	2	88	,	,	PUNCT
dpc-3672	2	89	private	private	ADJ
dpc-3672	2	90	practice	practice	NOUN
dpc-3672	2	91	,	,	PUNCT
dpc-3672	2	92	ankara	ankara	PROPN
dpc-3672	2	93	,	,	PUNCT
dpc-3672	2	94	turkey	turkey	PROPN
dpc-3672	2	95	key	key	ADJ
dpc-3672	2	96	words	word	NOUN
dpc-3672	2	97	:	:	PUNCT
dpc-3672	2	98	vitiligo	vitiligo	NOUN
dpc-3672	2	99	,	,	PUNCT
dpc-3672	2	100	cytokine	cytokine	NOUN
dpc-3672	2	101	,	,	PUNCT
dpc-3672	2	102	interleukin-12	interleukin-12	PROPN
dpc-3672	2	103	family	family	NOUN
dpc-3672	2	104	,	,	PUNCT
dpc-3672	2	105	disease	disease	NOUN
dpc-3672	2	106	characteristics	characteristics	PROPN
dpc-3672	2	107	citation	citation	NOUN
dpc-3672	2	108	:	:	PUNCT
dpc-3672	2	109	hayran	hayran	PROPN
dpc-3672	2	110	y	y	PROPN
dpc-3672	2	111	,	,	PUNCT
dpc-3672	2	112	yücel	yücel	PROPN
dpc-3672	2	113	ç	ç	SYM
dpc-3672	2	114	,	,	PUNCT
dpc-3672	2	115	fırat	fırat	NOUN
dpc-3672	2	116	oğuz	oğuz	PROPN
dpc-3672	2	117	e	e	PROPN
dpc-3672	2	118	,	,	PUNCT
dpc-3672	2	119	eren	eren	PROPN
dpc-3672	2	120	f	f	PROPN
dpc-3672	2	121	,	,	PUNCT
dpc-3672	2	122	turhan	turhan	PROPN
dpc-3672	2	123	t	t	PROPN
dpc-3672	2	124	,	,	PUNCT
dpc-3672	2	125	yalçın	yalçın	PROPN
dpc-3672	2	126	b.	b.	PROPN
dpc-3672	2	127	serum	serum	PROPN
dpc-3672	2	128	levels	level	NOUN
dpc-3672	2	129	of	of	ADP
dpc-3672	2	130	il-35	il-35	ADP
dpc-3672	2	131	,	,	PUNCT
dpc-3672	2	132	one	one	NUM
dpc-3672	2	133	of	of	ADP
dpc-3672	2	134	the	the	DET
dpc-3672	2	135	newest	new	ADJ
dpc-3672	2	136	members	member	NOUN
dpc-3672	2	137	of	of	ADP
dpc-3672	2	138	interleukin-12	interleukin-12	PROPN
dpc-3672	2	139	family	family	NOUN
dpc-3672	2	140	of	of	ADP
dpc-3672	2	141	cytokines	cytokine	NOUN
dpc-3672	2	142	,	,	PUNCT
dpc-3672	2	143	in	in	ADP
dpc-3672	2	144	patients	patient	NOUN
dpc-3672	2	145	with	with	ADP
dpc-3672	2	146	vitiligo	vitiligo	PROPN
dpc-3672	2	147	.	.	PUNCT
dpc-3672	3	1	dermatol	dermatol	NOUN
dpc-3672	3	2	pract	pract	PROPN
dpc-3672	3	3	concept	concept	NOUN
dpc-3672	3	4	.	.	PUNCT
dpc-3672	4	1	2024;14(2):e2024069	2024;14(2):e2024069	X
dpc-3672	4	2	.	.	PUNCT
dpc-3672	4	3	doi	doi	PROPN
dpc-3672	4	4	:	:	PUNCT
dpc-3672	4	5	https://doi.org/10.5826/dpc.1402a69	https://doi.org/10.5826/dpc.1402a69	PROPN
dpc-3672	4	6	accepted	accept	VERB
dpc-3672	4	7	:	:	PUNCT
dpc-3672	4	8	october	october	PROPN
dpc-3672	4	9	11	11	NUM
dpc-3672	4	10	,	,	PUNCT
dpc-3672	4	11	2023	2023	NUM
dpc-3672	4	12	;	;	PUNCT
dpc-3672	4	13	published	publish	VERB
dpc-3672	4	14	:	:	PUNCT
dpc-3672	4	15	april	april	PROPN
dpc-3672	4	16	2024	2024	NUM
dpc-3672	5	1	copyright	copyright	NOUN
dpc-3672	5	2	:	:	PUNCT
dpc-3672	5	3	©	©	PROPN
dpc-3672	5	4	2024	2024	NUM
dpc-3672	5	5	hayran	hayran	NOUN
dpc-3672	5	6	et	et	PROPN
dpc-3672	5	7	al	al	PROPN
dpc-3672	5	8	.	.	PUNCT
dpc-3672	6	1	this	this	PRON
dpc-3672	6	2	is	be	AUX
dpc-3672	6	3	an	an	DET
dpc-3672	6	4	open	open	ADJ
dpc-3672	6	5	-	-	PUNCT
dpc-3672	6	6	access	access	NOUN
dpc-3672	6	7	article	article	NOUN
dpc-3672	6	8	distributed	distribute	VERB
dpc-3672	6	9	under	under	ADP
dpc-3672	6	10	the	the	DET
dpc-3672	6	11	terms	term	NOUN
dpc-3672	6	12	of	of	ADP
dpc-3672	6	13	the	the	DET
dpc-3672	6	14	creative	creative	ADJ
dpc-3672	6	15	commons	common	NOUN
dpc-3672	6	16	attributionnoncommercial	attributionnoncommercial	ADJ
dpc-3672	6	17	license	license	NOUN
dpc-3672	6	18	(	(	PUNCT
dpc-3672	6	19	by	by	ADP
dpc-3672	6	20	-	-	PUNCT
dpc-3672	6	21	nc-4.0	nc-4.0	NOUN
dpc-3672	6	22	)	)	PUNCT
dpc-3672	6	23	,	,	PUNCT
dpc-3672	6	24	https://creativecommons.org/licenses/by-nc/4.0/	https://creativecommons.org/licenses/by-nc/4.0/	PROPN
dpc-3672	6	25	,	,	PUNCT
dpc-3672	6	26	which	which	PRON
dpc-3672	6	27	permits	permit	VERB
dpc-3672	6	28	unrestricted	unrestricted	ADJ
dpc-3672	6	29	noncommercial	noncommercial	ADJ
dpc-3672	6	30	use	use	NOUN
dpc-3672	6	31	,	,	PUNCT
dpc-3672	6	32	distribution	distribution	NOUN
dpc-3672	6	33	,	,	PUNCT
dpc-3672	6	34	and	and	CCONJ
dpc-3672	6	35	reproduction	reproduction	NOUN
dpc-3672	6	36	in	in	ADP
dpc-3672	6	37	any	any	DET
dpc-3672	6	38	medium	medium	NOUN
dpc-3672	6	39	,	,	PUNCT
dpc-3672	6	40	provided	provide	VERB
dpc-3672	6	41	the	the	DET
dpc-3672	6	42	original	original	ADJ
dpc-3672	6	43	authors	author	NOUN
dpc-3672	6	44	and	and	CCONJ
dpc-3672	6	45	source	source	NOUN
dpc-3672	6	46	are	be	AUX
dpc-3672	6	47	credited	credit	VERB
dpc-3672	6	48	.	.	PUNCT
dpc-3672	7	1	funding	funding	NOUN
dpc-3672	7	2	:	:	PUNCT
dpc-3672	7	3	this	this	DET
dpc-3672	7	4	study	study	NOUN
dpc-3672	7	5	was	be	AUX
dpc-3672	7	6	supported	support	VERB
dpc-3672	7	7	by	by	ADP
dpc-3672	7	8	a	a	DET
dpc-3672	7	9	research	research	NOUN
dpc-3672	7	10	grant	grant	NOUN
dpc-3672	7	11	from	from	ADP
dpc-3672	7	12	the	the	DET
dpc-3672	7	13	turkish	turkish	ADJ
dpc-3672	7	14	society	society	NOUN
dpc-3672	7	15	of	of	ADP
dpc-3672	7	16	dermatology	dermatology	NOUN
dpc-3672	7	17	(	(	PUNCT
dpc-3672	7	18	2019/78	2019/78	NUM
dpc-3672	7	19	)	)	PUNCT
dpc-3672	7	20	.	.	PUNCT
dpc-3672	8	1	competing	compete	VERB
dpc-3672	8	2	interests	interest	NOUN
dpc-3672	8	3	:	:	PUNCT
dpc-3672	8	4	none	none	NOUN
dpc-3672	8	5	.	.	PUNCT
dpc-3672	9	1	authorship	authorship	NOUN
dpc-3672	9	2	:	:	PUNCT
dpc-3672	9	3	all	all	DET
dpc-3672	9	4	authors	author	NOUN
dpc-3672	9	5	have	have	AUX
dpc-3672	9	6	contributed	contribute	VERB
dpc-3672	9	7	significantly	significantly	ADV
dpc-3672	9	8	to	to	ADP
dpc-3672	9	9	this	this	DET
dpc-3672	9	10	publication	publication	NOUN
dpc-3672	9	11	.	.	PUNCT
dpc-3672	10	1	corresponding	correspond	VERB
dpc-3672	10	2	author	author	NOUN
dpc-3672	10	3	:	:	PUNCT
dpc-3672	10	4	yıldız	yıldız	PROPN
dpc-3672	10	5	hayran	hayran	PROPN
dpc-3672	10	6	,	,	PUNCT
dpc-3672	10	7	üniversiteler	üniversiteler	PROPN
dpc-3672	10	8	mahallesi	mahallesi	PROPN
dpc-3672	10	9	1604	1604	NUM
dpc-3672	10	10	.	.	PUNCT
dpc-3672	10	11	cadde	cadde	VERB
dpc-3672	10	12	no	no	NOUN
dpc-3672	10	13	:	:	SYM
dpc-3672	10	14	9	9	NUM
dpc-3672	10	15	çankaya	çankaya	NOUN
dpc-3672	10	16	,	,	PUNCT
dpc-3672	10	17	06800	06800	NUM
dpc-3672	10	18	,	,	PUNCT
dpc-3672	10	19	ankara	ankara	PROPN
dpc-3672	10	20	,	,	PUNCT
dpc-3672	10	21	turkey	turkey	PROPN
dpc-3672	10	22	.	.	PUNCT
dpc-3672	11	1	tel	tel	ADP
dpc-3672	11	2	:	:	PUNCT
dpc-3672	11	3	+90312	+90312	NUM
dpc-3672	11	4	552	552	NUM
dpc-3672	11	5	60	60	NUM
dpc-3672	11	6	00	00	NUM
dpc-3672	11	7	fax	fax	NOUN
dpc-3672	11	8	:	:	PUNCT
dpc-3672	11	9	+903123126876	+903123126876	VERB
dpc-3672	11	10	e	e	NOUN
dpc-3672	11	11	-	-	NOUN
dpc-3672	11	12	mail	mail	NOUN
dpc-3672	11	13	:	:	PUNCT
dpc-3672	11	14	yildiz_kantarci@yahoo.com	yildiz_kantarci@yahoo.com	X
dpc-3672	12	1	introduction	introduction	NOUN
dpc-3672	12	2	:	:	PUNCT
dpc-3672	12	3	vitiligo	vitiligo	PROPN
dpc-3672	12	4	is	be	AUX
dpc-3672	12	5	a	a	DET
dpc-3672	12	6	chronic	chronic	ADJ
dpc-3672	12	7	skin	skin	NOUN
dpc-3672	12	8	disorder	disorder	NOUN
dpc-3672	12	9	in	in	ADP
dpc-3672	12	10	which	which	PRON
dpc-3672	12	11	immune	immune	ADJ
dpc-3672	12	12	dysregulation	dysregulation	NOUN
dpc-3672	12	13	has	have	AUX
dpc-3672	12	14	been	be	AUX
dpc-3672	12	15	reported	report	VERB
dpc-3672	12	16	as	as	ADP
dpc-3672	12	17	one	one	NUM
dpc-3672	12	18	of	of	ADP
dpc-3672	12	19	the	the	DET
dpc-3672	12	20	major	major	ADJ
dpc-3672	12	21	etiopathological	etiopathological	ADJ
dpc-3672	12	22	factors	factor	NOUN
dpc-3672	12	23	.	.	PUNCT
dpc-3672	13	1	interleukin-12	interleukin-12	NOUN
dpc-3672	13	2	(	(	PUNCT
dpc-3672	13	3	il-12	il-12	NOUN
dpc-3672	13	4	)	)	PUNCT
dpc-3672	13	5	,	,	PUNCT
dpc-3672	13	6	il-23	il-23	NOUN
dpc-3672	13	7	and	and	CCONJ
dpc-3672	13	8	il-27	il-27	ADP
dpc-3672	13	9	of	of	ADP
dpc-3672	13	10	il-12	il-12	DET
dpc-3672	13	11	cytokine	cytokine	ADJ
dpc-3672	13	12	family	family	NOUN
dpc-3672	13	13	were	be	AUX
dpc-3672	13	14	identified	identify	VERB
dpc-3672	13	15	as	as	ADP
dpc-3672	13	16	critical	critical	ADJ
dpc-3672	13	17	cytokines	cytokine	NOUN
dpc-3672	13	18	in	in	ADP
dpc-3672	13	19	the	the	DET
dpc-3672	13	20	pathogenesis	pathogenesis	NOUN
dpc-3672	13	21	of	of	ADP
dpc-3672	13	22	many	many	ADJ
dpc-3672	13	23	autoimmune	autoimmune	ADJ
dpc-3672	13	24	and	and	CCONJ
dpc-3672	13	25	inflammatory	inflammatory	ADJ
dpc-3672	13	26	skin	skin	NOUN
dpc-3672	13	27	diseases	disease	NOUN
dpc-3672	13	28	including	include	VERB
dpc-3672	13	29	vitiligo	vitiligo	NOUN
dpc-3672	13	30	.	.	PUNCT
dpc-3672	14	1	il-35	il-35	ADP
dpc-3672	14	2	is	be	AUX
dpc-3672	14	3	one	one	NUM
dpc-3672	14	4	of	of	ADP
dpc-3672	14	5	the	the	DET
dpc-3672	14	6	newest	new	ADJ
dpc-3672	14	7	member	member	NOUN
dpc-3672	14	8	of	of	ADP
dpc-3672	14	9	il-12	il-12	DET
dpc-3672	14	10	cytokine	cytokine	ADJ
dpc-3672	14	11	family	family	NOUN
dpc-3672	14	12	.	.	PUNCT
dpc-3672	15	1	objectives	objective	NOUN
dpc-3672	15	2	:	:	PUNCT
dpc-3672	15	3	the	the	DET
dpc-3672	15	4	purpose	purpose	NOUN
dpc-3672	15	5	of	of	ADP
dpc-3672	15	6	our	our	PRON
dpc-3672	15	7	study	study	NOUN
dpc-3672	15	8	was	be	AUX
dpc-3672	15	9	to	to	PART
dpc-3672	15	10	examine	examine	VERB
dpc-3672	15	11	serum	serum	NOUN
dpc-3672	15	12	il-35	il-35	ADP
dpc-3672	15	13	levels	level	NOUN
dpc-3672	15	14	in	in	ADP
dpc-3672	15	15	addition	addition	NOUN
dpc-3672	15	16	to	to	PART
dpc-3672	15	17	serum	serum	VERB
dpc-3672	15	18	il-12	il-12	NOUN
dpc-3672	15	19	,	,	PUNCT
dpc-3672	15	20	il-23	il-23	NOUN
dpc-3672	15	21	,	,	PUNCT
dpc-3672	15	22	il-27	il-27	NUM
dpc-3672	15	23	levels	level	NOUN
dpc-3672	15	24	in	in	ADP
dpc-3672	15	25	the	the	DET
dpc-3672	15	26	vitiligo	vitiligo	NOUN
dpc-3672	15	27	patients	patient	NOUN
dpc-3672	15	28	and	and	CCONJ
dpc-3672	15	29	control	control	NOUN
dpc-3672	15	30	group	group	NOUN
dpc-3672	15	31	,	,	PUNCT
dpc-3672	15	32	and	and	CCONJ
dpc-3672	15	33	to	to	PART
dpc-3672	15	34	investigate	investigate	VERB
dpc-3672	15	35	the	the	DET
dpc-3672	15	36	relationship	relationship	NOUN
dpc-3672	15	37	of	of	ADP
dpc-3672	15	38	these	these	DET
dpc-3672	15	39	cytokines	cytokine	NOUN
dpc-3672	15	40	with	with	ADP
dpc-3672	15	41	the	the	DET
dpc-3672	15	42	characteristics	characteristic	NOUN
dpc-3672	15	43	of	of	ADP
dpc-3672	15	44	vitiligo	vitiligo	NOUN
dpc-3672	15	45	.	.	PUNCT
dpc-3672	16	1	methods	method	NOUN
dpc-3672	16	2	:	:	PUNCT
dpc-3672	16	3	serum	serum	VERB
dpc-3672	16	4	il-12	il-12	NOUN
dpc-3672	16	5	,	,	PUNCT
dpc-3672	16	6	il-23	il-23	NOUN
dpc-3672	16	7	,	,	PUNCT
dpc-3672	16	8	il-27	il-27	NUM
dpc-3672	16	9	and	and	CCONJ
dpc-3672	16	10	il-35	il-35	ADP
dpc-3672	16	11	levels	level	NOUN
dpc-3672	16	12	of	of	ADP
dpc-3672	16	13	87	87	NUM
dpc-3672	16	14	vitiligo	vitiligo	NOUN
dpc-3672	16	15	patients	patient	NOUN
dpc-3672	16	16	and	and	CCONJ
dpc-3672	16	17	70	70	NUM
dpc-3672	16	18	healthy	healthy	ADJ
dpc-3672	16	19	volunteers	volunteer	NOUN
dpc-3672	16	20	were	be	AUX
dpc-3672	16	21	analyzed	analyze	VERB
dpc-3672	16	22	using	use	VERB
dpc-3672	16	23	the	the	DET
dpc-3672	16	24	enzyme	enzyme	NOUN
dpc-3672	16	25	-	-	PUNCT
dpc-3672	16	26	linked	link	VERB
dpc-3672	16	27	immunosorbent	immunosorbent	NOUN
dpc-3672	16	28	assay	assay	PROPN
dpc-3672	16	29	(	(	PUNCT
dpc-3672	16	30	elisa	elisa	NOUN
dpc-3672	16	31	)	)	PUNCT
dpc-3672	16	32	.	.	PUNCT
dpc-3672	17	1	we	we	PRON
dpc-3672	17	2	compared	compare	VERB
dpc-3672	17	3	the	the	DET
dpc-3672	17	4	il-12	il-12	DET
dpc-3672	17	5	cytokine	cytokine	ADJ
dpc-3672	17	6	family	family	NOUN
dpc-3672	17	7	levels	level	NOUN
dpc-3672	17	8	in	in	ADP
dpc-3672	17	9	the	the	DET
dpc-3672	17	10	patient	patient	ADJ
dpc-3672	17	11	and	and	CCONJ
dpc-3672	17	12	control	control	NOUN
dpc-3672	17	13	groups	group	NOUN
dpc-3672	17	14	,	,	PUNCT
dpc-3672	17	15	and	and	CCONJ
dpc-3672	17	16	investigated	investigate	VERB
dpc-3672	17	17	the	the	DET
dpc-3672	17	18	relationship	relationship	NOUN
dpc-3672	17	19	of	of	ADP
dpc-3672	17	20	these	these	DET
dpc-3672	17	21	levels	level	NOUN
dpc-3672	17	22	with	with	ADP
dpc-3672	17	23	the	the	DET
dpc-3672	17	24	characteristics	characteristic	NOUN
dpc-3672	17	25	of	of	ADP
dpc-3672	17	26	vitiligo	vitiligo	NOUN
dpc-3672	17	27	.	.	PUNCT
dpc-3672	18	1	results	result	NOUN
dpc-3672	18	2	:	:	PUNCT
dpc-3672	18	3	patients	patient	NOUN
dpc-3672	18	4	had	have	VERB
dpc-3672	18	5	higher	high	ADJ
dpc-3672	18	6	levels	level	NOUN
dpc-3672	18	7	of	of	ADP
dpc-3672	18	8	il-12	il-12	NOUN
dpc-3672	18	9	(	(	PUNCT
dpc-3672	18	10	31.2	31.2	NUM
dpc-3672	18	11	versus	versus	ADP
dpc-3672	18	12	20.1	20.1	NUM
dpc-3672	18	13	,	,	PUNCT
dpc-3672	18	14	p	p	X
dpc-3672	18	15	<	<	X
dpc-3672	18	16	0.001	0.001	NUM
dpc-3672	18	17	)	)	PUNCT
dpc-3672	18	18	and	and	CCONJ
dpc-3672	18	19	il-35	il-35	ADP
dpc-3672	18	20	(	(	PUNCT
dpc-3672	18	21	9.6	9.6	NUM
dpc-3672	18	22	versus	versus	ADP
dpc-3672	18	23	8.1	8.1	NUM
dpc-3672	18	24	,	,	PUNCT
dpc-3672	18	25	p	p	X
dpc-3672	18	26	=	=	NOUN
dpc-3672	18	27	0.031	0.031	NUM
dpc-3672	18	28	)	)	PUNCT
dpc-3672	18	29	.	.	PUNCT
dpc-3672	19	1	patient	patient	NOUN
dpc-3672	19	2	and	and	CCONJ
dpc-3672	19	3	control	control	NOUN
dpc-3672	19	4	groups	group	NOUN
dpc-3672	19	5	had	have	VERB
dpc-3672	19	6	similar	similar	ADJ
dpc-3672	19	7	levels	level	NOUN
dpc-3672	19	8	of	of	ADP
dpc-3672	19	9	il-23	il-23	NOUN
dpc-3672	19	10	(	(	PUNCT
dpc-3672	19	11	p	p	X
dpc-3672	19	12	=	=	NOUN
dpc-3672	19	13	0.78	0.78	NUM
dpc-3672	19	14	)	)	PUNCT
dpc-3672	19	15	but	but	CCONJ
dpc-3672	19	16	were	be	AUX
dpc-3672	19	17	correlated	correlate	VERB
dpc-3672	19	18	with	with	ADP
dpc-3672	19	19	the	the	DET
dpc-3672	19	20	vitiligo	vitiligo	NOUN
dpc-3672	19	21	area	area	NOUN
dpc-3672	19	22	scoring	scoring	NOUN
dpc-3672	19	23	index	index	NOUN
dpc-3672	19	24	(	(	PUNCT
dpc-3672	19	25	vasi	vasi	PROPN
dpc-3672	19	26	)	)	PUNCT
dpc-3672	19	27	(	(	PUNCT
dpc-3672	19	28	p	p	X
dpc-3672	19	29	=	=	NOUN
dpc-3672	19	30	0.022	0.022	NUM
dpc-3672	19	31	,	,	PUNCT
dpc-3672	19	32	r	r	NOUN
dpc-3672	19	33	=	=	NOUN
dpc-3672	19	34	0.35	0.35	NUM
dpc-3672	19	35	)	)	PUNCT
dpc-3672	19	36	.	.	PUNCT
dpc-3672	20	1	patients	patient	NOUN
dpc-3672	20	2	had	have	VERB
dpc-3672	20	3	lower	low	ADJ
dpc-3672	20	4	levels	level	NOUN
dpc-3672	20	5	of	of	ADP
dpc-3672	20	6	il-27	il-27	PROPN
dpc-3672	20	7	(	(	PUNCT
dpc-3672	20	8	207.6	207.6	NUM
dpc-3672	20	9	versus	versus	ADP
dpc-3672	20	10	258.7	258.7	NUM
dpc-3672	20	11	,	,	PUNCT
dpc-3672	20	12	p	p	X
dpc-3672	20	13	<	<	X
dpc-3672	20	14	0.001	0.001	NUM
dpc-3672	20	15	)	)	PUNCT
dpc-3672	20	16	.	.	PUNCT
dpc-3672	21	1	in	in	ADP
dpc-3672	21	2	addition	addition	NOUN
dpc-3672	21	3	,	,	PUNCT
dpc-3672	21	4	the	the	DET
dpc-3672	21	5	levels	level	NOUN
dpc-3672	21	6	of	of	ADP
dpc-3672	21	7	serum	serum	NOUN
dpc-3672	21	8	il-27	il-27	ADV
dpc-3672	21	9	were	be	AUX
dpc-3672	21	10	correlated	correlate	VERB
dpc-3672	21	11	negatively	negatively	ADV
dpc-3672	21	12	with	with	ADP
dpc-3672	21	13	the	the	DET
dpc-3672	21	14	vitiligo	vitiligo	NOUN
dpc-3672	21	15	disease	disease	NOUN
dpc-3672	21	16	activity	activity	NOUN
dpc-3672	21	17	(	(	PUNCT
dpc-3672	21	18	vida	vida	NOUN
dpc-3672	21	19	)	)	PUNCT
dpc-3672	21	20	,	,	PUNCT
dpc-3672	21	21	and	and	CCONJ
dpc-3672	21	22	positively	positively	ADV
dpc-3672	21	23	with	with	ADP
dpc-3672	21	24	disease	disease	NOUN
dpc-3672	21	25	duration	duration	NOUN
dpc-3672	21	26	(	(	PUNCT
dpc-3672	21	27	p	p	X
dpc-3672	21	28	=	=	PROPN
dpc-3672	21	29	0.007	0.007	NUM
dpc-3672	21	30	,	,	PUNCT
dpc-3672	21	31	r	r	NOUN
dpc-3672	21	32	=	=	NOUN
dpc-3672	21	33	0.30	0.30	NUM
dpc-3672	21	34	)	)	PUNCT
dpc-3672	21	35	.	.	PUNCT
dpc-3672	22	1	conclusions	conclusion	NOUN
dpc-3672	22	2	:	:	PUNCT
dpc-3672	22	3	differences	difference	NOUN
dpc-3672	22	4	of	of	ADP
dpc-3672	22	5	serum	serum	NOUN
dpc-3672	22	6	levels	level	NOUN
dpc-3672	22	7	between	between	ADP
dpc-3672	22	8	vitiligo	vitiligo	NOUN
dpc-3672	22	9	patients	patient	NOUN
dpc-3672	22	10	and	and	CCONJ
dpc-3672	22	11	healthy	healthy	ADJ
dpc-3672	22	12	controls	control	NOUN
dpc-3672	22	13	,	,	PUNCT
dpc-3672	22	14	significant	significant	ADJ
dpc-3672	22	15	relationships	relationship	NOUN
dpc-3672	22	16	with	with	ADP
dpc-3672	22	17	the	the	DET
dpc-3672	22	18	characteristics	characteristic	NOUN
dpc-3672	22	19	of	of	ADP
dpc-3672	22	20	vitiligo	vitiligo	NOUN
dpc-3672	22	21	suggest	suggest	VERB
dpc-3672	22	22	that	that	SCONJ
dpc-3672	22	23	the	the	DET
dpc-3672	22	24	il-12	il-12	DET
dpc-3672	22	25	cytokine	cytokine	ADJ
dpc-3672	22	26	family	family	NOUN
dpc-3672	22	27	may	may	AUX
dpc-3672	22	28	play	play	VERB
dpc-3672	22	29	a	a	DET
dpc-3672	22	30	role	role	NOUN
dpc-3672	22	31	in	in	ADP
dpc-3672	22	32	the	the	DET
dpc-3672	22	33	pathogenesis	pathogenesis	NOUN
dpc-3672	22	34	of	of	ADP
dpc-3672	22	35	vitiligo	vitiligo	NOUN
dpc-3672	22	36	.	.	PUNCT
dpc-3672	23	1	abstract	abstract	ADJ
dpc-3672	23	2	2	2	NUM
dpc-3672	23	3	original	original	ADJ
dpc-3672	23	4	article	article	NOUN
dpc-3672	23	5	|	|	ADV
dpc-3672	23	6	dermatol	dermatol	ADJ
dpc-3672	23	7	pract	pract	NOUN
dpc-3672	23	8	concept	concept	NOUN
dpc-3672	23	9	.	.	PUNCT
dpc-3672	24	1	2024;14(2):e2024069	2024;14(2):e2024069	NUM
dpc-3672	24	2	introduction	introduction	NOUN
dpc-3672	24	3	vitiligo	vitiligo	NOUN
dpc-3672	24	4	is	be	AUX
dpc-3672	24	5	an	an	DET
dpc-3672	24	6	autoimmune	autoimmune	ADJ
dpc-3672	24	7	disorder	disorder	NOUN
dpc-3672	24	8	characterized	characterize	VERB
dpc-3672	24	9	by	by	ADP
dpc-3672	24	10	depigmented	depigmented	ADJ
dpc-3672	24	11	patches	patch	NOUN
dpc-3672	24	12	on	on	ADP
dpc-3672	24	13	the	the	DET
dpc-3672	24	14	skin	skin	NOUN
dpc-3672	24	15	,	,	PUNCT
dpc-3672	24	16	skin	skin	NOUN
dpc-3672	24	17	appendages	appendage	NOUN
dpc-3672	24	18	and	and	CCONJ
dpc-3672	24	19	mucous	mucous	ADJ
dpc-3672	24	20	membranes	membrane	NOUN
dpc-3672	24	21	.	.	PUNCT
dpc-3672	25	1	its	its	PRON
dpc-3672	25	2	frequency	frequency	NOUN
dpc-3672	25	3	is	be	AUX
dpc-3672	25	4	approximately	approximately	ADV
dpc-3672	25	5	1	1	NUM
dpc-3672	25	6	%	%	NOUN
dpc-3672	25	7	.	.	PUNCT
dpc-3672	26	1	although	although	SCONJ
dpc-3672	26	2	vitiligo	vitiligo	NOUN
dpc-3672	26	3	most	most	ADV
dpc-3672	26	4	commonly	commonly	ADV
dpc-3672	26	5	develops	develop	VERB
dpc-3672	26	6	before	before	ADP
dpc-3672	26	7	the	the	DET
dpc-3672	26	8	second	second	ADJ
dpc-3672	26	9	decade	decade	NOUN
dpc-3672	26	10	,	,	PUNCT
dpc-3672	26	11	it	it	PRON
dpc-3672	26	12	can	can	AUX
dpc-3672	26	13	occur	occur	VERB
dpc-3672	26	14	in	in	ADP
dpc-3672	26	15	any	any	DET
dpc-3672	26	16	age	age	NOUN
dpc-3672	26	17	group	group	NOUN
dpc-3672	26	18	[	[	X
dpc-3672	26	19	1	1	NUM
dpc-3672	26	20	]	]	PUNCT
dpc-3672	26	21	.	.	PUNCT
dpc-3672	27	1	even	even	ADV
dpc-3672	27	2	if	if	SCONJ
dpc-3672	27	3	it	it	PRON
dpc-3672	27	4	is	be	AUX
dpc-3672	27	5	not	not	PART
dpc-3672	27	6	mortal	mortal	ADJ
dpc-3672	27	7	,	,	PUNCT
dpc-3672	27	8	it	it	PRON
dpc-3672	27	9	may	may	AUX
dpc-3672	27	10	cause	cause	VERB
dpc-3672	27	11	many	many	ADJ
dpc-3672	27	12	psychological	psychological	ADJ
dpc-3672	27	13	problems	problem	NOUN
dpc-3672	27	14	including	include	VERB
dpc-3672	27	15	anxiety	anxiety	NOUN
dpc-3672	27	16	,	,	PUNCT
dpc-3672	27	17	depression	depression	NOUN
dpc-3672	27	18	and	and	CCONJ
dpc-3672	27	19	sleep	sleep	VERB
dpc-3672	27	20	disorders	disorder	NOUN
dpc-3672	27	21	that	that	PRON
dpc-3672	27	22	seriously	seriously	ADV
dpc-3672	27	23	affects	affect	VERB
dpc-3672	27	24	the	the	DET
dpc-3672	27	25	quality	quality	NOUN
dpc-3672	27	26	of	of	ADP
dpc-3672	27	27	life	life	NOUN
dpc-3672	27	28	[	[	X
dpc-3672	27	29	1,2	1,2	NUM
dpc-3672	27	30	]	]	PUNCT
dpc-3672	27	31	.	.	PUNCT
dpc-3672	28	1	the	the	DET
dpc-3672	28	2	pathogenesis	pathogenesis	NOUN
dpc-3672	28	3	of	of	ADP
dpc-3672	28	4	vitiligo	vitiligo	NOUN
dpc-3672	28	5	has	have	AUX
dpc-3672	28	6	not	not	PART
dpc-3672	28	7	been	be	AUX
dpc-3672	28	8	fully	fully	ADV
dpc-3672	28	9	defined	define	VERB
dpc-3672	28	10	but	but	CCONJ
dpc-3672	28	11	oxidative	oxidative	ADJ
dpc-3672	28	12	stress	stress	NOUN
dpc-3672	28	13	and	and	CCONJ
dpc-3672	28	14	immune	immune	ADJ
dpc-3672	28	15	dysregulation	dysregulation	NOUN
dpc-3672	28	16	are	be	AUX
dpc-3672	28	17	thought	think	VERB
dpc-3672	28	18	to	to	PART
dpc-3672	28	19	be	be	AUX
dpc-3672	28	20	the	the	DET
dpc-3672	28	21	fundamental	fundamental	ADJ
dpc-3672	28	22	causes	cause	NOUN
dpc-3672	28	23	of	of	ADP
dpc-3672	28	24	vitiligo	vitiligo	NOUN
dpc-3672	28	25	in	in	ADP
dpc-3672	28	26	genetically	genetically	ADV
dpc-3672	28	27	predisposed	predispose	VERB
dpc-3672	28	28	individuals	individual	NOUN
dpc-3672	29	1	[	[	X
dpc-3672	29	2	3	3	NUM
dpc-3672	29	3	]	]	PUNCT
dpc-3672	29	4	.	.	PUNCT
dpc-3672	30	1	oxidative	oxidative	ADJ
dpc-3672	30	2	stress	stress	NOUN
dpc-3672	30	3	and	and	CCONJ
dpc-3672	30	4	similar	similar	ADJ
dpc-3672	30	5	other	other	ADJ
dpc-3672	30	6	internal	internal	ADJ
dpc-3672	30	7	and	and	CCONJ
dpc-3672	30	8	external	external	ADJ
dpc-3672	30	9	stimuli	stimulus	NOUN
dpc-3672	30	10	cause	cause	VERB
dpc-3672	30	11	the	the	DET
dpc-3672	30	12	release	release	NOUN
dpc-3672	30	13	of	of	ADP
dpc-3672	30	14	inflammatory	inflammatory	ADJ
dpc-3672	30	15	cytokines	cytokine	NOUN
dpc-3672	30	16	,	,	PUNCT
dpc-3672	30	17	which	which	PRON
dpc-3672	30	18	in	in	ADP
dpc-3672	30	19	turn	turn	NOUN
dpc-3672	30	20	stimulates	stimulate	VERB
dpc-3672	30	21	the	the	DET
dpc-3672	30	22	innate	innate	ADJ
dpc-3672	30	23	immune	immune	ADJ
dpc-3672	30	24	response	response	NOUN
dpc-3672	30	25	,	,	PUNCT
dpc-3672	30	26	and	and	CCONJ
dpc-3672	30	27	a	a	DET
dpc-3672	30	28	series	series	NOUN
dpc-3672	30	29	of	of	ADP
dpc-3672	30	30	reactions	reaction	NOUN
dpc-3672	30	31	that	that	PRON
dpc-3672	30	32	result	result	VERB
dpc-3672	30	33	in	in	ADP
dpc-3672	30	34	the	the	DET
dpc-3672	30	35	activation	activation	NOUN
dpc-3672	30	36	of	of	ADP
dpc-3672	30	37	adaptive	adaptive	ADJ
dpc-3672	30	38	immune	immune	ADJ
dpc-3672	30	39	response	response	NOUN
dpc-3672	30	40	and	and	CCONJ
dpc-3672	30	41	autoreactive	autoreactive	ADJ
dpc-3672	30	42	cd8	cd8	PROPN
dpc-3672	30	43	+	+	PROPN
dpc-3672	30	44	t	t	PROPN
dpc-3672	30	45	cells	cell	NOUN
dpc-3672	30	46	[	[	X
dpc-3672	30	47	3	3	NUM
dpc-3672	30	48	]	]	PUNCT
dpc-3672	30	49	.	.	PUNCT
dpc-3672	31	1	the	the	DET
dpc-3672	31	2	role	role	NOUN
dpc-3672	31	3	of	of	ADP
dpc-3672	31	4	interleukins	interleukin	NOUN
dpc-3672	31	5	in	in	ADP
dpc-3672	31	6	the	the	DET
dpc-3672	31	7	pathogenesis	pathogenesis	NOUN
dpc-3672	31	8	of	of	ADP
dpc-3672	31	9	vitiligo	vitiligo	NOUN
dpc-3672	31	10	is	be	AUX
dpc-3672	31	11	also	also	ADV
dpc-3672	31	12	well	well	ADV
dpc-3672	31	13	known	know	VERB
dpc-3672	31	14	.	.	PUNCT
dpc-3672	32	1	many	many	ADJ
dpc-3672	32	2	interleukins	interleukin	NOUN
dpc-3672	32	3	including	include	VERB
dpc-3672	32	4	primarily	primarily	ADV
dpc-3672	32	5	il-17	il-17	NUM
dpc-3672	32	6	,	,	PUNCT
dpc-3672	32	7	and	and	CCONJ
dpc-3672	32	8	il-1	il-1	PROPN
dpc-3672	32	9	,	,	PUNCT
dpc-3672	32	10	il-2	il-2	NUM
dpc-3672	32	11	,	,	PUNCT
dpc-3672	32	12	il-4	il-4	NOUN
dpc-3672	32	13	,	,	PUNCT
dpc-3672	32	14	il-6	il-6	NOUN
dpc-3672	32	15	,	,	PUNCT
dpc-3672	32	16	il-8	il-8	NOUN
dpc-3672	32	17	,	,	PUNCT
dpc-3672	32	18	il-10	il-10	PRON
dpc-3672	32	19	,	,	PUNCT
dpc-3672	32	20	il-13	il-13	NUM
dpc-3672	32	21	,	,	PUNCT
dpc-3672	32	22	il-19	il-19	PRON
dpc-3672	32	23	,	,	PUNCT
dpc-3672	32	24	il-23	il-23	NOUN
dpc-3672	32	25	and	and	CCONJ
dpc-3672	32	26	il-33	il-33	ADJ
dpc-3672	32	27	have	have	AUX
dpc-3672	32	28	been	be	AUX
dpc-3672	32	29	examined	examine	VERB
dpc-3672	32	30	in	in	ADP
dpc-3672	32	31	vitiligo	vitiligo	NOUN
dpc-3672	32	32	patients	patient	NOUN
dpc-3672	32	33	.	.	PUNCT
dpc-3672	33	1	significant	significant	ADJ
dpc-3672	33	2	relations	relation	NOUN
dpc-3672	33	3	have	have	AUX
dpc-3672	33	4	been	be	AUX
dpc-3672	33	5	shown	show	VERB
dpc-3672	33	6	between	between	ADP
dpc-3672	33	7	the	the	DET
dpc-3672	33	8	dysregulation	dysregulation	NOUN
dpc-3672	33	9	of	of	ADP
dpc-3672	33	10	interleukin	interleukin	NOUN
dpc-3672	33	11	levels	level	NOUN
dpc-3672	33	12	and	and	CCONJ
dpc-3672	33	13	clinical	clinical	ADJ
dpc-3672	33	14	factors	factor	NOUN
dpc-3672	33	15	such	such	ADJ
dpc-3672	33	16	as	as	ADP
dpc-3672	33	17	the	the	DET
dpc-3672	33	18	degree	degree	NOUN
dpc-3672	33	19	and	and	CCONJ
dpc-3672	33	20	extensiveness	extensiveness	NOUN
dpc-3672	33	21	of	of	ADP
dpc-3672	33	22	the	the	DET
dpc-3672	33	23	disease	disease	NOUN
dpc-3672	33	24	[	[	X
dpc-3672	33	25	4	4	NUM
dpc-3672	33	26	]	]	PUNCT
dpc-3672	33	27	.	.	PUNCT
dpc-3672	34	1	the	the	DET
dpc-3672	34	2	il-12	il-12	DET
dpc-3672	34	3	family	family	NOUN
dpc-3672	34	4	consists	consist	VERB
dpc-3672	34	5	of	of	ADP
dpc-3672	34	6	il-12	il-12	NOUN
dpc-3672	34	7	,	,	PUNCT
dpc-3672	34	8	il-23	il-23	NOUN
dpc-3672	34	9	,	,	PUNCT
dpc-3672	34	10	il-27	il-27	NUM
dpc-3672	34	11	,	,	PUNCT
dpc-3672	34	12	and	and	CCONJ
dpc-3672	34	13	il-35	il-35	ADP
dpc-3672	34	14	[	[	X
dpc-3672	34	15	5,6	5,6	NUM
dpc-3672	34	16	]	]	PUNCT
dpc-3672	34	17	.	.	PUNCT
dpc-3672	35	1	these	these	DET
dpc-3672	35	2	cytokines	cytokine	NOUN
dpc-3672	35	3	are	be	AUX
dpc-3672	35	4	heterodimeric	heterodimeric	ADJ
dpc-3672	35	5	and	and	CCONJ
dpc-3672	35	6	consist	consist	VERB
dpc-3672	35	7	of	of	ADP
dpc-3672	35	8	an	an	DET
dpc-3672	35	9	alpha	alpha	NOUN
dpc-3672	35	10	subunit	subunit	NOUN
dpc-3672	35	11	(	(	PUNCT
dpc-3672	35	12	p19	p19	NOUN
dpc-3672	35	13	,	,	PUNCT
dpc-3672	35	14	p35	p35	NOUN
dpc-3672	35	15	,	,	PUNCT
dpc-3672	35	16	or	or	CCONJ
dpc-3672	35	17	p28	p28	NOUN
dpc-3672	35	18	)	)	PUNCT
dpc-3672	35	19	and	and	CCONJ
dpc-3672	35	20	a	a	DET
dpc-3672	35	21	beta	beta	ADJ
dpc-3672	35	22	subunit	subunit	NOUN
dpc-3672	35	23	(	(	PUNCT
dpc-3672	35	24	p40	p40	NOUN
dpc-3672	35	25	or	or	CCONJ
dpc-3672	35	26	epstein	epstein	PROPN
dpc-3672	35	27	-	-	PUNCT
dpc-3672	35	28	barr	barr	PROPN
dpc-3672	35	29	virus	virus	PROPN
dpc-3672	35	30	induced	induce	VERB
dpc-3672	35	31	gene	gene	NOUN
dpc-3672	35	32	3	3	NUM
dpc-3672	35	33	,	,	PUNCT
dpc-3672	35	34	ebi3	ebi3	PROPN
dpc-3672	35	35	)	)	PUNCT
dpc-3672	36	1	[	[	X
dpc-3672	36	2	5	5	NUM
dpc-3672	36	3	]	]	PUNCT
dpc-3672	36	4	.	.	PUNCT
dpc-3672	37	1	cytokines	cytokine	NOUN
dpc-3672	37	2	of	of	ADP
dpc-3672	37	3	the	the	DET
dpc-3672	37	4	il-12	il-12	DET
dpc-3672	37	5	family	family	NOUN
dpc-3672	37	6	bind	bind	VERB
dpc-3672	37	7	to	to	ADP
dpc-3672	37	8	heterodimeric	heterodimeric	ADJ
dpc-3672	37	9	receptors	receptor	NOUN
dpc-3672	37	10	and	and	CCONJ
dpc-3672	37	11	act	act	VERB
dpc-3672	37	12	through	through	ADP
dpc-3672	37	13	the	the	DET
dpc-3672	37	14	jak	jak	PROPN
dpc-3672	37	15	-	-	PUNCT
dpc-3672	37	16	stat	stat	PROPN
dpc-3672	37	17	signaling	signal	VERB
dpc-3672	37	18	pathway	pathway	NOUN
dpc-3672	37	19	[	[	X
dpc-3672	37	20	5	5	NUM
dpc-3672	37	21	]	]	PUNCT
dpc-3672	37	22	.	.	PUNCT
dpc-3672	38	1	although	although	SCONJ
dpc-3672	38	2	,	,	PUNCT
dpc-3672	38	3	the	the	DET
dpc-3672	38	4	members	member	NOUN
dpc-3672	38	5	of	of	ADP
dpc-3672	38	6	this	this	DET
dpc-3672	38	7	cytokine	cytokine	ADJ
dpc-3672	38	8	family	family	NOUN
dpc-3672	38	9	have	have	VERB
dpc-3672	38	10	common	common	ADJ
dpc-3672	38	11	subunits	subunit	NOUN
dpc-3672	38	12	in	in	ADP
dpc-3672	38	13	its	its	PRON
dpc-3672	38	14	structure	structure	NOUN
dpc-3672	38	15	and	and	CCONJ
dpc-3672	38	16	receptors	receptor	NOUN
dpc-3672	38	17	,	,	PUNCT
dpc-3672	38	18	they	they	PRON
dpc-3672	38	19	have	have	VERB
dpc-3672	38	20	different	different	ADJ
dpc-3672	38	21	functions	function	NOUN
dpc-3672	38	22	.	.	PUNCT
dpc-3672	39	1	il-12	il-12	NOUN
dpc-3672	39	2	,	,	PUNCT
dpc-3672	39	3	il-23	il-23	NOUN
dpc-3672	39	4	,	,	PUNCT
dpc-3672	39	5	il-27	il-27	PUNCT
dpc-3672	39	6	and	and	CCONJ
dpc-3672	39	7	il-35	il-35	ADV
dpc-3672	39	8	may	may	AUX
dpc-3672	39	9	have	have	VERB
dpc-3672	39	10	pro	pro	ADJ
dpc-3672	39	11	-	-	ADJ
dpc-3672	39	12	inflammatory	inflammatory	ADJ
dpc-3672	39	13	or	or	CCONJ
dpc-3672	39	14	anti	anti	ADJ
dpc-3672	39	15	-	-	ADJ
dpc-3672	39	16	inflammatory	inflammatory	ADJ
dpc-3672	39	17	effects	effect	NOUN
dpc-3672	39	18	by	by	ADP
dpc-3672	39	19	affecting	affect	VERB
dpc-3672	39	20	different	different	ADJ
dpc-3672	39	21	t	t	NOUN
dpc-3672	39	22	lymphocyte	lymphocyte	NOUN
dpc-3672	39	23	subsets	subset	NOUN
dpc-3672	39	24	.	.	PUNCT
dpc-3672	40	1	il-12	il-12	NOUN
dpc-3672	40	2	and	and	CCONJ
dpc-3672	40	3	il-23	il-23	NOUN
dpc-3672	40	4	are	be	AUX
dpc-3672	40	5	mostly	mostly	ADV
dpc-3672	40	6	proinflammatory	proinflammatory	ADJ
dpc-3672	40	7	,	,	PUNCT
dpc-3672	40	8	il-35	il-35	ADP
dpc-3672	40	9	is	be	AUX
dpc-3672	40	10	mostly	mostly	ADV
dpc-3672	40	11	anti	anti	ADJ
dpc-3672	40	12	-	-	ADJ
dpc-3672	40	13	inflammatory	inflammatory	ADJ
dpc-3672	40	14	,	,	PUNCT
dpc-3672	40	15	while	while	SCONJ
dpc-3672	40	16	il-27	il-27	ADV
dpc-3672	40	17	shows	show	VERB
dpc-3672	40	18	pro	pro	ADJ
dpc-3672	40	19	inflammatory	inflammatory	ADJ
dpc-3672	40	20	and	and	CCONJ
dpc-3672	40	21	anti	anti	ADJ
dpc-3672	40	22	-	-	ADJ
dpc-3672	40	23	inflammatory	inflammatory	ADJ
dpc-3672	40	24	properties	property	NOUN
dpc-3672	40	25	at	at	ADP
dpc-3672	40	26	different	different	ADJ
dpc-3672	40	27	times	time	NOUN
dpc-3672	41	1	[	[	X
dpc-3672	41	2	5,6	5,6	NUM
dpc-3672	41	3	]	]	PUNCT
dpc-3672	41	4	.	.	PUNCT
dpc-3672	42	1	although	although	SCONJ
dpc-3672	42	2	the	the	DET
dpc-3672	42	3	il-12	il-12	DET
dpc-3672	42	4	cytokine	cytokine	ADJ
dpc-3672	42	5	family	family	NOUN
dpc-3672	42	6	has	have	AUX
dpc-3672	42	7	been	be	AUX
dpc-3672	42	8	studied	study	VERB
dpc-3672	42	9	in	in	ADP
dpc-3672	42	10	many	many	ADJ
dpc-3672	42	11	inflammatory	inflammatory	ADJ
dpc-3672	42	12	and	and	CCONJ
dpc-3672	42	13	neoplastic	neoplastic	ADJ
dpc-3672	42	14	diseases	disease	NOUN
dpc-3672	42	15	,	,	PUNCT
dpc-3672	42	16	few	few	ADJ
dpc-3672	42	17	studies	study	NOUN
dpc-3672	42	18	investigate	investigate	VERB
dpc-3672	42	19	its	its	PRON
dpc-3672	42	20	effects	effect	NOUN
dpc-3672	42	21	on	on	ADP
dpc-3672	42	22	vitiligo	vitiligo	NOUN
dpc-3672	42	23	,	,	PUNCT
dpc-3672	42	24	and	and	CCONJ
dpc-3672	42	25	major	major	ADJ
dpc-3672	42	26	differences	difference	NOUN
dpc-3672	42	27	were	be	AUX
dpc-3672	42	28	found	find	VERB
dpc-3672	42	29	between	between	ADP
dpc-3672	42	30	the	the	DET
dpc-3672	42	31	results	result	NOUN
dpc-3672	42	32	of	of	ADP
dpc-3672	42	33	those	those	DET
dpc-3672	42	34	studies	study	NOUN
dpc-3672	42	35	[	[	X
dpc-3672	42	36	7	7	NUM
dpc-3672	42	37	]	]	PUNCT
dpc-3672	42	38	.	.	PUNCT
dpc-3672	43	1	objectives	objective	VERB
dpc-3672	43	2	the	the	DET
dpc-3672	43	3	purpose	purpose	NOUN
dpc-3672	43	4	of	of	ADP
dpc-3672	43	5	the	the	DET
dpc-3672	43	6	present	present	ADJ
dpc-3672	43	7	study	study	NOUN
dpc-3672	43	8	was	be	AUX
dpc-3672	43	9	to	to	PART
dpc-3672	43	10	investigate	investigate	VERB
dpc-3672	43	11	the	the	DET
dpc-3672	43	12	levels	level	NOUN
dpc-3672	43	13	of	of	ADP
dpc-3672	43	14	serum	serum	NOUN
dpc-3672	43	15	il-12	il-12	NOUN
dpc-3672	43	16	,	,	PUNCT
dpc-3672	43	17	il-23	il-23	NOUN
dpc-3672	43	18	,	,	PUNCT
dpc-3672	43	19	il-27	il-27	PUNCT
dpc-3672	43	20	and	and	CCONJ
dpc-3672	43	21	il-35	il-35	VERB
dpc-3672	43	22	in	in	ADP
dpc-3672	43	23	patients	patient	NOUN
dpc-3672	43	24	with	with	ADP
dpc-3672	43	25	vitiligo	vitiligo	NOUN
dpc-3672	43	26	compared	compare	VERB
dpc-3672	43	27	to	to	ADP
dpc-3672	43	28	healthy	healthy	ADJ
dpc-3672	43	29	controls	control	NOUN
dpc-3672	43	30	,	,	PUNCT
dpc-3672	43	31	and	and	CCONJ
dpc-3672	43	32	identify	identify	VERB
dpc-3672	43	33	the	the	DET
dpc-3672	43	34	relations	relation	NOUN
dpc-3672	43	35	between	between	ADP
dpc-3672	43	36	cytokine	cytokine	ADJ
dpc-3672	43	37	levels	level	NOUN
dpc-3672	43	38	and	and	CCONJ
dpc-3672	43	39	clinical	clinical	ADJ
dpc-3672	43	40	features	feature	NOUN
dpc-3672	43	41	.	.	PUNCT
dpc-3672	44	1	methods	method	NOUN
dpc-3672	44	2	eighty	eighty	NUM
dpc-3672	44	3	-	-	PUNCT
dpc-3672	44	4	seven	seven	NUM
dpc-3672	44	5	(	(	PUNCT
dpc-3672	44	6	52	52	NUM
dpc-3672	44	7	females	female	NOUN
dpc-3672	44	8	,	,	PUNCT
dpc-3672	44	9	35	35	NUM
dpc-3672	44	10	males	male	NOUN
dpc-3672	44	11	)	)	PUNCT
dpc-3672	44	12	vitiligo	vitiligo	NOUN
dpc-3672	44	13	patients	patient	NOUN
dpc-3672	44	14	and	and	CCONJ
dpc-3672	44	15	70	70	NUM
dpc-3672	44	16	healthy	healthy	ADJ
dpc-3672	44	17	controls	control	NOUN
dpc-3672	44	18	were	be	AUX
dpc-3672	44	19	included	include	VERB
dpc-3672	44	20	in	in	ADP
dpc-3672	44	21	the	the	DET
dpc-3672	44	22	study.patient	study.patient	NOUN
dpc-3672	44	23	and	and	CCONJ
dpc-3672	44	24	control	control	NOUN
dpc-3672	44	25	groups	group	NOUN
dpc-3672	44	26	were	be	AUX
dpc-3672	44	27	similar	similar	ADJ
dpc-3672	44	28	in	in	ADP
dpc-3672	44	29	terms	term	NOUN
dpc-3672	44	30	of	of	ADP
dpc-3672	44	31	age	age	NOUN
dpc-3672	44	32	and	and	CCONJ
dpc-3672	44	33	sex	sex	NOUN
dpc-3672	44	34	(	(	PUNCT
dpc-3672	44	35	p	p	X
dpc-3672	44	36	=	=	NOUN
dpc-3672	44	37	0.51	0.51	NUM
dpc-3672	44	38	and	and	CCONJ
dpc-3672	44	39	0.39	0.39	NUM
dpc-3672	44	40	,	,	PUNCT
dpc-3672	44	41	respectively	respectively	ADV
dpc-3672	44	42	)	)	PUNCT
dpc-3672	44	43	.	.	PUNCT
dpc-3672	45	1	the	the	DET
dpc-3672	45	2	patients	patient	NOUN
dpc-3672	45	3	were	be	AUX
dpc-3672	45	4	clinically	clinically	ADV
dpc-3672	45	5	diagnosed	diagnose	VERB
dpc-3672	45	6	with	with	ADP
dpc-3672	45	7	vitiligo	vitiligo	NOUN
dpc-3672	45	8	.	.	PUNCT
dpc-3672	46	1	patients	patient	NOUN
dpc-3672	46	2	who	who	PRON
dpc-3672	46	3	came	come	VERB
dpc-3672	46	4	to	to	ADP
dpc-3672	46	5	the	the	DET
dpc-3672	46	6	dermatology	dermatology	NOUN
dpc-3672	46	7	outpatient	outpatient	NOUN
dpc-3672	46	8	clinic	clinic	NOUN
dpc-3672	46	9	with	with	ADP
dpc-3672	46	10	complaints	complaint	NOUN
dpc-3672	46	11	of	of	ADP
dpc-3672	46	12	skin	skin	NOUN
dpc-3672	46	13	discoloration	discoloration	NOUN
dpc-3672	46	14	were	be	AUX
dpc-3672	46	15	evaluated	evaluate	VERB
dpc-3672	46	16	.	.	PUNCT
dpc-3672	47	1	patients	patient	NOUN
dpc-3672	47	2	with	with	ADP
dpc-3672	47	3	hypopigmented	hypopigmented	ADJ
dpc-3672	47	4	/	/	SYM
dpc-3672	47	5	depigmented	depigmente	VERB
dpc-3672	47	6	macules	macule	NOUN
dpc-3672	47	7	and	and	CCONJ
dpc-3672	47	8	patches	patch	NOUN
dpc-3672	47	9	were	be	AUX
dpc-3672	47	10	examined	examine	VERB
dpc-3672	47	11	under	under	ADP
dpc-3672	47	12	wood	wood	NOUN
dpc-3672	47	13	light	light	NOUN
dpc-3672	47	14	,	,	PUNCT
dpc-3672	47	15	and	and	CCONJ
dpc-3672	47	16	patients	patient	NOUN
dpc-3672	47	17	with	with	ADP
dpc-3672	47	18	depigmented	depigmented	ADJ
dpc-3672	47	19	patches	patch	NOUN
dpc-3672	47	20	matching	match	VERB
dpc-3672	47	21	the	the	DET
dpc-3672	47	22	definition	definition	NOUN
dpc-3672	47	23	of	of	ADP
dpc-3672	47	24	vitiligo	vitiligo	NOUN
dpc-3672	47	25	were	be	AUX
dpc-3672	47	26	included	include	VERB
dpc-3672	47	27	in	in	ADP
dpc-3672	47	28	the	the	DET
dpc-3672	47	29	study	study	NOUN
dpc-3672	47	30	.	.	PUNCT
dpc-3672	48	1	patients	patient	NOUN
dpc-3672	48	2	with	with	ADP
dpc-3672	48	3	lesions	lesion	NOUN
dpc-3672	48	4	spreading	spread	VERB
dpc-3672	48	5	segmentally	segmentally	ADV
dpc-3672	48	6	were	be	AUX
dpc-3672	48	7	excluded	exclude	VERB
dpc-3672	48	8	from	from	ADP
dpc-3672	48	9	the	the	DET
dpc-3672	48	10	study	study	NOUN
dpc-3672	48	11	even	even	ADV
dpc-3672	48	12	if	if	SCONJ
dpc-3672	48	13	they	they	PRON
dpc-3672	48	14	were	be	AUX
dpc-3672	48	15	diagnosed	diagnose	VERB
dpc-3672	48	16	with	with	ADP
dpc-3672	48	17	vitiligo	vitiligo	PROPN
dpc-3672	48	18	.	.	PUNCT
dpc-3672	49	1	vitiligo	vitiligo	NOUN
dpc-3672	49	2	activity	activity	NOUN
dpc-3672	49	3	and	and	CCONJ
dpc-3672	49	4	severity	severity	NOUN
dpc-3672	49	5	index	index	NOUN
dpc-3672	49	6	(	(	PUNCT
dpc-3672	49	7	vasi	vasi	PROPN
dpc-3672	49	8	)	)	PUNCT
dpc-3672	49	9	was	be	AUX
dpc-3672	49	10	used	use	VERB
dpc-3672	49	11	to	to	PART
dpc-3672	49	12	determine	determine	VERB
dpc-3672	49	13	the	the	DET
dpc-3672	49	14	extent	extent	NOUN
dpc-3672	49	15	of	of	ADP
dpc-3672	49	16	vitiligo	vitiligo	NOUN
dpc-3672	49	17	,	,	PUNCT
dpc-3672	49	18	and	and	CCONJ
dpc-3672	49	19	vitiligo	vitiligo	NOUN
dpc-3672	49	20	disease	disease	NOUN
dpc-3672	49	21	activity	activity	NOUN
dpc-3672	49	22	score	score	NOUN
dpc-3672	49	23	(	(	PUNCT
dpc-3672	49	24	vida	vida	NOUN
dpc-3672	49	25	)	)	PUNCT
dpc-3672	49	26	was	be	AUX
dpc-3672	49	27	used	use	VERB
dpc-3672	49	28	to	to	PART
dpc-3672	49	29	evaluate	evaluate	VERB
dpc-3672	49	30	the	the	DET
dpc-3672	49	31	disease	disease	NOUN
dpc-3672	49	32	activity	activity	NOUN
dpc-3672	49	33	of	of	ADP
dpc-3672	49	34	vitiligo	vitiligo	NOUN
dpc-3672	49	35	.	.	PUNCT
dpc-3672	50	1	the	the	DET
dpc-3672	50	2	vitiligo	vitiligo	NOUN
dpc-3672	50	3	disease	disease	NOUN
dpc-3672	50	4	activity	activity	NOUN
dpc-3672	50	5	score	score	NOUN
dpc-3672	50	6	(	(	PUNCT
dpc-3672	50	7	vida	vida	NOUN
dpc-3672	50	8	)	)	PUNCT
dpc-3672	50	9	is	be	AUX
dpc-3672	50	10	a	a	DET
dpc-3672	50	11	six	six	NUM
dpc-3672	50	12	-	-	PUNCT
dpc-3672	50	13	point	point	NOUN
dpc-3672	50	14	scale	scale	NOUN
dpc-3672	50	15	that	that	PRON
dpc-3672	50	16	is	be	AUX
dpc-3672	50	17	used	use	VERB
dpc-3672	50	18	to	to	PART
dpc-3672	50	19	evaluate	evaluate	VERB
dpc-3672	50	20	the	the	DET
dpc-3672	50	21	vitiligo	vitiligo	NOUN
dpc-3672	50	22	disease	disease	NOUN
dpc-3672	50	23	activity	activity	NOUN
dpc-3672	50	24	.	.	PUNCT
dpc-3672	51	1	the	the	DET
dpc-3672	51	2	vida	vida	PROPN
dpc-3672	51	3	score	score	NOUN
dpc-3672	51	4	is	be	AUX
dpc-3672	51	5	evaluated	evaluate	VERB
dpc-3672	51	6	as	as	ADP
dpc-3672	51	7	“	"	PUNCT
dpc-3672	51	8	+4	+4	PROPN
dpc-3672	51	9	=	=	SYM
dpc-3672	51	10	active	active	ADJ
dpc-3672	51	11	for	for	ADP
dpc-3672	51	12	the	the	DET
dpc-3672	51	13	last	last	ADJ
dpc-3672	51	14	6	6	NUM
dpc-3672	51	15	weeks	week	NOUN
dpc-3672	51	16	,	,	PUNCT
dpc-3672	51	17	+3	+3	PROPN
dpc-3672	51	18	=	=	PUNCT
dpc-3672	51	19	active	active	ADJ
dpc-3672	51	20	for	for	ADP
dpc-3672	51	21	the	the	DET
dpc-3672	51	22	last	last	ADJ
dpc-3672	51	23	3	3	NUM
dpc-3672	51	24	months	month	NOUN
dpc-3672	51	25	,	,	PUNCT
dpc-3672	51	26	+2	+2	PROPN
dpc-3672	51	27	=	=	PUNCT
dpc-3672	51	28	active	active	ADJ
dpc-3672	51	29	for	for	ADP
dpc-3672	51	30	the	the	DET
dpc-3672	51	31	last	last	ADJ
dpc-3672	51	32	6	6	NUM
dpc-3672	51	33	months	month	NOUN
dpc-3672	51	34	,	,	PUNCT
dpc-3672	51	35	+1	+1	NOUN
dpc-3672	51	36	=	=	PUNCT
dpc-3672	51	37	active	active	ADJ
dpc-3672	51	38	for	for	ADP
dpc-3672	51	39	the	the	DET
dpc-3672	51	40	last	last	ADJ
dpc-3672	51	41	1	1	NUM
dpc-3672	51	42	year	year	NOUN
dpc-3672	51	43	,	,	PUNCT
dpc-3672	51	44	0	0	NUM
dpc-3672	52	1	=	=	SYM
dpc-3672	52	2	stable	stable	ADJ
dpc-3672	52	3	over	over	ADP
dpc-3672	52	4	the	the	DET
dpc-3672	52	5	last	last	ADJ
dpc-3672	52	6	year	year	NOUN
dpc-3672	52	7	,	,	PUNCT
dpc-3672	52	8	-1	-1	PUNCT
dpc-3672	52	9	=	=	NOUN
dpc-3672	52	10	stable	stable	ADJ
dpc-3672	52	11	with	with	ADP
dpc-3672	52	12	spontaneous	spontaneous	ADJ
dpc-3672	52	13	re	re	NOUN
dpc-3672	52	14	-	-	NOUN
dpc-3672	52	15	pigmentation	pigmentation	NOUN
dpc-3672	52	16	over	over	ADP
dpc-3672	52	17	the	the	DET
dpc-3672	52	18	last	last	ADJ
dpc-3672	52	19	year	year	NOUN
dpc-3672	52	20	”	"	PUNCT
dpc-3672	53	1	[	[	X
dpc-3672	53	2	8	8	NUM
dpc-3672	53	3	]	]	PUNCT
dpc-3672	53	4	.	.	PUNCT
dpc-3672	54	1	the	the	DET
dpc-3672	54	2	age	age	NOUN
dpc-3672	54	3	of	of	ADP
dpc-3672	54	4	onset	onset	NOUN
dpc-3672	54	5	,	,	PUNCT
dpc-3672	54	6	duration	duration	NOUN
dpc-3672	54	7	of	of	ADP
dpc-3672	54	8	the	the	DET
dpc-3672	54	9	disease	disease	NOUN
dpc-3672	54	10	,	,	PUNCT
dpc-3672	54	11	presence	presence	NOUN
dpc-3672	54	12	of	of	ADP
dpc-3672	54	13	additional	additional	ADJ
dpc-3672	54	14	autoimmune	autoimmune	ADJ
dpc-3672	54	15	disease	disease	NOUN
dpc-3672	54	16	,	,	PUNCT
dpc-3672	54	17	presence	presence	NOUN
dpc-3672	54	18	of	of	ADP
dpc-3672	54	19	vitiligo	vitiligo	NOUN
dpc-3672	54	20	in	in	ADP
dpc-3672	54	21	the	the	DET
dpc-3672	54	22	family	family	NOUN
dpc-3672	54	23	,	,	PUNCT
dpc-3672	54	24	and	and	CCONJ
dpc-3672	54	25	presence	presence	NOUN
dpc-3672	54	26	of	of	ADP
dpc-3672	54	27	additional	additional	ADJ
dpc-3672	54	28	autoimmune	autoimmune	ADJ
dpc-3672	54	29	disease	disease	NOUN
dpc-3672	54	30	in	in	ADP
dpc-3672	54	31	the	the	DET
dpc-3672	54	32	family	family	NOUN
dpc-3672	54	33	were	be	AUX
dpc-3672	54	34	recorded	record	VERB
dpc-3672	54	35	based	base	VERB
dpc-3672	54	36	on	on	ADP
dpc-3672	54	37	a	a	DET
dpc-3672	54	38	detailed	detailed	ADJ
dpc-3672	54	39	history	history	NOUN
dpc-3672	54	40	taken	take	VERB
dpc-3672	54	41	from	from	ADP
dpc-3672	54	42	the	the	DET
dpc-3672	54	43	patients	patient	NOUN
dpc-3672	54	44	.	.	PUNCT
dpc-3672	55	1	all	all	DET
dpc-3672	55	2	participants	participant	NOUN
dpc-3672	55	3	gave	gave	AUX
dpc-3672	55	4	written	write	VERB
dpc-3672	55	5	informed	informed	ADJ
dpc-3672	55	6	consent	consent	NOUN
dpc-3672	55	7	prior	prior	ADV
dpc-3672	55	8	to	to	ADP
dpc-3672	55	9	the	the	DET
dpc-3672	55	10	study	study	NOUN
dpc-3672	55	11	.	.	PUNCT
dpc-3672	56	1	examination	examination	NOUN
dpc-3672	56	2	of	of	ADP
dpc-3672	56	3	il-12	il-12	PRON
dpc-3672	56	4	cytokine	cytokine	ADJ
dpc-3672	56	5	family	family	NOUN
dpc-3672	56	6	level	level	NOUN
dpc-3672	56	7	venous	venous	ADJ
dpc-3672	56	8	blood	blood	NOUN
dpc-3672	56	9	samples	sample	NOUN
dpc-3672	56	10	were	be	AUX
dpc-3672	56	11	collected	collect	VERB
dpc-3672	56	12	from	from	ADP
dpc-3672	56	13	all	all	DET
dpc-3672	56	14	participants	participant	NOUN
dpc-3672	56	15	after	after	ADP
dpc-3672	56	16	12	12	NUM
dpc-3672	56	17	hours	hour	NOUN
dpc-3672	56	18	of	of	ADP
dpc-3672	56	19	fasting	fasting	NOUN
dpc-3672	56	20	.	.	PUNCT
dpc-3672	57	1	blood	blood	NOUN
dpc-3672	57	2	samples	sample	NOUN
dpc-3672	57	3	collected	collect	VERB
dpc-3672	57	4	for	for	ADP
dpc-3672	57	5	analysis	analysis	NOUN
dpc-3672	57	6	were	be	AUX
dpc-3672	57	7	centrifuged	centrifuge	VERB
dpc-3672	57	8	at	at	ADP
dpc-3672	57	9	4000	4000	NUM
dpc-3672	57	10	rpm	rpm	NOUN
dpc-3672	57	11	for	for	ADP
dpc-3672	57	12	10	10	NUM
dpc-3672	57	13	minutes	minute	NOUN
dpc-3672	57	14	.	.	PUNCT
dpc-3672	58	1	separated	separate	VERB
dpc-3672	58	2	sera	sera	NOUN
dpc-3672	58	3	were	be	AUX
dpc-3672	58	4	aliquoted	aliquote	VERB
dpc-3672	58	5	into	into	ADP
dpc-3672	58	6	eppendorf	eppendorf	PROPN
dpc-3672	58	7	tubes	tube	NOUN
dpc-3672	58	8	and	and	CCONJ
dpc-3672	58	9	stored	store	VERB
dpc-3672	58	10	at	at	ADP
dpc-3672	58	11	-80	-80	NOUN
dpc-3672	58	12	°	°	ADP
dpc-3672	58	13	c	c	NOUN
dpc-3672	58	14	until	until	ADP
dpc-3672	58	15	the	the	DET
dpc-3672	58	16	time	time	NOUN
dpc-3672	58	17	of	of	ADP
dpc-3672	58	18	analysis	analysis	NOUN
dpc-3672	58	19	.	.	PUNCT
dpc-3672	59	1	serum	serum	NOUN
dpc-3672	59	2	il-12	il-12	NOUN
dpc-3672	59	3	,	,	PUNCT
dpc-3672	59	4	il-23	il-23	NOUN
dpc-3672	59	5	,	,	PUNCT
dpc-3672	59	6	il-27	il-27	NUM
dpc-3672	59	7	and	and	CCONJ
dpc-3672	59	8	il-35	il-35	ADP
dpc-3672	59	9	levels	level	NOUN
dpc-3672	59	10	were	be	AUX
dpc-3672	59	11	detected	detect	VERB
dpc-3672	59	12	with	with	ADP
dpc-3672	59	13	human	human	ADJ
dpc-3672	59	14	elisa	elisa	PROPN
dpc-3672	59	15	(	(	PUNCT
dpc-3672	59	16	double	double	ADJ
dpc-3672	59	17	antibody	antibody	NOUN
dpc-3672	59	18	sandwich	sandwich	NOUN
dpc-3672	59	19	elisa	elisa	NOUN
dpc-3672	59	20	method	method	PROPN
dpc-3672	59	21	)	)	PUNCT
dpc-3672	59	22	kits	kit	NOUN
dpc-3672	59	23	according	accord	VERB
dpc-3672	59	24	to	to	ADP
dpc-3672	59	25	manufacturer	manufacturer	NOUN
dpc-3672	59	26	instructions	instruction	NOUN
dpc-3672	59	27	(	(	PUNCT
dpc-3672	59	28	manufacturer	manufacturer	NOUN
dpc-3672	59	29	:	:	PUNCT
dpc-3672	59	30	uscn	uscn	ADJ
dpc-3672	59	31	life	life	NOUN
dpc-3672	59	32	sciences	science	NOUN
dpc-3672	59	33	)	)	PUNCT
dpc-3672	59	34	.	.	PUNCT
dpc-3672	60	1	all	all	DET
dpc-3672	60	2	values	value	NOUN
dpc-3672	60	3	are	be	AUX
dpc-3672	60	4	expressed	express	VERB
dpc-3672	60	5	as	as	ADP
dpc-3672	60	6	pg	pg	NOUN
dpc-3672	60	7	/	/	SYM
dpc-3672	60	8	ml	ml	NOUN
dpc-3672	60	9	.	.	PUNCT
dpc-3672	60	10	intra	intra	ADJ
dpc-3672	60	11	-	-	ADJ
dpc-3672	60	12	assay	assay	ADJ
dpc-3672	60	13	cv	cv	PROPN
dpc-3672	60	14	values	value	NOUN
dpc-3672	60	15	were	be	AUX
dpc-3672	60	16	less	less	ADJ
dpc-3672	60	17	than	than	ADP
dpc-3672	60	18	10	10	NUM
dpc-3672	60	19	%	%	NOUN
dpc-3672	60	20	and	and	CCONJ
dpc-3672	60	21	inter	inter	ADJ
dpc-3672	60	22	-	-	ADJ
dpc-3672	60	23	assay	assay	ADJ
dpc-3672	60	24	cv	cv	PROPN
dpc-3672	60	25	values	value	NOUN
dpc-3672	60	26	were	be	AUX
dpc-3672	60	27	less	less	ADJ
dpc-3672	60	28	than	than	ADP
dpc-3672	60	29	12	12	NUM
dpc-3672	60	30	%	%	NOUN
dpc-3672	60	31	for	for	ADP
dpc-3672	60	32	all	all	DET
dpc-3672	60	33	parameters	parameter	NOUN
dpc-3672	60	34	.	.	PUNCT
dpc-3672	61	1	statistical	statistical	ADJ
dpc-3672	61	2	methods	method	NOUN
dpc-3672	61	3	the	the	DET
dpc-3672	61	4	data	datum	NOUN
dpc-3672	61	5	were	be	AUX
dpc-3672	61	6	analyzed	analyze	VERB
dpc-3672	61	7	using	use	VERB
dpc-3672	61	8	spss	spss	PROPN
dpc-3672	61	9	/	/	SYM
dpc-3672	61	10	ibm	ibm	PROPN
dpc-3672	61	11	for	for	ADP
dpc-3672	61	12	windows	window	NOUN
dpc-3672	61	13	21.0	21.0	NUM
dpc-3672	61	14	.	.	PUNCT
dpc-3672	62	1	descriptive	descriptive	ADJ
dpc-3672	62	2	statistics	statistic	NOUN
dpc-3672	62	3	such	such	ADJ
dpc-3672	62	4	as	as	ADP
dpc-3672	62	5	percentage	percentage	NOUN
dpc-3672	62	6	,	,	PUNCT
dpc-3672	62	7	mean	mean	ADJ
dpc-3672	62	8	,	,	PUNCT
dpc-3672	62	9	median	median	ADJ
dpc-3672	62	10	,	,	PUNCT
dpc-3672	62	11	standard	standard	ADJ
dpc-3672	62	12	deviation	deviation	NOUN
dpc-3672	62	13	and	and	CCONJ
dpc-3672	62	14	interquartile	interquartile	ADJ
dpc-3672	62	15	range	range	NOUN
dpc-3672	62	16	(	(	PUNCT
dpc-3672	62	17	iqr	iqr	NOUN
dpc-3672	62	18	)	)	PUNCT
dpc-3672	62	19	were	be	AUX
dpc-3672	62	20	used	use	VERB
dpc-3672	62	21	to	to	PART
dpc-3672	62	22	define	define	VERB
dpc-3672	62	23	the	the	DET
dpc-3672	62	24	sample	sample	NOUN
dpc-3672	62	25	.	.	PUNCT
dpc-3672	63	1	the	the	DET
dpc-3672	63	2	assumption	assumption	NOUN
dpc-3672	63	3	of	of	ADP
dpc-3672	63	4	conformity	conformity	NOUN
dpc-3672	63	5	to	to	ADP
dpc-3672	63	6	the	the	DET
dpc-3672	63	7	normal	normal	ADJ
dpc-3672	63	8	distribution	distribution	NOUN
dpc-3672	63	9	was	be	AUX
dpc-3672	63	10	examined	examine	VERB
dpc-3672	63	11	using	use	VERB
dpc-3672	63	12	the	the	DET
dpc-3672	63	13	shapiro	shapiro	PROPN
dpc-3672	63	14	wilk	wilk	PROPN
dpc-3672	63	15	test	test	PROPN
dpc-3672	63	16	.	.	PUNCT
dpc-3672	64	1	the	the	DET
dpc-3672	64	2	difference	difference	NOUN
dpc-3672	64	3	between	between	ADP
dpc-3672	64	4	the	the	DET
dpc-3672	64	5	means	mean	NOUN
dpc-3672	64	6	of	of	ADP
dpc-3672	64	7	two	two	NUM
dpc-3672	64	8	independent	independent	ADJ
dpc-3672	64	9	groups	group	NOUN
dpc-3672	64	10	was	be	AUX
dpc-3672	64	11	analyzed	analyze	VERB
dpc-3672	64	12	by	by	ADP
dpc-3672	64	13	the	the	DET
dpc-3672	64	14	student	student	NOUN
dpc-3672	64	15	t	t	PROPN
dpc-3672	64	16	test	test	NOUN
dpc-3672	64	17	in	in	ADP
dpc-3672	64	18	cases	case	NOUN
dpc-3672	64	19	where	where	SCONJ
dpc-3672	64	20	parametric	parametric	ADJ
dpc-3672	64	21	test	test	NOUN
dpc-3672	64	22	assumptions	assumption	NOUN
dpc-3672	64	23	were	be	AUX
dpc-3672	64	24	met	meet	VERB
dpc-3672	64	25	,	,	PUNCT
dpc-3672	64	26	and	and	CCONJ
dpc-3672	64	27	the	the	DET
dpc-3672	64	28	difference	difference	NOUN
dpc-3672	64	29	original	original	ADJ
dpc-3672	64	30	article	article	NOUN
dpc-3672	64	31	|	|	ADV
dpc-3672	64	32	dermatol	dermatol	ADJ
dpc-3672	64	33	pract	pract	NOUN
dpc-3672	64	34	concept	concept	NOUN
dpc-3672	64	35	.	.	PUNCT
dpc-3672	65	1	2024;14(2):e2024069	2024;14(2):e2024069	NUM
dpc-3672	65	2	3	3	NUM
dpc-3672	65	3	between	between	ADP
dpc-3672	65	4	the	the	DET
dpc-3672	65	5	medians	median	NOUN
dpc-3672	65	6	of	of	ADP
dpc-3672	65	7	two	two	NUM
dpc-3672	65	8	independent	independent	ADJ
dpc-3672	65	9	groups	group	NOUN
dpc-3672	65	10	was	be	AUX
dpc-3672	65	11	analyzed	analyze	VERB
dpc-3672	65	12	by	by	ADP
dpc-3672	65	13	mann	mann	PROPN
dpc-3672	65	14	-	-	PUNCT
dpc-3672	65	15	whitney	whitney	PROPN
dpc-3672	65	16	u	u	PROPN
dpc-3672	65	17	test	test	NOUN
dpc-3672	65	18	in	in	ADP
dpc-3672	65	19	cases	case	NOUN
dpc-3672	65	20	where	where	SCONJ
dpc-3672	65	21	parametric	parametric	ADJ
dpc-3672	65	22	test	test	NOUN
dpc-3672	65	23	assumptions	assumption	NOUN
dpc-3672	65	24	were	be	AUX
dpc-3672	65	25	not	not	PART
dpc-3672	65	26	met	meet	VERB
dpc-3672	65	27	.	.	PUNCT
dpc-3672	66	1	spearman	spearman	NOUN
dpc-3672	66	2	or	or	CCONJ
dpc-3672	66	3	pearson	pearson	NOUN
dpc-3672	66	4	tests	test	NOUN
dpc-3672	66	5	were	be	AUX
dpc-3672	66	6	used	use	VERB
dpc-3672	66	7	to	to	PART
dpc-3672	66	8	evaluate	evaluate	VERB
dpc-3672	66	9	the	the	DET
dpc-3672	66	10	correlation	correlation	NOUN
dpc-3672	66	11	between	between	ADP
dpc-3672	66	12	two	two	NUM
dpc-3672	66	13	numerical	numerical	ADJ
dpc-3672	66	14	values	value	NOUN
dpc-3672	66	15	.	.	PUNCT
dpc-3672	67	1	categorical	categorical	ADJ
dpc-3672	67	2	data	datum	NOUN
dpc-3672	67	3	were	be	AUX
dpc-3672	67	4	analyzed	analyze	VERB
dpc-3672	67	5	with	with	ADP
dpc-3672	67	6	the	the	DET
dpc-3672	67	7	chi	chi	ADJ
dpc-3672	67	8	-	-	PUNCT
dpc-3672	67	9	square	square	ADJ
dpc-3672	67	10	significance	significance	NOUN
dpc-3672	67	11	test	test	NOUN
dpc-3672	67	12	or	or	CCONJ
dpc-3672	67	13	fisher	fisher	PROPN
dpc-3672	67	14	exact	exact	ADJ
dpc-3672	67	15	test	test	NOUN
dpc-3672	67	16	.	.	PUNCT
dpc-3672	68	1	a	a	DET
dpc-3672	68	2	95	95	NUM
dpc-3672	68	3	%	%	NOUN
dpc-3672	68	4	level	level	NOUN
dpc-3672	68	5	of	of	ADP
dpc-3672	68	6	significance	significance	NOUN
dpc-3672	68	7	(	(	PUNCT
dpc-3672	68	8	error	error	NOUN
dpc-3672	68	9	margin	margin	NOUN
dpc-3672	68	10	:	:	PUNCT
dpc-3672	68	11	α	α	NOUN
dpc-3672	68	12	=	=	NOUN
dpc-3672	68	13	0.05	0.05	NUM
dpc-3672	68	14	)	)	PUNCT
dpc-3672	68	15	was	be	AUX
dpc-3672	68	16	used	use	VERB
dpc-3672	68	17	to	to	PART
dpc-3672	68	18	determine	determine	VERB
dpc-3672	68	19	the	the	DET
dpc-3672	68	20	statistically	statistically	ADV
dpc-3672	68	21	significant	significant	ADJ
dpc-3672	68	22	differences	difference	NOUN
dpc-3672	68	23	in	in	ADP
dpc-3672	68	24	the	the	DET
dpc-3672	68	25	analyses	analysis	NOUN
dpc-3672	68	26	.	.	PUNCT
dpc-3672	69	1	results	result	NOUN
dpc-3672	69	2	demographic	demographic	ADJ
dpc-3672	69	3	and	and	CCONJ
dpc-3672	69	4	clinical	clinical	ADJ
dpc-3672	69	5	features	feature	NOUN
dpc-3672	69	6	of	of	ADP
dpc-3672	69	7	study	study	NOUN
dpc-3672	69	8	population	population	NOUN
dpc-3672	69	9	fifty	fifty	NUM
dpc-3672	69	10	-	-	PUNCT
dpc-3672	69	11	nine	nine	NUM
dpc-3672	69	12	point	point	NOUN
dpc-3672	69	13	eight	eight	NUM
dpc-3672	69	14	percent	percent	NOUN
dpc-3672	69	15	of	of	ADP
dpc-3672	69	16	the	the	DET
dpc-3672	69	17	vitiligo	vitiligo	NOUN
dpc-3672	69	18	patients	patient	NOUN
dpc-3672	69	19	were	be	AUX
dpc-3672	69	20	female	female	ADJ
dpc-3672	69	21	and	and	CCONJ
dpc-3672	69	22	40.2	40.2	NUM
dpc-3672	69	23	%	%	NOUN
dpc-3672	69	24	were	be	AUX
dpc-3672	69	25	male	male	ADJ
dpc-3672	69	26	.	.	PUNCT
dpc-3672	70	1	the	the	DET
dpc-3672	70	2	mean	mean	ADJ
dpc-3672	70	3	age	age	NOUN
dpc-3672	70	4	of	of	ADP
dpc-3672	70	5	the	the	DET
dpc-3672	70	6	patients	patient	NOUN
dpc-3672	70	7	was	be	AUX
dpc-3672	70	8	39.8	39.8	NUM
dpc-3672	70	9	years	year	NOUN
dpc-3672	70	10	(	(	PUNCT
dpc-3672	70	11	sd=13.2	sd=13.2	NOUN
dpc-3672	70	12	years	year	NOUN
dpc-3672	70	13	)	)	PUNCT
dpc-3672	70	14	.	.	PUNCT
dpc-3672	71	1	55.2	55.2	NUM
dpc-3672	71	2	%	%	NOUN
dpc-3672	71	3	(	(	PUNCT
dpc-3672	71	4	n	n	NOUN
dpc-3672	71	5	=	=	SYM
dpc-3672	71	6	48	48	NUM
dpc-3672	71	7	)	)	PUNCT
dpc-3672	71	8	of	of	ADP
dpc-3672	71	9	the	the	DET
dpc-3672	71	10	patients	patient	NOUN
dpc-3672	71	11	had	have	VERB
dpc-3672	71	12	generalized	generalize	VERB
dpc-3672	71	13	vitiligo	vitiligo	NOUN
dpc-3672	71	14	and	and	CCONJ
dpc-3672	71	15	34.5	34.5	NUM
dpc-3672	71	16	%	%	NOUN
dpc-3672	71	17	(	(	PUNCT
dpc-3672	71	18	n	n	NOUN
dpc-3672	71	19	=	=	SYM
dpc-3672	71	20	30	30	NUM
dpc-3672	71	21	)	)	PUNCT
dpc-3672	71	22	had	have	VERB
dpc-3672	71	23	localized	localize	VERB
dpc-3672	71	24	vitiligo	vitiligo	NOUN
dpc-3672	71	25	.	.	PUNCT
dpc-3672	72	1	the	the	DET
dpc-3672	72	2	median	median	PROPN
dpc-3672	72	3	vasi	vasi	PROPN
dpc-3672	72	4	was	be	AUX
dpc-3672	72	5	4	4	NUM
dpc-3672	72	6	(	(	PUNCT
dpc-3672	72	7	iqr	iqr	NOUN
dpc-3672	72	8	=	=	NOUN
dpc-3672	72	9	1.18	1.18	NUM
dpc-3672	72	10	-	-	SYM
dpc-3672	72	11	10.3	10.3	NUM
dpc-3672	72	12	)	)	PUNCT
dpc-3672	72	13	.	.	PUNCT
dpc-3672	73	1	the	the	DET
dpc-3672	73	2	age	age	NOUN
dpc-3672	73	3	of	of	ADP
dpc-3672	73	4	onset	onset	NOUN
dpc-3672	73	5	was	be	AUX
dpc-3672	73	6	26	26	NUM
dpc-3672	73	7	(	(	PUNCT
dpc-3672	73	8	iqr	iqr	NOUN
dpc-3672	73	9	=	=	NOUN
dpc-3672	73	10	13	13	NUM
dpc-3672	73	11	-	-	SYM
dpc-3672	73	12	40	40	NUM
dpc-3672	73	13	)	)	PUNCT
dpc-3672	73	14	and	and	CCONJ
dpc-3672	73	15	the	the	DET
dpc-3672	73	16	duration	duration	NOUN
dpc-3672	73	17	of	of	ADP
dpc-3672	73	18	the	the	DET
dpc-3672	73	19	disease	disease	NOUN
dpc-3672	73	20	was	be	AUX
dpc-3672	73	21	8	8	NUM
dpc-3672	73	22	months	month	NOUN
dpc-3672	73	23	(	(	PUNCT
dpc-3672	73	24	iqr	iqr	NOUN
dpc-3672	73	25	=	=	SYM
dpc-3672	73	26	2	2	NUM
dpc-3672	73	27	-	-	SYM
dpc-3672	73	28	21	21	NUM
dpc-3672	73	29	months	month	NOUN
dpc-3672	73	30	)	)	PUNCT
dpc-3672	73	31	.	.	PUNCT
dpc-3672	74	1	the	the	DET
dpc-3672	74	2	vida	vida	PROPN
dpc-3672	74	3	score	score	NOUN
dpc-3672	74	4	was	be	AUX
dpc-3672	74	5	“	"	PUNCT
dpc-3672	74	6	-1	-1	INTJ
dpc-3672	74	7	”	"	PUNCT
dpc-3672	74	8	for	for	ADP
dpc-3672	74	9	23	23	NUM
dpc-3672	74	10	%	%	NOUN
dpc-3672	74	11	,	,	PUNCT
dpc-3672	74	12	“	"	PUNCT
dpc-3672	74	13	0	0	NUM
dpc-3672	74	14	”	"	PUNCT
dpc-3672	74	15	for	for	ADP
dpc-3672	74	16	12.6	12.6	NUM
dpc-3672	74	17	%	%	NOUN
dpc-3672	74	18	,	,	PUNCT
dpc-3672	74	19	“	"	PUNCT
dpc-3672	74	20	1	1	NUM
dpc-3672	74	21	”	"	PUNCT
dpc-3672	74	22	for	for	ADP
dpc-3672	74	23	10.3	10.3	NUM
dpc-3672	74	24	%	%	NOUN
dpc-3672	74	25	,	,	PUNCT
dpc-3672	74	26	“	"	PUNCT
dpc-3672	74	27	2	2	NUM
dpc-3672	74	28	”	"	PUNCT
dpc-3672	74	29	for	for	ADP
dpc-3672	74	30	19.5	19.5	NUM
dpc-3672	74	31	%	%	NOUN
dpc-3672	74	32	,	,	PUNCT
dpc-3672	74	33	“	"	PUNCT
dpc-3672	74	34	3	3	NUM
dpc-3672	74	35	”	"	PUNCT
dpc-3672	74	36	for	for	ADP
dpc-3672	74	37	8.4	8.4	NUM
dpc-3672	74	38	%	%	NOUN
dpc-3672	74	39	,	,	PUNCT
dpc-3672	74	40	and	and	CCONJ
dpc-3672	74	41	“	"	PUNCT
dpc-3672	74	42	4	4	NUM
dpc-3672	74	43	”	"	PUNCT
dpc-3672	74	44	for	for	ADP
dpc-3672	74	45	3.4	3.4	NUM
dpc-3672	74	46	%	%	NOUN
dpc-3672	74	47	of	of	ADP
dpc-3672	74	48	the	the	DET
dpc-3672	74	49	patients	patient	NOUN
dpc-3672	74	50	.	.	PUNCT
dpc-3672	75	1	while	while	SCONJ
dpc-3672	75	2	29.9	29.9	NUM
dpc-3672	75	3	%	%	NOUN
dpc-3672	75	4	of	of	ADP
dpc-3672	75	5	the	the	DET
dpc-3672	75	6	patients	patient	NOUN
dpc-3672	75	7	had	have	VERB
dpc-3672	75	8	a	a	DET
dpc-3672	75	9	history	history	NOUN
dpc-3672	75	10	of	of	ADP
dpc-3672	75	11	non	non	ADJ
dpc-3672	75	12	-	-	ADJ
dpc-3672	75	13	vitiligo	vitiligo	ADJ
dpc-3672	75	14	autoimmune	autoimmune	ADJ
dpc-3672	75	15	disease	disease	NOUN
dpc-3672	75	16	,	,	PUNCT
dpc-3672	75	17	21.8	21.8	NUM
dpc-3672	75	18	%	%	NOUN
dpc-3672	75	19	had	have	VERB
dpc-3672	75	20	a	a	DET
dpc-3672	75	21	family	family	NOUN
dpc-3672	75	22	history	history	NOUN
dpc-3672	75	23	of	of	ADP
dpc-3672	75	24	vitiligo	vitiligo	NOUN
dpc-3672	75	25	,	,	PUNCT
dpc-3672	75	26	and	and	CCONJ
dpc-3672	75	27	21.8	21.8	NUM
dpc-3672	75	28	%	%	NOUN
dpc-3672	75	29	had	have	VERB
dpc-3672	75	30	a	a	DET
dpc-3672	75	31	family	family	NOUN
dpc-3672	75	32	history	history	NOUN
dpc-3672	75	33	of	of	ADP
dpc-3672	75	34	non	non	ADJ
dpc-3672	75	35	-	-	ADJ
dpc-3672	75	36	vitiligo	vitiligo	ADJ
dpc-3672	75	37	autoimmune	autoimmune	ADJ
dpc-3672	75	38	disease	disease	NOUN
dpc-3672	75	39	.	.	PUNCT
dpc-3672	76	1	serum	serum	NOUN
dpc-3672	76	2	il-12	il-12	NOUN
dpc-3672	76	3	,	,	PUNCT
dpc-3672	76	4	il-23	il-23	NOUN
dpc-3672	76	5	,	,	PUNCT
dpc-3672	76	6	il-27	il-27	NUM
dpc-3672	76	7	,	,	PUNCT
dpc-3672	76	8	and	and	CCONJ
dpc-3672	76	9	il-35	il-35	ADP
dpc-3672	76	10	concentrations	concentration	NOUN
dpc-3672	76	11	in	in	ADP
dpc-3672	76	12	vitiligo	vitiligo	NOUN
dpc-3672	76	13	patients	patient	NOUN
dpc-3672	76	14	and	and	CCONJ
dpc-3672	76	15	control	control	PROPN
dpc-3672	76	16	group	group	NOUN
dpc-3672	76	17	serum	serum	VERB
dpc-3672	76	18	il-12	il-12	NOUN
dpc-3672	76	19	,	,	PUNCT
dpc-3672	76	20	il-23	il-23	NOUN
dpc-3672	76	21	,	,	PUNCT
dpc-3672	76	22	il-27	il-27	NUM
dpc-3672	76	23	,	,	PUNCT
dpc-3672	76	24	and	and	CCONJ
dpc-3672	76	25	il-35	il-35	ADP
dpc-3672	76	26	concentrations	concentration	NOUN
dpc-3672	76	27	in	in	ADP
dpc-3672	76	28	vitiligo	vitiligo	NOUN
dpc-3672	76	29	patients	patient	NOUN
dpc-3672	76	30	and	and	CCONJ
dpc-3672	76	31	control	control	NOUN
dpc-3672	76	32	group	group	NOUN
dpc-3672	76	33	are	be	AUX
dpc-3672	76	34	summarized	summarize	VERB
dpc-3672	76	35	in	in	ADP
dpc-3672	76	36	table	table	NOUN
dpc-3672	76	37	1	1	NUM
dpc-3672	76	38	.	.	PUNCT
dpc-3672	77	1	serum	serum	VERB
dpc-3672	77	2	il-12	il-12	NOUN
dpc-3672	77	3	and	and	CCONJ
dpc-3672	77	4	il-35	il-35	ADP
dpc-3672	77	5	levels	level	NOUN
dpc-3672	77	6	were	be	AUX
dpc-3672	77	7	higher	high	ADJ
dpc-3672	77	8	in	in	ADP
dpc-3672	77	9	vitiligo	vitiligo	ADJ
dpc-3672	77	10	patients	patient	NOUN
dpc-3672	77	11	compared	compare	VERB
dpc-3672	77	12	to	to	ADP
dpc-3672	77	13	healthy	healthy	ADJ
dpc-3672	77	14	controls	control	NOUN
dpc-3672	77	15	(	(	PUNCT
dpc-3672	77	16	31.2	31.2	NUM
dpc-3672	77	17	versus	versus	ADP
dpc-3672	77	18	20.1	20.1	NUM
dpc-3672	77	19	,	,	PUNCT
dpc-3672	77	20	p	p	X
dpc-3672	77	21	<	<	X
dpc-3672	77	22	0.001	0.001	NUM
dpc-3672	77	23	and	and	CCONJ
dpc-3672	77	24	9.6	9.6	NUM
dpc-3672	77	25	versus	versus	ADP
dpc-3672	77	26	8.1	8.1	NUM
dpc-3672	77	27	,	,	PUNCT
dpc-3672	77	28	p	p	X
dpc-3672	77	29	=	=	NOUN
dpc-3672	77	30	0.031	0.031	NUM
dpc-3672	77	31	,	,	PUNCT
dpc-3672	77	32	respectively	respectively	ADV
dpc-3672	77	33	)	)	PUNCT
dpc-3672	77	34	(	(	PUNCT
dpc-3672	77	35	figure	figure	NOUN
dpc-3672	77	36	1	1	NUM
dpc-3672	77	37	)	)	PUNCT
dpc-3672	77	38	.	.	PUNCT
dpc-3672	78	1	serum	serum	PROPN
dpc-3672	78	2	il-27	il-27	PROPN
dpc-3672	78	3	levels	level	NOUN
dpc-3672	78	4	were	be	AUX
dpc-3672	78	5	207.6	207.6	NUM
dpc-3672	78	6	(	(	PUNCT
dpc-3672	78	7	sd=71.3	sd=71.3	PROPN
dpc-3672	78	8	)	)	PUNCT
dpc-3672	78	9	in	in	ADP
dpc-3672	78	10	vitiligo	vitiligo	NOUN
dpc-3672	78	11	patients	patient	NOUN
dpc-3672	78	12	table	table	VERB
dpc-3672	78	13	1	1	NUM
dpc-3672	78	14	.	.	PUNCT
dpc-3672	79	1	serum	serum	VERB
dpc-3672	79	2	il-12	il-12	NOUN
dpc-3672	79	3	,	,	PUNCT
dpc-3672	79	4	il-23	il-23	NOUN
dpc-3672	79	5	,	,	PUNCT
dpc-3672	79	6	il-27	il-27	NUM
dpc-3672	79	7	,	,	PUNCT
dpc-3672	79	8	and	and	CCONJ
dpc-3672	79	9	il-35	il-35	ADP
dpc-3672	79	10	concentrations	concentration	NOUN
dpc-3672	79	11	in	in	ADP
dpc-3672	79	12	vitiligo	vitiligo	NOUN
dpc-3672	79	13	patients	patient	NOUN
dpc-3672	79	14	and	and	CCONJ
dpc-3672	79	15	control	control	PROPN
dpc-3672	79	16	group	group	NOUN
dpc-3672	79	17	vitiligo	vitiligo	NOUN
dpc-3672	79	18	control	control	NOUN
dpc-3672	79	19	p	p	NOUN
dpc-3672	79	20	value	value	NOUN
dpc-3672	79	21	il-12	il-12	NOUN
dpc-3672	79	22	(	(	PUNCT
dpc-3672	79	23	pg	pg	NOUN
dpc-3672	79	24	/	/	SYM
dpc-3672	79	25	ml	ml	NOUN
dpc-3672	79	26	)	)	PUNCT
dpc-3672	79	27	,	,	PUNCT
dpc-3672	79	28	median	median	NOUN
dpc-3672	79	29	(	(	PUNCT
dpc-3672	79	30	iqr	iqr	NOUN
dpc-3672	79	31	)	)	PUNCT
dpc-3672	79	32	31.2	31.2	NUM
dpc-3672	79	33	(	(	PUNCT
dpc-3672	79	34	25.4	25.4	NUM
dpc-3672	79	35	-	-	SYM
dpc-3672	79	36	42.1	42.1	NUM
dpc-3672	79	37	)	)	PUNCT
dpc-3672	79	38	20.1	20.1	NUM
dpc-3672	79	39	(	(	PUNCT
dpc-3672	79	40	13.3	13.3	NUM
dpc-3672	79	41	-	-	SYM
dpc-3672	79	42	32.8	32.8	NUM
dpc-3672	79	43	)	)	PUNCT
dpc-3672	79	44	<	<	X
dpc-3672	79	45	0.001	0.001	NUM
dpc-3672	79	46	il-23	il-23	NOUN
dpc-3672	79	47	(	(	PUNCT
dpc-3672	79	48	pg	pg	NOUN
dpc-3672	79	49	/	/	SYM
dpc-3672	79	50	ml	ml	NOUN
dpc-3672	79	51	)	)	PUNCT
dpc-3672	79	52	,	,	PUNCT
dpc-3672	79	53	median	median	NOUN
dpc-3672	79	54	(	(	PUNCT
dpc-3672	79	55	iqr	iqr	NOUN
dpc-3672	79	56	)	)	PUNCT
dpc-3672	79	57	25.1	25.1	NUM
dpc-3672	79	58	(	(	PUNCT
dpc-3672	79	59	19.9	19.9	NUM
dpc-3672	79	60	-	-	SYM
dpc-3672	79	61	31.8	31.8	NUM
dpc-3672	79	62	)	)	PUNCT
dpc-3672	79	63	21.8	21.8	NUM
dpc-3672	79	64	(	(	PUNCT
dpc-3672	79	65	18.9	18.9	NUM
dpc-3672	79	66	-	-	SYM
dpc-3672	79	67	72.2	72.2	NUM
dpc-3672	79	68	)	)	PUNCT
dpc-3672	79	69	0.78	0.78	NUM
dpc-3672	79	70	il-27	il-27	NUM
dpc-3672	79	71	(	(	PUNCT
dpc-3672	79	72	pg	pg	NOUN
dpc-3672	79	73	/	/	SYM
dpc-3672	79	74	ml	ml	VERB
dpc-3672	79	75	)	)	PUNCT
dpc-3672	79	76	,	,	PUNCT
dpc-3672	79	77	mean	mean	INTJ
dpc-3672	79	78	(	(	PUNCT
dpc-3672	79	79	sd	sd	NOUN
dpc-3672	79	80	)	)	PUNCT
dpc-3672	79	81	207.6	207.6	NUM
dpc-3672	79	82	(	(	PUNCT
dpc-3672	79	83	71.3	71.3	NUM
dpc-3672	79	84	)	)	PUNCT
dpc-3672	79	85	258.7	258.7	NUM
dpc-3672	79	86	(	(	PUNCT
dpc-3672	79	87	85.5	85.5	NUM
dpc-3672	79	88	)	)	PUNCT
dpc-3672	79	89	<	<	X
dpc-3672	79	90	0.001	0.001	NUM
dpc-3672	79	91	il-35	il-35	ADP
dpc-3672	79	92	(	(	PUNCT
dpc-3672	79	93	pg	pg	NOUN
dpc-3672	79	94	/	/	SYM
dpc-3672	79	95	ml	ml	NOUN
dpc-3672	79	96	)	)	PUNCT
dpc-3672	79	97	,	,	PUNCT
dpc-3672	79	98	median	median	NOUN
dpc-3672	79	99	(	(	PUNCT
dpc-3672	79	100	iqr	iqr	PROPN
dpc-3672	79	101	)	)	PUNCT
dpc-3672	79	102	9.6	9.6	NUM
dpc-3672	79	103	(	(	PUNCT
dpc-3672	79	104	5.8	5.8	NUM
dpc-3672	79	105	-	-	SYM
dpc-3672	79	106	20.8	20.8	NUM
dpc-3672	79	107	)	)	PUNCT
dpc-3672	79	108	8.1	8.1	NUM
dpc-3672	79	109	(	(	PUNCT
dpc-3672	79	110	5.1	5.1	NUM
dpc-3672	79	111	-	-	SYM
dpc-3672	79	112	11.3	11.3	NUM
dpc-3672	79	113	)	)	PUNCT
dpc-3672	79	114	0.031	0.031	NUM
dpc-3672	79	115	iqr	iqr	X
dpc-3672	79	116	=	=	NOUN
dpc-3672	79	117	interquartile	interquartile	NOUN
dpc-3672	79	118	range	range	NOUN
dpc-3672	79	119	;	;	PUNCT
dpc-3672	79	120	sd	sd	NOUN
dpc-3672	79	121	=	=	SYM
dpc-3672	79	122	standard	standard	ADJ
dpc-3672	79	123	deviation	deviation	NOUN
dpc-3672	79	124	.	.	PUNCT
dpc-3672	80	1	figure	figure	NOUN
dpc-3672	80	2	1	1	NUM
dpc-3672	80	3	.	.	PUNCT
dpc-3672	80	4	comparison	comparison	NOUN
dpc-3672	80	5	of	of	ADP
dpc-3672	80	6	serum	serum	NOUN
dpc-3672	80	7	il-12	il-12	NOUN
dpc-3672	80	8	,	,	PUNCT
dpc-3672	80	9	il-23	il-23	NOUN
dpc-3672	80	10	,	,	PUNCT
dpc-3672	80	11	il-27	il-27	NUM
dpc-3672	80	12	,	,	PUNCT
dpc-3672	80	13	and	and	CCONJ
dpc-3672	80	14	il-35	il-35	ADP
dpc-3672	80	15	concentrations	concentration	NOUN
dpc-3672	80	16	in	in	ADP
dpc-3672	80	17	vitiligo	vitiligo	NOUN
dpc-3672	80	18	and	and	CCONJ
dpc-3672	80	19	control	control	NOUN
dpc-3672	80	20	groups	group	NOUN
dpc-3672	80	21	(	(	PUNCT
dpc-3672	80	22	*	*	PUNCT
dpc-3672	80	23	*	*	PUNCT
dpc-3672	80	24	*	*	PUNCT
dpc-3672	80	25	p	p	X
dpc-3672	80	26	<	<	X
dpc-3672	80	27	0.001	0.001	NUM
dpc-3672	80	28	,	,	PUNCT
dpc-3672	80	29	*	*	PUNCT
dpc-3672	80	30	p	p	X
dpc-3672	80	31	<	<	X
dpc-3672	80	32	0.05	0.05	NUM
dpc-3672	80	33	)	)	PUNCT
dpc-3672	80	34	.	.	PUNCT
dpc-3672	81	1	4	4	NUM
dpc-3672	81	2	original	original	ADJ
dpc-3672	81	3	article	article	NOUN
dpc-3672	81	4	|	|	ADV
dpc-3672	81	5	dermatol	dermatol	ADJ
dpc-3672	81	6	pract	pract	NOUN
dpc-3672	81	7	concept	concept	NOUN
dpc-3672	81	8	.	.	PUNCT
dpc-3672	82	1	2024;14(2):e2024069	2024;14(2):e2024069	NUM
dpc-3672	82	2	il-23	il-23	NOUN
dpc-3672	82	3	(	(	PUNCT
dpc-3672	82	4	p	p	X
dpc-3672	82	5	=	=	NOUN
dpc-3672	82	6	0.022	0.022	NUM
dpc-3672	82	7	,	,	PUNCT
dpc-3672	82	8	r=	r=	ADJ
dpc-3672	82	9	0.35	0.35	NUM
dpc-3672	82	10	)	)	PUNCT
dpc-3672	82	11	,	,	PUNCT
dpc-3672	82	12	vasi	vasi	PROPN
dpc-3672	82	13	and	and	CCONJ
dpc-3672	82	14	serum	serum	VERB
dpc-3672	82	15	il-12	il-12	NOUN
dpc-3672	82	16	(	(	PUNCT
dpc-3672	82	17	p	p	X
dpc-3672	82	18	=	=	NOUN
dpc-3672	82	19	0.74	0.74	NUM
dpc-3672	82	20	,	,	PUNCT
dpc-3672	82	21	r	r	NOUN
dpc-3672	82	22	=	=	NOUN
dpc-3672	82	23	-0.04	-0.04	NUM
dpc-3672	82	24	)	)	PUNCT
dpc-3672	82	25	,	,	PUNCT
dpc-3672	82	26	il-27	il-27	PUNCT
dpc-3672	82	27	(	(	PUNCT
dpc-3672	82	28	p	p	X
dpc-3672	82	29	=	=	NOUN
dpc-3672	82	30	0.11	0.11	NUM
dpc-3672	82	31	,	,	PUNCT
dpc-3672	82	32	r	r	NOUN
dpc-3672	82	33	=	=	SYM
dpc-3672	82	34	0.18	0.18	NUM
dpc-3672	82	35	)	)	PUNCT
dpc-3672	82	36	,	,	PUNCT
dpc-3672	82	37	and	and	CCONJ
dpc-3672	82	38	il-35	il-35	ADP
dpc-3672	82	39	(	(	PUNCT
dpc-3672	82	40	p	p	X
dpc-3672	82	41	=	=	NOUN
dpc-3672	82	42	0.49	0.49	NUM
dpc-3672	82	43	,	,	PUNCT
dpc-3672	82	44	r	r	NOUN
dpc-3672	82	45	=	=	SYM
dpc-3672	82	46	-0.08	-0.08	PRON
dpc-3672	82	47	)	)	PUNCT
dpc-3672	82	48	levels	level	NOUN
dpc-3672	82	49	were	be	AUX
dpc-3672	82	50	not	not	PART
dpc-3672	82	51	correlated	correlate	VERB
dpc-3672	82	52	(	(	PUNCT
dpc-3672	82	53	figure	figure	NOUN
dpc-3672	82	54	2	2	NUM
dpc-3672	82	55	)	)	PUNCT
dpc-3672	82	56	.	.	PUNCT
dpc-3672	83	1	vida	vida	PROPN
dpc-3672	83	2	scores	score	NOUN
dpc-3672	83	3	and	and	CCONJ
dpc-3672	83	4	il-27	il-27	NUM
dpc-3672	83	5	levels	level	NOUN
dpc-3672	83	6	were	be	AUX
dpc-3672	83	7	negatively	negatively	ADV
dpc-3672	83	8	correlated	correlate	VERB
dpc-3672	83	9	.	.	PUNCT
dpc-3672	84	1	patients	patient	NOUN
dpc-3672	84	2	with	with	ADP
dpc-3672	84	3	high	high	ADJ
dpc-3672	84	4	vida	vida	PROPN
dpc-3672	84	5	scores	score	NOUN
dpc-3672	84	6	and	and	CCONJ
dpc-3672	84	7	active	active	ADJ
dpc-3672	84	8	disease	disease	NOUN
dpc-3672	84	9	had	have	VERB
dpc-3672	84	10	significantly	significantly	ADV
dpc-3672	84	11	lower	low	ADJ
dpc-3672	84	12	levels	level	NOUN
dpc-3672	84	13	of	of	ADP
dpc-3672	84	14	il-27	il-27	PROPN
dpc-3672	84	15	(	(	PUNCT
dpc-3672	84	16	p	p	X
dpc-3672	84	17	=	=	NOUN
dpc-3672	84	18	0.024	0.024	NUM
dpc-3672	84	19	,	,	PUNCT
dpc-3672	84	20	r	r	NOUN
dpc-3672	84	21	=	=	SYM
dpc-3672	84	22	-0.26	-0.26	NOUN
dpc-3672	84	23	)	)	PUNCT
dpc-3672	84	24	.	.	PUNCT
dpc-3672	85	1	no	no	DET
dpc-3672	85	2	correlation	correlation	NOUN
dpc-3672	85	3	was	be	AUX
dpc-3672	85	4	observed	observe	VERB
dpc-3672	85	5	between	between	ADP
dpc-3672	85	6	vida	vida	PROPN
dpc-3672	85	7	and	and	CCONJ
dpc-3672	85	8	serum	serum	NOUN
dpc-3672	85	9	il-12	il-12	NOUN
dpc-3672	85	10	(	(	PUNCT
dpc-3672	85	11	p	p	X
dpc-3672	85	12	=	=	NOUN
dpc-3672	85	13	0.79	0.79	NUM
dpc-3672	85	14	,	,	PUNCT
dpc-3672	85	15	r	r	NOUN
dpc-3672	85	16	=	=	SYM
dpc-3672	85	17	-0.03	-0.03	NUM
dpc-3672	85	18	)	)	PUNCT
dpc-3672	85	19	,	,	PUNCT
dpc-3672	85	20	il-23	il-23	PUNCT
dpc-3672	85	21	(	(	PUNCT
dpc-3672	85	22	p	p	X
dpc-3672	85	23	=	=	NOUN
dpc-3672	85	24	0.58	0.58	NUM
dpc-3672	85	25	,	,	PUNCT
dpc-3672	85	26	r	r	NOUN
dpc-3672	85	27	=	=	SYM
dpc-3672	85	28	-0.08	-0.08	NUM
dpc-3672	85	29	)	)	PUNCT
dpc-3672	85	30	or	or	CCONJ
dpc-3672	85	31	il-35	il-35	ADP
dpc-3672	85	32	(	(	PUNCT
dpc-3672	85	33	p	p	X
dpc-3672	85	34	=	=	NOUN
dpc-3672	85	35	0.91	0.91	NUM
dpc-3672	85	36	,	,	PUNCT
dpc-3672	85	37	r	r	NOUN
dpc-3672	85	38	=	=	SYM
dpc-3672	85	39	-0.01	-0.01	NUM
dpc-3672	85	40	)	)	PUNCT
dpc-3672	85	41	levels	level	NOUN
dpc-3672	85	42	.	.	PUNCT
dpc-3672	86	1	vitiligo	vitiligo	NOUN
dpc-3672	86	2	age	age	NOUN
dpc-3672	86	3	of	of	ADP
dpc-3672	86	4	onset	onset	NOUN
dpc-3672	86	5	and	and	CCONJ
dpc-3672	86	6	the	the	DET
dpc-3672	86	7	levels	level	NOUN
dpc-3672	86	8	of	of	ADP
dpc-3672	86	9	il-12	il-12	NOUN
dpc-3672	86	10	,	,	PUNCT
dpc-3672	86	11	il-23	il-23	NOUN
dpc-3672	86	12	,	,	PUNCT
dpc-3672	86	13	il-27	il-27	NUM
dpc-3672	86	14	,	,	PUNCT
dpc-3672	86	15	or	or	CCONJ
dpc-3672	86	16	il-35	il-35	ADP
dpc-3672	86	17	were	be	AUX
dpc-3672	86	18	not	not	PART
dpc-3672	86	19	found	find	VERB
dpc-3672	86	20	to	to	PART
dpc-3672	86	21	be	be	AUX
dpc-3672	86	22	correlated	correlate	VERB
dpc-3672	86	23	(	(	PUNCT
dpc-3672	86	24	all	all	DET
dpc-3672	86	25	p	p	NOUN
dpc-3672	86	26	values	value	NOUN
dpc-3672	86	27	>	>	X
dpc-3672	86	28	0.05	0.05	NUM
dpc-3672	86	29	)	)	PUNCT
dpc-3672	86	30	,	,	PUNCT
dpc-3672	86	31	but	but	CCONJ
dpc-3672	86	32	il-27	il-27	NUM
dpc-3672	86	33	levels	level	NOUN
dpc-3672	86	34	and	and	CCONJ
dpc-3672	86	35	disease	disease	NOUN
dpc-3672	86	36	duration	duration	NOUN
dpc-3672	86	37	were	be	AUX
dpc-3672	86	38	positively	positively	ADV
dpc-3672	86	39	correlated	correlate	VERB
dpc-3672	86	40	(	(	PUNCT
dpc-3672	86	41	p	p	X
dpc-3672	86	42	=	=	NOUN
dpc-3672	86	43	0.007	0.007	NUM
dpc-3672	86	44	,	,	PUNCT
dpc-3672	86	45	r	r	NOUN
dpc-3672	86	46	=	=	NOUN
dpc-3672	86	47	0.30	0.30	NUM
dpc-3672	86	48	)	)	PUNCT
dpc-3672	86	49	.	.	PUNCT
dpc-3672	87	1	the	the	DET
dpc-3672	87	2	correlation	correlation	NOUN
dpc-3672	87	3	between	between	ADP
dpc-3672	87	4	the	the	DET
dpc-3672	87	5	disease	disease	NOUN
dpc-3672	87	6	duration	duration	NOUN
dpc-3672	87	7	and	and	CCONJ
dpc-3672	87	8	il-23	il-23	NOUN
dpc-3672	87	9	,	,	PUNCT
dpc-3672	87	10	il-27	il-27	NOUN
dpc-3672	87	11	or	or	CCONJ
dpc-3672	87	12	il-35	il-35	ADP
dpc-3672	87	13	level	level	NOUN
dpc-3672	87	14	is	be	AUX
dpc-3672	87	15	shown	show	VERB
dpc-3672	87	16	in	in	ADP
dpc-3672	87	17	the	the	DET
dpc-3672	87	18	figure	figure	NOUN
dpc-3672	87	19	3	3	NUM
dpc-3672	87	20	.	.	PUNCT
dpc-3672	88	1	patients	patient	NOUN
dpc-3672	88	2	with	with	ADP
dpc-3672	88	3	and	and	CCONJ
dpc-3672	88	4	without	without	ADP
dpc-3672	88	5	a	a	DET
dpc-3672	88	6	non	non	ADJ
dpc-3672	88	7	-	-	ADJ
dpc-3672	88	8	vitiligo	vitiligo	ADJ
dpc-3672	88	9	autoimmune	autoimmune	ADJ
dpc-3672	88	10	disease	disease	NOUN
dpc-3672	88	11	,	,	PUNCT
dpc-3672	88	12	patients	patient	NOUN
dpc-3672	88	13	with	with	ADP
dpc-3672	88	14	and	and	CCONJ
dpc-3672	88	15	without	without	ADP
dpc-3672	88	16	a	a	DET
dpc-3672	88	17	family	family	NOUN
dpc-3672	88	18	history	history	NOUN
dpc-3672	88	19	of	of	ADP
dpc-3672	88	20	vitiligo	vitiligo	NOUN
dpc-3672	88	21	,	,	PUNCT
dpc-3672	88	22	and	and	CCONJ
dpc-3672	88	23	patients	patient	NOUN
dpc-3672	88	24	with	with	ADP
dpc-3672	88	25	and	and	CCONJ
dpc-3672	88	26	without	without	ADP
dpc-3672	88	27	a	a	DET
dpc-3672	88	28	family	family	NOUN
dpc-3672	88	29	history	history	NOUN
dpc-3672	88	30	of	of	ADP
dpc-3672	88	31	nonvitiligo	nonvitiligo	PROPN
dpc-3672	88	32	autoimmune	autoimmune	PROPN
dpc-3672	88	33	disease	disease	NOUN
dpc-3672	88	34	had	have	VERB
dpc-3672	88	35	similar	similar	ADJ
dpc-3672	88	36	levels	level	NOUN
dpc-3672	88	37	of	of	ADP
dpc-3672	88	38	serum	serum	NOUN
dpc-3672	88	39	il-12	il-12	NOUN
dpc-3672	88	40	,	,	PUNCT
dpc-3672	88	41	il-23	il-23	NOUN
dpc-3672	88	42	,	,	PUNCT
dpc-3672	88	43	il-27	il-27	NUM
dpc-3672	88	44	,	,	PUNCT
dpc-3672	88	45	and	and	CCONJ
dpc-3672	88	46	il-35	il-35	X
dpc-3672	88	47	(	(	PUNCT
dpc-3672	88	48	all	all	DET
dpc-3672	88	49	p	p	NOUN
dpc-3672	88	50	values	value	NOUN
dpc-3672	88	51	>	>	X
dpc-3672	88	52	0.05	0.05	NUM
dpc-3672	88	53	)	)	PUNCT
dpc-3672	88	54	.	.	PUNCT
dpc-3672	89	1	and	and	CCONJ
dpc-3672	89	2	258.7	258.7	NUM
dpc-3672	89	3	(	(	PUNCT
dpc-3672	89	4	sd=85.5	sd=85.5	PROPN
dpc-3672	89	5	)	)	PUNCT
dpc-3672	89	6	in	in	ADP
dpc-3672	89	7	controls	control	NOUN
dpc-3672	89	8	.	.	PUNCT
dpc-3672	90	1	serum	serum	PROPN
dpc-3672	90	2	il-27	il-27	PROPN
dpc-3672	90	3	levels	level	NOUN
dpc-3672	90	4	were	be	AUX
dpc-3672	90	5	statistically	statistically	ADV
dpc-3672	90	6	lower	low	ADJ
dpc-3672	90	7	in	in	ADP
dpc-3672	90	8	patient	patient	ADJ
dpc-3672	90	9	group	group	NOUN
dpc-3672	90	10	compared	compare	VERB
dpc-3672	90	11	to	to	ADP
dpc-3672	90	12	healthy	healthy	ADJ
dpc-3672	90	13	controls	control	NOUN
dpc-3672	90	14	(	(	PUNCT
dpc-3672	90	15	p	p	X
dpc-3672	90	16	<	<	X
dpc-3672	90	17	0.001	0.001	NUM
dpc-3672	90	18	)	)	PUNCT
dpc-3672	90	19	(	(	PUNCT
dpc-3672	90	20	figure	figure	NOUN
dpc-3672	90	21	1	1	NUM
dpc-3672	90	22	)	)	PUNCT
dpc-3672	90	23	.	.	PUNCT
dpc-3672	91	1	serum	serum	NOUN
dpc-3672	91	2	il-23	il-23	NOUN
dpc-3672	91	3	levels	level	NOUN
dpc-3672	91	4	were	be	AUX
dpc-3672	91	5	similar	similar	ADJ
dpc-3672	91	6	among	among	ADP
dpc-3672	91	7	patient	patient	NOUN
dpc-3672	91	8	and	and	CCONJ
dpc-3672	91	9	control	control	NOUN
dpc-3672	91	10	groups	group	NOUN
dpc-3672	91	11	(	(	PUNCT
dpc-3672	91	12	p	p	X
dpc-3672	91	13	=	=	NOUN
dpc-3672	91	14	0.78	0.78	NUM
dpc-3672	91	15	)	)	PUNCT
dpc-3672	91	16	(	(	PUNCT
dpc-3672	91	17	figure	figure	NOUN
dpc-3672	91	18	1	1	NUM
dpc-3672	91	19	)	)	PUNCT
dpc-3672	91	20	.	.	PUNCT
dpc-3672	92	1	association	association	NOUN
dpc-3672	92	2	of	of	ADP
dpc-3672	92	3	the	the	DET
dpc-3672	92	4	il-12	il-12	NOUN
dpc-3672	92	5	cytokine	cytokine	ADJ
dpc-3672	92	6	family	family	NOUN
dpc-3672	92	7	with	with	ADP
dpc-3672	92	8	 	 	SPACE
dpc-3672	92	9	patient	patient	ADJ
dpc-3672	92	10	demographics	demographic	NOUN
dpc-3672	92	11	and	and	CCONJ
dpc-3672	92	12	vitiligo	vitiligo	NOUN
dpc-3672	92	13	disease	disease	NOUN
dpc-3672	92	14	 	 	SPACE
dpc-3672	92	15	characteristics	characteristic	NOUN
dpc-3672	92	16	serum	serum	VERB
dpc-3672	92	17	il-12	il-12	NOUN
dpc-3672	92	18	,	,	PUNCT
dpc-3672	92	19	il-23	il-23	NOUN
dpc-3672	92	20	,	,	PUNCT
dpc-3672	92	21	il-27	il-27	NUM
dpc-3672	92	22	,	,	PUNCT
dpc-3672	92	23	and	and	CCONJ
dpc-3672	92	24	il-35	il-35	ADP
dpc-3672	92	25	levels	level	NOUN
dpc-3672	92	26	were	be	AUX
dpc-3672	92	27	similar	similar	ADJ
dpc-3672	92	28	among	among	ADP
dpc-3672	92	29	male	male	ADJ
dpc-3672	92	30	and	and	CCONJ
dpc-3672	92	31	female	female	ADJ
dpc-3672	92	32	patients	patient	NOUN
dpc-3672	92	33	(	(	PUNCT
dpc-3672	92	34	p	p	X
dpc-3672	92	35	=	=	PROPN
dpc-3672	92	36	0.93	0.93	NUM
dpc-3672	92	37	,	,	PUNCT
dpc-3672	92	38	0.25	0.25	NUM
dpc-3672	92	39	,	,	PUNCT
dpc-3672	92	40	0.79	0.79	NUM
dpc-3672	92	41	,	,	PUNCT
dpc-3672	92	42	and	and	CCONJ
dpc-3672	92	43	0.96	0.96	NUM
dpc-3672	92	44	,	,	PUNCT
dpc-3672	92	45	respectively	respectively	ADV
dpc-3672	92	46	)	)	PUNCT
dpc-3672	92	47	.	.	PUNCT
dpc-3672	93	1	serum	serum	NOUN
dpc-3672	93	2	il-23	il-23	NOUN
dpc-3672	93	3	levels	level	NOUN
dpc-3672	93	4	positively	positively	ADV
dpc-3672	93	5	correlated	correlate	VERB
dpc-3672	93	6	with	with	ADP
dpc-3672	93	7	age	age	NOUN
dpc-3672	93	8	(	(	PUNCT
dpc-3672	93	9	p	p	X
dpc-3672	93	10	=	=	PUNCT
dpc-3672	93	11	0.025	0.025	NUM
dpc-3672	93	12	,	,	PUNCT
dpc-3672	93	13	r	r	NOUN
dpc-3672	93	14	=	=	NOUN
dpc-3672	93	15	0.34	0.34	NUM
dpc-3672	93	16	)	)	PUNCT
dpc-3672	93	17	but	but	CCONJ
dpc-3672	93	18	no	no	DET
dpc-3672	93	19	statistically	statistically	ADV
dpc-3672	93	20	significant	significant	ADJ
dpc-3672	93	21	correlation	correlation	NOUN
dpc-3672	93	22	was	be	AUX
dpc-3672	93	23	observed	observe	VERB
dpc-3672	93	24	between	between	ADP
dpc-3672	93	25	age	age	NOUN
dpc-3672	93	26	and	and	CCONJ
dpc-3672	93	27	serum	serum	NOUN
dpc-3672	93	28	il-12	il-12	NOUN
dpc-3672	93	29	(	(	PUNCT
dpc-3672	93	30	p	p	X
dpc-3672	93	31	=	=	NOUN
dpc-3672	93	32	0.19	0.19	NUM
dpc-3672	93	33	,	,	PUNCT
dpc-3672	93	34	r=	r=	NOUN
dpc-3672	93	35	-0.11	-0.11	NUM
dpc-3672	93	36	)	)	PUNCT
dpc-3672	93	37	,	,	PUNCT
dpc-3672	93	38	il-27	il-27	PUNCT
dpc-3672	93	39	(	(	PUNCT
dpc-3672	93	40	p	p	X
dpc-3672	93	41	=	=	NOUN
dpc-3672	93	42	0.29	0.29	NUM
dpc-3672	93	43	,	,	PUNCT
dpc-3672	93	44	r	r	NOUN
dpc-3672	93	45	=	=	NOUN
dpc-3672	93	46	0.12	0.12	NUM
dpc-3672	93	47	)	)	PUNCT
dpc-3672	93	48	,	,	PUNCT
dpc-3672	93	49	and	and	CCONJ
dpc-3672	93	50	il-35	il-35	ADP
dpc-3672	93	51	(	(	PUNCT
dpc-3672	93	52	p	p	X
dpc-3672	93	53	=	=	NOUN
dpc-3672	93	54	0.91	0.91	NUM
dpc-3672	93	55	,	,	PUNCT
dpc-3672	93	56	r	r	NOUN
dpc-3672	93	57	=	=	SYM
dpc-3672	93	58	-0.01	-0.01	NUM
dpc-3672	93	59	)	)	PUNCT
dpc-3672	93	60	levels	level	NOUN
dpc-3672	93	61	.	.	PUNCT
dpc-3672	94	1	serum	serum	NOUN
dpc-3672	94	2	il-12	il-12	NOUN
dpc-3672	94	3	,	,	PUNCT
dpc-3672	94	4	il-23	il-23	NOUN
dpc-3672	94	5	,	,	PUNCT
dpc-3672	94	6	il-27	il-27	NUM
dpc-3672	94	7	,	,	PUNCT
dpc-3672	94	8	and	and	CCONJ
dpc-3672	94	9	il-35	il-35	ADP
dpc-3672	94	10	levels	level	NOUN
dpc-3672	94	11	were	be	AUX
dpc-3672	94	12	similar	similar	ADJ
dpc-3672	94	13	among	among	ADP
dpc-3672	94	14	vitiligo	vitiligo	ADJ
dpc-3672	94	15	patients	patient	NOUN
dpc-3672	94	16	with	with	ADP
dpc-3672	94	17	localized	localized	ADJ
dpc-3672	94	18	and	and	CCONJ
dpc-3672	94	19	generalized	generalized	ADJ
dpc-3672	94	20	vitiligo	vitiligo	NOUN
dpc-3672	94	21	(	(	PUNCT
dpc-3672	94	22	p	p	X
dpc-3672	94	23	=	=	NOUN
dpc-3672	94	24	0.44	0.44	NUM
dpc-3672	94	25	,	,	PUNCT
dpc-3672	94	26	0.16	0.16	NUM
dpc-3672	94	27	,	,	PUNCT
dpc-3672	94	28	0.49	0.49	NUM
dpc-3672	94	29	,	,	PUNCT
dpc-3672	94	30	0.32	0.32	NUM
dpc-3672	94	31	,	,	PUNCT
dpc-3672	94	32	respectively	respectively	ADV
dpc-3672	94	33	)	)	PUNCT
dpc-3672	94	34	.	.	PUNCT
dpc-3672	95	1	while	while	SCONJ
dpc-3672	95	2	there	there	PRON
dpc-3672	95	3	was	be	VERB
dpc-3672	95	4	a	a	DET
dpc-3672	95	5	significant	significant	ADJ
dpc-3672	95	6	correlation	correlation	NOUN
dpc-3672	95	7	between	between	ADP
dpc-3672	95	8	the	the	DET
dpc-3672	95	9	vasi	vasi	PROPN
dpc-3672	95	10	value	value	NOUN
dpc-3672	95	11	and	and	CCONJ
dpc-3672	95	12	figure	figure	NOUN
dpc-3672	95	13	2	2	NUM
dpc-3672	95	14	.	.	PUNCT
dpc-3672	96	1	the	the	DET
dpc-3672	96	2	correlation	correlation	NOUN
dpc-3672	96	3	between	between	ADP
dpc-3672	96	4	vitiligo	vitiligo	NOUN
dpc-3672	96	5	area	area	NOUN
dpc-3672	96	6	scoring	scoring	NOUN
dpc-3672	96	7	index	index	NOUN
dpc-3672	96	8	(	(	PUNCT
dpc-3672	96	9	vasi	vasi	PROPN
dpc-3672	96	10	)	)	PUNCT
dpc-3672	96	11	and	and	CCONJ
dpc-3672	96	12	the	the	DET
dpc-3672	96	13	interleukin-12	interleukin-12	PROPN
dpc-3672	96	14	family	family	NOUN
dpc-3672	96	15	of	of	ADP
dpc-3672	96	16	cytokines	cytokine	NOUN
dpc-3672	96	17	.	.	PUNCT
dpc-3672	97	1	original	original	ADJ
dpc-3672	97	2	article	article	NOUN
dpc-3672	97	3	|	|	ADV
dpc-3672	97	4	dermatol	dermatol	ADJ
dpc-3672	97	5	pract	pract	NOUN
dpc-3672	97	6	concept	concept	NOUN
dpc-3672	97	7	.	.	PUNCT
dpc-3672	98	1	2024;14(2):e2024069	2024;14(2):e2024069	NUM
dpc-3672	98	2	5	5	NUM
dpc-3672	98	3	the	the	DET
dpc-3672	98	4	release	release	NOUN
dpc-3672	98	5	ifn	ifn	NOUN
dpc-3672	98	6	-	-	PUNCT
dpc-3672	98	7	γ	γ	NOUN
dpc-3672	98	8	and	and	CCONJ
dpc-3672	98	9	the	the	DET
dpc-3672	98	10	development	development	NOUN
dpc-3672	98	11	of	of	ADP
dpc-3672	98	12	t	t	PROPN
dpc-3672	98	13	helper	helper	NOUN
dpc-3672	98	14	type	type	NOUN
dpc-3672	98	15	1	1	NUM
dpc-3672	98	16	(	(	PUNCT
dpc-3672	98	17	th1	th1	NOUN
dpc-3672	98	18	)	)	PUNCT
dpc-3672	98	19	immune	immune	ADJ
dpc-3672	98	20	response	response	NOUN
dpc-3672	98	21	,	,	PUNCT
dpc-3672	98	22	eliminating	eliminate	VERB
dpc-3672	98	23	intracellular	intracellular	ADJ
dpc-3672	98	24	bacteria	bacteria	NOUN
dpc-3672	98	25	and	and	CCONJ
dpc-3672	98	26	viruses	virus	NOUN
dpc-3672	98	27	and	and	CCONJ
dpc-3672	98	28	stimulating	stimulate	VERB
dpc-3672	98	29	inflammation	inflammation	NOUN
dpc-3672	98	30	[	[	X
dpc-3672	98	31	9,10	9,10	NUM
dpc-3672	98	32	]	]	X
dpc-3672	98	33	.	.	PUNCT
dpc-3672	99	1	in	in	ADP
dpc-3672	99	2	our	our	PRON
dpc-3672	99	3	study	study	NOUN
dpc-3672	99	4	,	,	PUNCT
dpc-3672	99	5	we	we	PRON
dpc-3672	99	6	found	find	VERB
dpc-3672	99	7	significantly	significantly	ADV
dpc-3672	99	8	higher	high	ADJ
dpc-3672	99	9	levels	level	NOUN
dpc-3672	99	10	of	of	ADP
dpc-3672	99	11	serum	serum	NOUN
dpc-3672	99	12	il-12	il-12	NOUN
dpc-3672	99	13	in	in	ADP
dpc-3672	99	14	vitiligo	vitiligo	ADJ
dpc-3672	99	15	patients	patient	NOUN
dpc-3672	99	16	compared	compare	VERB
dpc-3672	99	17	to	to	ADP
dpc-3672	99	18	healthy	healthy	ADJ
dpc-3672	99	19	volunteers	volunteer	NOUN
dpc-3672	99	20	.	.	PUNCT
dpc-3672	100	1	in	in	ADP
dpc-3672	100	2	a	a	DET
dpc-3672	100	3	study	study	NOUN
dpc-3672	100	4	on	on	ADP
dpc-3672	100	5	innate	innate	ADJ
dpc-3672	100	6	pro	pro	ADJ
dpc-3672	100	7	-	-	ADJ
dpc-3672	100	8	inflammatory	inflammatory	ADJ
dpc-3672	100	9	cytokines	cytokine	NOUN
dpc-3672	100	10	in	in	ADP
dpc-3672	100	11	patients	patient	NOUN
dpc-3672	100	12	with	with	ADP
dpc-3672	100	13	vitiligo	vitiligo	NOUN
dpc-3672	100	14	,	,	PUNCT
dpc-3672	100	15	gholijani	gholijani	PROPN
dpc-3672	100	16	et	et	PROPN
dpc-3672	100	17	al	al	PROPN
dpc-3672	100	18	found	find	VERB
dpc-3672	100	19	high	high	ADJ
dpc-3672	100	20	levels	level	NOUN
dpc-3672	100	21	of	of	ADP
dpc-3672	100	22	serum	serum	NOUN
dpc-3672	100	23	il-12	il-12	NOUN
dpc-3672	100	24	,	,	PUNCT
dpc-3672	100	25	which	which	PRON
dpc-3672	100	26	was	be	AUX
dpc-3672	100	27	consistent	consistent	ADJ
dpc-3672	100	28	with	with	ADP
dpc-3672	100	29	our	our	PRON
dpc-3672	100	30	findings	finding	NOUN
dpc-3672	100	31	[	[	X
dpc-3672	100	32	11	11	NUM
dpc-3672	100	33	]	]	PUNCT
dpc-3672	100	34	.	.	PUNCT
dpc-3672	101	1	il-12	il-12	NOUN
dpc-3672	101	2	may	may	AUX
dpc-3672	101	3	play	play	VERB
dpc-3672	101	4	a	a	DET
dpc-3672	101	5	role	role	NOUN
dpc-3672	101	6	in	in	ADP
dpc-3672	101	7	the	the	DET
dpc-3672	101	8	pathogenesis	pathogenesis	NOUN
dpc-3672	101	9	of	of	ADP
dpc-3672	101	10	vitiligo	vitiligo	NOUN
dpc-3672	101	11	by	by	ADP
dpc-3672	101	12	affecting	affect	VERB
dpc-3672	101	13	many	many	ADJ
dpc-3672	101	14	pathways	pathway	NOUN
dpc-3672	101	15	.	.	PUNCT
dpc-3672	102	1	il-12	il-12	NOUN
dpc-3672	102	2	is	be	AUX
dpc-3672	102	3	known	know	VERB
dpc-3672	102	4	to	to	PART
dpc-3672	102	5	activate	activate	VERB
dpc-3672	102	6	type	type	NOUN
dpc-3672	102	7	1	1	NUM
dpc-3672	102	8	cytotoxic	cytotoxic	ADJ
dpc-3672	102	9	cd8	cd8	PROPN
dpc-3672	102	10	t	t	PROPN
dpc-3672	102	11	cells	cell	NOUN
dpc-3672	102	12	to	to	PART
dpc-3672	102	13	direct	direct	VERB
dpc-3672	102	14	the	the	DET
dpc-3672	102	15	granzyme	granzyme	NOUN
dpc-3672	102	16	and	and	CCONJ
dpc-3672	102	17	perforin	perforin	NOUN
dpc-3672	102	18	-	-	PUNCT
dpc-3672	102	19	mediated	mediate	VERB
dpc-3672	102	20	cytotoxic	cytotoxic	ADJ
dpc-3672	102	21	activity	activity	NOUN
dpc-3672	102	22	[	[	X
dpc-3672	102	23	10	10	NUM
dpc-3672	102	24	]	]	PUNCT
dpc-3672	102	25	.	.	PUNCT
dpc-3672	103	1	il-12	il-12	NOUN
dpc-3672	103	2	may	may	AUX
dpc-3672	103	3	also	also	ADV
dpc-3672	103	4	contribute	contribute	VERB
dpc-3672	103	5	to	to	ADP
dpc-3672	103	6	the	the	DET
dpc-3672	103	7	formation	formation	NOUN
dpc-3672	103	8	of	of	ADP
dpc-3672	103	9	vitiligo	vitiligo	NOUN
dpc-3672	103	10	by	by	ADP
dpc-3672	103	11	affecting	affect	VERB
dpc-3672	103	12	the	the	DET
dpc-3672	103	13	presentation	presentation	NOUN
dpc-3672	103	14	of	of	ADP
dpc-3672	103	15	autoantigens	autoantigen	NOUN
dpc-3672	103	16	.	.	PUNCT
dpc-3672	104	1	in	in	ADP
dpc-3672	104	2	a	a	DET
dpc-3672	104	3	study	study	NOUN
dpc-3672	104	4	on	on	ADP
dpc-3672	104	5	generalized	generalized	ADJ
dpc-3672	104	6	vitiligo	vitiligo	NOUN
dpc-3672	104	7	patients	patient	NOUN
dpc-3672	104	8	,	,	PUNCT
dpc-3672	104	9	singh	singh	PROPN
dpc-3672	104	10	et	et	PROPN
dpc-3672	104	11	al	al	PROPN
dpc-3672	104	12	investigated	investigate	VERB
dpc-3672	104	13	the	the	DET
dpc-3672	104	14	relationship	relationship	NOUN
dpc-3672	104	15	between	between	ADP
dpc-3672	104	16	il-12	il-12	NOUN
dpc-3672	104	17	levels	level	NOUN
dpc-3672	104	18	and	and	CCONJ
dpc-3672	104	19	dendritic	dendritic	ADJ
dpc-3672	104	20	cell	cell	NOUN
dpc-3672	104	21	counts	count	NOUN
dpc-3672	104	22	of	of	ADP
dpc-3672	104	23	the	the	DET
dpc-3672	104	24	vitiligo	vitiligo	NOUN
dpc-3672	104	25	and	and	CCONJ
dpc-3672	104	26	control	control	NOUN
dpc-3672	104	27	groups	group	NOUN
dpc-3672	104	28	.	.	PUNCT
dpc-3672	105	1	they	they	PRON
dpc-3672	105	2	found	find	VERB
dpc-3672	105	3	an	an	DET
dpc-3672	105	4	increase	increase	NOUN
dpc-3672	105	5	in	in	ADP
dpc-3672	105	6	dendritic	dendritic	ADJ
dpc-3672	105	7	cells	cell	NOUN
dpc-3672	105	8	in	in	ADP
dpc-3672	105	9	addition	addition	NOUN
dpc-3672	105	10	to	to	ADP
dpc-3672	105	11	an	an	DET
dpc-3672	105	12	increase	increase	NOUN
dpc-3672	105	13	in	in	ADP
dpc-3672	105	14	serum	serum	NOUN
dpc-3672	105	15	il-12	il-12	NOUN
dpc-3672	105	16	levels	level	NOUN
dpc-3672	105	17	in	in	ADP
dpc-3672	105	18	the	the	DET
dpc-3672	105	19	vitiligo	vitiligo	NOUN
dpc-3672	105	20	group	group	NOUN
dpc-3672	105	21	.	.	PUNCT
dpc-3672	106	1	the	the	DET
dpc-3672	106	2	authors	author	NOUN
dpc-3672	106	3	stated	state	VERB
dpc-3672	106	4	that	that	SCONJ
dpc-3672	106	5	increased	increase	VERB
dpc-3672	106	6	dendritic	dendritic	ADJ
dpc-3672	106	7	cell	cell	NOUN
dpc-3672	106	8	frequencies	frequency	NOUN
dpc-3672	106	9	and	and	CCONJ
dpc-3672	106	10	proinflammatory	proinflammatory	ADJ
dpc-3672	106	11	cytokines	cytokine	NOUN
dpc-3672	106	12	including	include	VERB
dpc-3672	106	13	il-12	il-12	PRON
dpc-3672	106	14	may	may	AUX
dpc-3672	106	15	be	be	AUX
dpc-3672	106	16	associated	associate	VERB
dpc-3672	106	17	with	with	ADP
dpc-3672	106	18	defective	defective	ADJ
dpc-3672	106	19	antigen	antigen	ADJ
dpc-3672	106	20	presentation	presentation	NOUN
dpc-3672	106	21	[	[	X
dpc-3672	106	22	7	7	NUM
dpc-3672	106	23	]	]	PUNCT
dpc-3672	106	24	.	.	PUNCT
dpc-3672	107	1	conclusions	conclusion	NOUN
dpc-3672	107	2	we	we	PRON
dpc-3672	107	3	compared	compare	VERB
dpc-3672	107	4	the	the	DET
dpc-3672	107	5	levels	level	NOUN
dpc-3672	107	6	of	of	ADP
dpc-3672	107	7	il-12	il-12	NOUN
dpc-3672	107	8	,	,	PUNCT
dpc-3672	107	9	il-23	il-23	NOUN
dpc-3672	107	10	,	,	PUNCT
dpc-3672	107	11	il-27	il-27	PUNCT
dpc-3672	107	12	and	and	CCONJ
dpc-3672	107	13	il-35	il-35	X
dpc-3672	107	14	in	in	ADP
dpc-3672	107	15	vitiligo	vitiligo	ADJ
dpc-3672	107	16	patients	patient	NOUN
dpc-3672	107	17	and	and	CCONJ
dpc-3672	107	18	healthy	healthy	ADJ
dpc-3672	107	19	volunteers	volunteer	NOUN
dpc-3672	107	20	.	.	PUNCT
dpc-3672	108	1	patients	patient	NOUN
dpc-3672	108	2	had	have	VERB
dpc-3672	108	3	higher	high	ADJ
dpc-3672	108	4	levels	level	NOUN
dpc-3672	108	5	of	of	ADP
dpc-3672	108	6	il-12	il-12	NOUN
dpc-3672	108	7	and	and	CCONJ
dpc-3672	108	8	il-35	il-35	ADP
dpc-3672	108	9	,	,	PUNCT
dpc-3672	108	10	and	and	CCONJ
dpc-3672	108	11	lower	low	ADJ
dpc-3672	108	12	levels	level	NOUN
dpc-3672	108	13	of	of	ADP
dpc-3672	108	14	il-27	il-27	NUM
dpc-3672	108	15	.	.	PUNCT
dpc-3672	109	1	while	while	SCONJ
dpc-3672	109	2	patient	patient	ADJ
dpc-3672	109	3	and	and	CCONJ
dpc-3672	109	4	control	control	NOUN
dpc-3672	109	5	groups	group	NOUN
dpc-3672	109	6	had	have	VERB
dpc-3672	109	7	similar	similar	ADJ
dpc-3672	109	8	il-23	il-23	NOUN
dpc-3672	109	9	levels	level	NOUN
dpc-3672	109	10	,	,	PUNCT
dpc-3672	109	11	serum	serum	NOUN
dpc-3672	109	12	il-23	il-23	NOUN
dpc-3672	109	13	levels	level	NOUN
dpc-3672	109	14	were	be	AUX
dpc-3672	109	15	correlated	correlate	VERB
dpc-3672	109	16	with	with	ADP
dpc-3672	109	17	the	the	DET
dpc-3672	109	18	extensiveness	extensiveness	NOUN
dpc-3672	109	19	of	of	ADP
dpc-3672	109	20	the	the	DET
dpc-3672	109	21	disease	disease	NOUN
dpc-3672	109	22	.	.	PUNCT
dpc-3672	110	1	we	we	PRON
dpc-3672	110	2	observed	observe	VERB
dpc-3672	110	3	a	a	DET
dpc-3672	110	4	negative	negative	ADJ
dpc-3672	110	5	correlation	correlation	NOUN
dpc-3672	110	6	between	between	ADP
dpc-3672	110	7	serum	serum	NOUN
dpc-3672	110	8	il-27	il-27	PART
dpc-3672	110	9	levels	level	NOUN
dpc-3672	110	10	and	and	CCONJ
dpc-3672	110	11	vida	vida	PROPN
dpc-3672	110	12	scores	score	NOUN
dpc-3672	110	13	,	,	PUNCT
dpc-3672	110	14	and	and	CCONJ
dpc-3672	110	15	a	a	DET
dpc-3672	110	16	positive	positive	ADJ
dpc-3672	110	17	correlation	correlation	NOUN
dpc-3672	110	18	between	between	ADP
dpc-3672	110	19	disease	disease	NOUN
dpc-3672	110	20	duration	duration	NOUN
dpc-3672	110	21	and	and	CCONJ
dpc-3672	110	22	serum	serum	NOUN
dpc-3672	110	23	il-27	il-27	PART
dpc-3672	110	24	levels	level	NOUN
dpc-3672	110	25	.	.	PUNCT
dpc-3672	111	1	il-12	il-12	NOUN
dpc-3672	111	2	is	be	AUX
dpc-3672	111	3	released	release	VERB
dpc-3672	111	4	from	from	ADP
dpc-3672	111	5	dendritic	dendritic	ADJ
dpc-3672	111	6	cells	cell	NOUN
dpc-3672	111	7	,	,	PUNCT
dpc-3672	111	8	macrophages	macrophage	NOUN
dpc-3672	111	9	and	and	CCONJ
dpc-3672	111	10	b	b	NOUN
dpc-3672	111	11	cells	cell	NOUN
dpc-3672	111	12	in	in	ADP
dpc-3672	111	13	response	response	NOUN
dpc-3672	111	14	to	to	ADP
dpc-3672	111	15	internal	internal	ADJ
dpc-3672	111	16	and	and	CCONJ
dpc-3672	111	17	external	external	ADJ
dpc-3672	111	18	stimuli	stimulus	NOUN
dpc-3672	111	19	.	.	PUNCT
dpc-3672	112	1	comprised	comprise	VERB
dpc-3672	112	2	of	of	ADP
dpc-3672	112	3	p40	p40	NOUN
dpc-3672	112	4	and	and	CCONJ
dpc-3672	112	5	p35	p35	NOUN
dpc-3672	112	6	subunits	subunit	NOUN
dpc-3672	112	7	,	,	PUNCT
dpc-3672	112	8	il-12	il-12	PRON
dpc-3672	112	9	exerts	exert	VERB
dpc-3672	112	10	its	its	PRON
dpc-3672	112	11	effect	effect	NOUN
dpc-3672	112	12	by	by	ADP
dpc-3672	112	13	binding	bind	VERB
dpc-3672	112	14	to	to	ADP
dpc-3672	112	15	the	the	DET
dpc-3672	112	16	heterodimeric	heterodimeric	ADJ
dpc-3672	112	17	receptor	receptor	NOUN
dpc-3672	112	18	that	that	PRON
dpc-3672	112	19	is	be	AUX
dpc-3672	112	20	made	make	VERB
dpc-3672	112	21	up	up	ADP
dpc-3672	112	22	of	of	ADP
dpc-3672	112	23	the	the	DET
dpc-3672	112	24	il-12rβ1	il-12rβ1	PROPN
dpc-3672	112	25	and	and	CCONJ
dpc-3672	112	26	il-12rβ2	il-12rβ2	VERB
dpc-3672	112	27	subunits	subunit	NOUN
dpc-3672	112	28	.	.	PUNCT
dpc-3672	113	1	binding	bind	VERB
dpc-3672	113	2	of	of	ADP
dpc-3672	113	3	il-12	il-12	NOUN
dpc-3672	113	4	to	to	ADP
dpc-3672	113	5	the	the	DET
dpc-3672	113	6	receptor	receptor	NOUN
dpc-3672	113	7	activates	activate	VERB
dpc-3672	113	8	janus	janus	PROPN
dpc-3672	113	9	kinase	kinase	PROPN
dpc-3672	113	10	2	2	PROPN
dpc-3672	113	11	(	(	PUNCT
dpc-3672	113	12	jak2	jak2	PROPN
dpc-3672	113	13	)	)	PUNCT
dpc-3672	113	14	and	and	CCONJ
dpc-3672	113	15	tyrosine	tyrosine	NOUN
dpc-3672	113	16	kinase	kinase	NOUN
dpc-3672	113	17	2	2	NUM
dpc-3672	113	18	(	(	PUNCT
dpc-3672	113	19	tyk2	tyk2	NOUN
dpc-3672	113	20	)	)	PUNCT
dpc-3672	113	21	,	,	PUNCT
dpc-3672	113	22	phosphorylating	phosphorylate	VERB
dpc-3672	113	23	stat4	stat4	NOUN
dpc-3672	113	24	for	for	ADP
dpc-3672	113	25	biological	biological	ADJ
dpc-3672	113	26	effects	effect	NOUN
dpc-3672	113	27	[	[	X
dpc-3672	113	28	9	9	NUM
dpc-3672	113	29	]	]	PUNCT
dpc-3672	113	30	.	.	PUNCT
dpc-3672	114	1	il-12	il-12	NOUN
dpc-3672	114	2	is	be	AUX
dpc-3672	114	3	a	a	DET
dpc-3672	114	4	proinflammatory	proinflammatory	ADJ
dpc-3672	114	5	cytokine	cytokine	NOUN
dpc-3672	114	6	and	and	CCONJ
dpc-3672	114	7	it	it	PRON
dpc-3672	114	8	performs	perform	VERB
dpc-3672	114	9	these	these	DET
dpc-3672	114	10	functions	function	NOUN
dpc-3672	114	11	mainly	mainly	ADV
dpc-3672	114	12	through	through	ADP
dpc-3672	114	13	its	its	PRON
dpc-3672	114	14	effects	effect	NOUN
dpc-3672	114	15	on	on	ADP
dpc-3672	114	16	t	t	PROPN
dpc-3672	114	17	cell	cell	NOUN
dpc-3672	114	18	differentiation	differentiation	NOUN
dpc-3672	114	19	and	and	CCONJ
dpc-3672	114	20	functions	function	NOUN
dpc-3672	114	21	.	.	PUNCT
dpc-3672	115	1	recognition	recognition	NOUN
dpc-3672	115	2	of	of	ADP
dpc-3672	115	3	pathogens	pathogen	NOUN
dpc-3672	115	4	by	by	ADP
dpc-3672	115	5	an	an	DET
dpc-3672	115	6	antigenpresenting	antigenpresente	VERB
dpc-3672	115	7	cell	cell	NOUN
dpc-3672	115	8	stimulates	stimulate	VERB
dpc-3672	115	9	the	the	DET
dpc-3672	115	10	production	production	NOUN
dpc-3672	115	11	of	of	ADP
dpc-3672	115	12	il-12	il-12	NOUN
dpc-3672	115	13	,	,	PUNCT
dpc-3672	115	14	which	which	PRON
dpc-3672	115	15	in	in	ADP
dpc-3672	115	16	turn	turn	NOUN
dpc-3672	115	17	stimulates	stimulate	NOUN
dpc-3672	115	18	figure	figure	NOUN
dpc-3672	115	19	3	3	NUM
dpc-3672	115	20	.	.	PUNCT
dpc-3672	116	1	the	the	DET
dpc-3672	116	2	correlation	correlation	NOUN
dpc-3672	116	3	between	between	ADP
dpc-3672	116	4	vitiligo	vitiligo	NOUN
dpc-3672	116	5	duration	duration	NOUN
dpc-3672	116	6	and	and	CCONJ
dpc-3672	116	7	the	the	DET
dpc-3672	116	8	interleukin-12	interleukin-12	PROPN
dpc-3672	116	9	family	family	NOUN
dpc-3672	116	10	of	of	ADP
dpc-3672	116	11	cytokines	cytokine	NOUN
dpc-3672	116	12	.	.	PUNCT
dpc-3672	117	1	6	6	NUM
dpc-3672	117	2	original	original	ADJ
dpc-3672	117	3	article	article	NOUN
dpc-3672	117	4	|	|	ADV
dpc-3672	117	5	dermatol	dermatol	ADJ
dpc-3672	117	6	pract	pract	NOUN
dpc-3672	117	7	concept	concept	NOUN
dpc-3672	117	8	.	.	PUNCT
dpc-3672	118	1	2024;14(2):e2024069	2024;14(2):e2024069	NUM
dpc-3672	118	2	of	of	ADP
dpc-3672	118	3	il-23	il-23	NOUN
dpc-3672	118	4	is	be	AUX
dpc-3672	118	5	generally	generally	ADV
dpc-3672	118	6	proinflammatory	proinflammatory	ADJ
dpc-3672	118	7	.	.	PUNCT
dpc-3672	119	1	il-23	il-23	PUNCT
dpc-3672	119	2	stimulates	stimulate	NOUN
dpc-3672	119	3	il-17	il-17	NUM
dpc-3672	119	4	and/or	and/or	CCONJ
dpc-3672	119	5	il-22	il-22	ADJ
dpc-3672	119	6	production	production	NOUN
dpc-3672	119	7	from	from	ADP
dpc-3672	119	8	th17	th17	NOUN
dpc-3672	119	9	cells	cell	NOUN
dpc-3672	119	10	,	,	PUNCT
dpc-3672	119	11	group	group	NOUN
dpc-3672	119	12	3	3	NUM
dpc-3672	119	13	innate	innate	ADJ
dpc-3672	119	14	lymphoid	lymphoid	NOUN
dpc-3672	119	15	cells	cell	NOUN
dpc-3672	119	16	(	(	PUNCT
dpc-3672	119	17	ilc3	ilc3	PROPN
dpc-3672	119	18	)	)	PUNCT
dpc-3672	119	19	,	,	PUNCT
dpc-3672	119	20	γδ	γδ	ADP
dpc-3672	119	21	t	t	PROPN
dpc-3672	119	22	cells	cell	NOUN
dpc-3672	119	23	and	and	CCONJ
dpc-3672	119	24	il-17	il-17	ADV
dpc-3672	119	25	-	-	PUNCT
dpc-3672	119	26	producing	produce	VERB
dpc-3672	119	27	cd8	cd8	PROPN
dpc-3672	119	28	+	+	PROPN
dpc-3672	119	29	t	t	PROPN
dpc-3672	119	30	(	(	PUNCT
dpc-3672	119	31	tc17	tc17	PROPN
dpc-3672	119	32	)	)	PUNCT
dpc-3672	119	33	cells	cell	NOUN
dpc-3672	119	34	,	,	PUNCT
dpc-3672	119	35	and	and	CCONJ
dpc-3672	119	36	plays	play	VERB
dpc-3672	119	37	a	a	DET
dpc-3672	119	38	role	role	NOUN
dpc-3672	119	39	in	in	ADP
dpc-3672	119	40	stabilization	stabilization	NOUN
dpc-3672	119	41	of	of	ADP
dpc-3672	119	42	th17	th17	PROPN
dpc-3672	119	43	cells	cell	NOUN
dpc-3672	119	44	[	[	X
dpc-3672	119	45	9	9	NUM
dpc-3672	119	46	,	,	PUNCT
dpc-3672	119	47	10	10	NUM
dpc-3672	119	48	]	]	PUNCT
dpc-3672	119	49	.	.	PUNCT
dpc-3672	120	1	although	although	SCONJ
dpc-3672	120	2	the	the	DET
dpc-3672	120	3	main	main	ADJ
dpc-3672	120	4	role	role	NOUN
dpc-3672	120	5	of	of	ADP
dpc-3672	120	6	il-23	il-23	NOUN
dpc-3672	120	7	in	in	ADP
dpc-3672	120	8	the	the	DET
dpc-3672	120	9	pathogenesis	pathogenesis	NOUN
dpc-3672	120	10	of	of	ADP
dpc-3672	120	11	vitiligo	vitiligo	NOUN
dpc-3672	120	12	has	have	AUX
dpc-3672	120	13	not	not	PART
dpc-3672	120	14	been	be	AUX
dpc-3672	120	15	fully	fully	ADV
dpc-3672	120	16	understood	understand	VERB
dpc-3672	120	17	,	,	PUNCT
dpc-3672	120	18	there	there	PRON
dpc-3672	120	19	are	be	VERB
dpc-3672	120	20	abundant	abundant	ADJ
dpc-3672	120	21	data	datum	NOUN
dpc-3672	120	22	supporting	support	VERB
dpc-3672	120	23	the	the	DET
dpc-3672	120	24	effect	effect	NOUN
dpc-3672	120	25	of	of	ADP
dpc-3672	120	26	il-17	il-17	NUM
dpc-3672	120	27	in	in	ADP
dpc-3672	120	28	the	the	DET
dpc-3672	120	29	development	development	NOUN
dpc-3672	120	30	of	of	ADP
dpc-3672	120	31	vitiligo	vitiligo	NOUN
dpc-3672	120	32	[	[	X
dpc-3672	120	33	16,17	16,17	NUM
dpc-3672	120	34	]	]	PUNCT
dpc-3672	120	35	.	.	PUNCT
dpc-3672	121	1	vitiligo	vitiligo	NOUN
dpc-3672	121	2	patients	patient	NOUN
dpc-3672	121	3	have	have	VERB
dpc-3672	121	4	higher	high	ADJ
dpc-3672	121	5	levels	level	NOUN
dpc-3672	121	6	of	of	ADP
dpc-3672	121	7	il-17	il-17	NUM
dpc-3672	121	8	and	and	CCONJ
dpc-3672	121	9	more	more	ADJ
dpc-3672	121	10	th17	th17	NOUN
dpc-3672	121	11	cells	cell	NOUN
dpc-3672	121	12	in	in	ADP
dpc-3672	121	13	peripheral	peripheral	ADJ
dpc-3672	121	14	blood	blood	NOUN
dpc-3672	121	15	than	than	ADP
dpc-3672	121	16	controls	control	NOUN
dpc-3672	121	17	.	.	PUNCT
dpc-3672	122	1	vitiligo	vitiligo	PROPN
dpc-3672	122	2	tissues	tissue	NOUN
dpc-3672	122	3	have	have	VERB
dpc-3672	122	4	th17	th17	NOUN
dpc-3672	122	5	cell	cell	NOUN
dpc-3672	122	6	infiltration	infiltration	NOUN
dpc-3672	122	7	and	and	CCONJ
dpc-3672	122	8	increased	increase	VERB
dpc-3672	122	9	il-17	il-17	NUM
dpc-3672	122	10	mrna	mrna	PROPN
dpc-3672	122	11	expression	expression	NOUN
dpc-3672	122	12	.	.	PUNCT
dpc-3672	123	1	in	in	ADP
dpc-3672	123	2	addition	addition	NOUN
dpc-3672	123	3	,	,	PUNCT
dpc-3672	123	4	in	in	ADP
dpc-3672	123	5	-	-	PUNCT
dpc-3672	123	6	vitro	vitro	ADJ
dpc-3672	123	7	studies	study	NOUN
dpc-3672	123	8	showing	show	VERB
dpc-3672	123	9	that	that	PRON
dpc-3672	123	10	il-17	il-17	ADV
dpc-3672	123	11	reduces	reduce	VERB
dpc-3672	123	12	melanin	melanin	NOUN
dpc-3672	123	13	production	production	NOUN
dpc-3672	123	14	and	and	CCONJ
dpc-3672	123	15	causes	cause	VERB
dpc-3672	123	16	shrinking	shrink	VERB
dpc-3672	123	17	in	in	ADP
dpc-3672	123	18	melanocytes	melanocyte	NOUN
dpc-3672	123	19	supports	support	VERB
dpc-3672	123	20	the	the	DET
dpc-3672	123	21	possible	possible	ADJ
dpc-3672	123	22	role	role	NOUN
dpc-3672	123	23	of	of	ADP
dpc-3672	123	24	il-17	il-17	NUM
dpc-3672	123	25	in	in	ADP
dpc-3672	123	26	the	the	DET
dpc-3672	123	27	pathogenesis	pathogenesis	NOUN
dpc-3672	123	28	of	of	ADP
dpc-3672	123	29	vitiligo	vitiligo	NOUN
dpc-3672	123	30	[	[	X
dpc-3672	123	31	16,17	16,17	NUM
dpc-3672	123	32	]	]	PUNCT
dpc-3672	123	33	.	.	PUNCT
dpc-3672	124	1	stimulating	stimulate	VERB
dpc-3672	124	2	th17	th17	PROPN
dpc-3672	124	3	cell	cell	NOUN
dpc-3672	124	4	differentiation	differentiation	NOUN
dpc-3672	124	5	,	,	PUNCT
dpc-3672	124	6	hence	hence	ADV
dpc-3672	124	7	production	production	NOUN
dpc-3672	124	8	of	of	ADP
dpc-3672	124	9	il-17	il-17	NOUN
dpc-3672	124	10	cytokines	cytokine	NOUN
dpc-3672	124	11	,	,	PUNCT
dpc-3672	124	12	il-23	il-23	NOUN
dpc-3672	124	13	may	may	AUX
dpc-3672	124	14	contribute	contribute	VERB
dpc-3672	124	15	to	to	ADP
dpc-3672	124	16	the	the	DET
dpc-3672	124	17	pathogenesis	pathogenesis	NOUN
dpc-3672	124	18	of	of	ADP
dpc-3672	124	19	vitiligo	vitiligo	NOUN
dpc-3672	124	20	directly	directly	ADV
dpc-3672	124	21	or	or	CCONJ
dpc-3672	124	22	through	through	ADP
dpc-3672	124	23	th17	th17	PROPN
dpc-3672	124	24	/	/	SYM
dpc-3672	124	25	il-17	il-17	NUM
dpc-3672	124	26	pathway	pathway	NOUN
dpc-3672	124	27	.	.	PUNCT
dpc-3672	125	1	although	although	SCONJ
dpc-3672	125	2	il-12	il-12	NOUN
dpc-3672	125	3	and	and	CCONJ
dpc-3672	125	4	il-23	il-23	NOUN
dpc-3672	125	5	are	be	AUX
dpc-3672	125	6	thought	think	VERB
dpc-3672	125	7	to	to	PART
dpc-3672	125	8	play	play	VERB
dpc-3672	125	9	a	a	DET
dpc-3672	125	10	role	role	NOUN
dpc-3672	125	11	in	in	ADP
dpc-3672	125	12	the	the	DET
dpc-3672	125	13	pathogenesis	pathogenesis	NOUN
dpc-3672	125	14	of	of	ADP
dpc-3672	125	15	vitiligo	vitiligo	NOUN
dpc-3672	125	16	,	,	PUNCT
dpc-3672	125	17	whether	whether	SCONJ
dpc-3672	125	18	il-12	il-12	NOUN
dpc-3672	125	19	/	/	SYM
dpc-3672	125	20	il-23	il-23	NOUN
dpc-3672	125	21	blockers	blocker	NOUN
dpc-3672	125	22	can	can	AUX
dpc-3672	125	23	be	be	AUX
dpc-3672	125	24	used	use	VERB
dpc-3672	125	25	in	in	ADP
dpc-3672	125	26	the	the	DET
dpc-3672	125	27	treatment	treatment	NOUN
dpc-3672	125	28	of	of	ADP
dpc-3672	125	29	vitiligo	vitiligo	NOUN
dpc-3672	125	30	is	be	AUX
dpc-3672	125	31	not	not	PART
dpc-3672	125	32	clear	clear	ADJ
dpc-3672	125	33	.	.	PUNCT
dpc-3672	126	1	il-12/23	il-12/23	ADJ
dpc-3672	126	2	inhibitors	inhibitor	NOUN
dpc-3672	126	3	have	have	VERB
dpc-3672	126	4	very	very	ADV
dpc-3672	126	5	different	different	ADJ
dpc-3672	126	6	effects	effect	NOUN
dpc-3672	126	7	on	on	ADP
dpc-3672	126	8	vitiligo	vitiligo	ADJ
dpc-3672	126	9	lesions	lesion	NOUN
dpc-3672	126	10	.	.	PUNCT
dpc-3672	127	1	patients	patient	NOUN
dpc-3672	127	2	administered	administer	VERB
dpc-3672	127	3	il-12/23	il-12/23	ADJ
dpc-3672	127	4	inhibitors	inhibitor	NOUN
dpc-3672	127	5	have	have	AUX
dpc-3672	127	6	reported	report	VERB
dpc-3672	127	7	formation	formation	NOUN
dpc-3672	127	8	of	of	ADP
dpc-3672	127	9	de	de	X
dpc-3672	127	10	novo	novo	NOUN
dpc-3672	127	11	vitiligo	vitiligo	NOUN
dpc-3672	127	12	and	and	CCONJ
dpc-3672	127	13	deterioration	deterioration	NOUN
dpc-3672	127	14	of	of	ADP
dpc-3672	127	15	vitiligo	vitiligo	NOUN
dpc-3672	127	16	as	as	ADV
dpc-3672	127	17	well	well	ADV
dpc-3672	127	18	as	as	ADP
dpc-3672	127	19	improvement	improvement	NOUN
dpc-3672	127	20	in	in	ADP
dpc-3672	127	21	vitiligo	vitiligo	NOUN
dpc-3672	127	22	and	and	CCONJ
dpc-3672	127	23	repigmentation	repigmentation	NOUN
dpc-3672	127	24	of	of	ADP
dpc-3672	127	25	depigmented	depigmented	ADJ
dpc-3672	127	26	patches	patch	NOUN
dpc-3672	127	27	[	[	X
dpc-3672	127	28	18,19	18,19	NUM
dpc-3672	127	29	]	]	PUNCT
dpc-3672	127	30	.	.	PUNCT
dpc-3672	128	1	serum	serum	PROPN
dpc-3672	128	2	il-27	il-27	PROPN
dpc-3672	128	3	levels	level	NOUN
dpc-3672	128	4	were	be	AUX
dpc-3672	128	5	lower	low	ADJ
dpc-3672	128	6	in	in	ADP
dpc-3672	128	7	vitiligo	vitiligo	ADJ
dpc-3672	128	8	patients	patient	NOUN
dpc-3672	128	9	compared	compare	VERB
dpc-3672	128	10	to	to	ADP
dpc-3672	128	11	controls	control	NOUN
dpc-3672	128	12	.	.	PUNCT
dpc-3672	129	1	il-27	il-27	PROPN
dpc-3672	129	2	levels	level	NOUN
dpc-3672	129	3	of	of	ADP
dpc-3672	129	4	vitiligo	vitiligo	NOUN
dpc-3672	129	5	patients	patient	NOUN
dpc-3672	129	6	had	have	AUX
dpc-3672	129	7	been	be	AUX
dpc-3672	129	8	analyzed	analyze	VERB
dpc-3672	129	9	in	in	ADP
dpc-3672	129	10	a	a	DET
dpc-3672	129	11	previous	previous	ADJ
dpc-3672	129	12	study	study	NOUN
dpc-3672	129	13	.	.	PUNCT
dpc-3672	130	1	hosseini	hosseini	PROPN
dpc-3672	130	2	et	et	PROPN
dpc-3672	130	3	al	al	PROPN
dpc-3672	130	4	.	.	PROPN
dpc-3672	130	5	compared	compare	VERB
dpc-3672	130	6	il-27	il-27	PART
dpc-3672	130	7	levels	level	NOUN
dpc-3672	130	8	of	of	ADP
dpc-3672	130	9	79	79	NUM
dpc-3672	130	10	vitiligo	vitiligo	NOUN
dpc-3672	130	11	patients	patient	NOUN
dpc-3672	130	12	and	and	CCONJ
dpc-3672	130	13	45	45	NUM
dpc-3672	130	14	healthy	healthy	ADJ
dpc-3672	130	15	controls	control	NOUN
dpc-3672	130	16	,	,	PUNCT
dpc-3672	130	17	and	and	CCONJ
dpc-3672	130	18	reported	report	VERB
dpc-3672	130	19	lower	low	ADJ
dpc-3672	130	20	il-27	il-27	PROPN
dpc-3672	130	21	levels	level	NOUN
dpc-3672	130	22	in	in	ADP
dpc-3672	130	23	vitiligo	vitiligo	ADJ
dpc-3672	130	24	patients	patient	NOUN
dpc-3672	130	25	in	in	ADP
dpc-3672	130	26	parallel	parallel	NOUN
dpc-3672	130	27	with	with	ADP
dpc-3672	130	28	our	our	PRON
dpc-3672	130	29	results	result	NOUN
dpc-3672	130	30	.	.	PUNCT
dpc-3672	131	1	the	the	DET
dpc-3672	131	2	study	study	NOUN
dpc-3672	131	3	did	do	AUX
dpc-3672	131	4	not	not	PART
dpc-3672	131	5	report	report	VERB
dpc-3672	131	6	any	any	DET
dpc-3672	131	7	correlation	correlation	NOUN
dpc-3672	131	8	between	between	ADP
dpc-3672	131	9	il-27	il-27	NOUN
dpc-3672	131	10	levels	level	NOUN
dpc-3672	131	11	and	and	CCONJ
dpc-3672	131	12	gender	gender	NOUN
dpc-3672	131	13	,	,	PUNCT
dpc-3672	131	14	extensiveness	extensiveness	NOUN
dpc-3672	131	15	of	of	ADP
dpc-3672	131	16	the	the	DET
dpc-3672	131	17	disease	disease	NOUN
dpc-3672	131	18	in	in	ADP
dpc-3672	131	19	terms	term	NOUN
dpc-3672	131	20	of	of	ADP
dpc-3672	131	21	body	body	NOUN
dpc-3672	131	22	surface	surface	NOUN
dpc-3672	131	23	area	area	NOUN
dpc-3672	131	24	,	,	PUNCT
dpc-3672	131	25	type	type	NOUN
dpc-3672	131	26	of	of	ADP
dpc-3672	131	27	vitiligo	vitiligo	NOUN
dpc-3672	131	28	,	,	PUNCT
dpc-3672	131	29	and	and	CCONJ
dpc-3672	131	30	treatment	treatment	NOUN
dpc-3672	131	31	responses	response	NOUN
dpc-3672	131	32	[	[	X
dpc-3672	131	33	20	20	NUM
dpc-3672	131	34	]	]	PUNCT
dpc-3672	131	35	.	.	PUNCT
dpc-3672	132	1	we	we	PRON
dpc-3672	132	2	could	could	AUX
dpc-3672	132	3	not	not	PART
dpc-3672	132	4	find	find	VERB
dpc-3672	132	5	any	any	DET
dpc-3672	132	6	correlation	correlation	NOUN
dpc-3672	132	7	between	between	ADP
dpc-3672	132	8	il-27	il-27	NOUN
dpc-3672	132	9	levels	level	NOUN
dpc-3672	132	10	and	and	CCONJ
dpc-3672	132	11	extensiveness	extensiveness	NOUN
dpc-3672	132	12	of	of	ADP
dpc-3672	132	13	the	the	DET
dpc-3672	132	14	disease	disease	NOUN
dpc-3672	132	15	either	either	ADV
dpc-3672	132	16	,	,	PUNCT
dpc-3672	132	17	but	but	CCONJ
dpc-3672	132	18	il-27	il-27	NUM
dpc-3672	132	19	levels	level	NOUN
dpc-3672	132	20	were	be	AUX
dpc-3672	132	21	negatively	negatively	ADV
dpc-3672	132	22	correlated	correlate	VERB
dpc-3672	132	23	with	with	ADP
dpc-3672	132	24	the	the	DET
dpc-3672	132	25	disease	disease	NOUN
dpc-3672	132	26	activity	activity	NOUN
dpc-3672	132	27	.	.	PUNCT
dpc-3672	133	1	patients	patient	NOUN
dpc-3672	133	2	with	with	ADP
dpc-3672	133	3	active	active	ADJ
dpc-3672	133	4	vitiligo	vitiligo	NOUN
dpc-3672	133	5	had	have	VERB
dpc-3672	133	6	lower	low	ADJ
dpc-3672	133	7	levels	level	NOUN
dpc-3672	133	8	of	of	ADP
dpc-3672	133	9	il-27	il-27	NUM
dpc-3672	133	10	,	,	PUNCT
dpc-3672	133	11	patients	patient	NOUN
dpc-3672	133	12	with	with	ADP
dpc-3672	133	13	a	a	DET
dpc-3672	133	14	stable	stable	ADJ
dpc-3672	133	15	course	course	NOUN
dpc-3672	133	16	of	of	ADP
dpc-3672	133	17	disease	disease	NOUN
dpc-3672	133	18	had	have	VERB
dpc-3672	133	19	higher	high	ADJ
dpc-3672	133	20	il-27	il-27	NUM
dpc-3672	133	21	levels	level	NOUN
dpc-3672	133	22	.	.	PUNCT
dpc-3672	134	1	il-27	il-27	PROPN
dpc-3672	134	2	levels	level	NOUN
dpc-3672	134	3	were	be	AUX
dpc-3672	134	4	also	also	ADV
dpc-3672	134	5	correlated	correlate	VERB
dpc-3672	134	6	with	with	ADP
dpc-3672	134	7	disease	disease	NOUN
dpc-3672	134	8	duration	duration	NOUN
dpc-3672	134	9	.	.	PUNCT
dpc-3672	135	1	the	the	DET
dpc-3672	135	2	fact	fact	NOUN
dpc-3672	135	3	that	that	SCONJ
dpc-3672	135	4	il-27	il-27	ADV
dpc-3672	135	5	was	be	AUX
dpc-3672	135	6	lower	low	ADJ
dpc-3672	135	7	in	in	ADP
dpc-3672	135	8	patients	patient	NOUN
dpc-3672	135	9	with	with	ADP
dpc-3672	135	10	a	a	DET
dpc-3672	135	11	shorter	short	ADJ
dpc-3672	135	12	disease	disease	NOUN
dpc-3672	135	13	duration	duration	NOUN
dpc-3672	135	14	and	and	CCONJ
dpc-3672	135	15	a	a	DET
dpc-3672	135	16	higher	high	ADJ
dpc-3672	135	17	activity	activity	NOUN
dpc-3672	135	18	score	score	NOUN
dpc-3672	135	19	suggests	suggest	VERB
dpc-3672	135	20	that	that	SCONJ
dpc-3672	135	21	il-27	il-27	ADV
dpc-3672	135	22	may	may	AUX
dpc-3672	135	23	play	play	VERB
dpc-3672	135	24	a	a	DET
dpc-3672	135	25	role	role	NOUN
dpc-3672	135	26	in	in	ADP
dpc-3672	135	27	formation	formation	NOUN
dpc-3672	135	28	of	of	ADP
dpc-3672	135	29	vitiligo	vitiligo	ADJ
dpc-3672	135	30	patches	patch	NOUN
dpc-3672	135	31	at	at	ADP
dpc-3672	135	32	early	early	ADJ
dpc-3672	135	33	stages	stage	NOUN
dpc-3672	135	34	of	of	ADP
dpc-3672	135	35	the	the	DET
dpc-3672	135	36	pathogenesis	pathogenesis	NOUN
dpc-3672	135	37	of	of	ADP
dpc-3672	135	38	vitiligo	vitiligo	PROPN
dpc-3672	135	39	.	.	PUNCT
dpc-3672	136	1	il-27	il-27	PROPN
dpc-3672	136	2	was	be	AUX
dpc-3672	136	3	thought	think	VERB
dpc-3672	136	4	to	to	PART
dpc-3672	136	5	be	be	AUX
dpc-3672	136	6	a	a	DET
dpc-3672	136	7	pro	pro	ADJ
dpc-3672	136	8	-	-	ADJ
dpc-3672	136	9	inflammatory	inflammatory	ADJ
dpc-3672	136	10	cytokine	cytokine	NOUN
dpc-3672	136	11	since	since	SCONJ
dpc-3672	136	12	it	it	PRON
dpc-3672	136	13	stimulates	stimulate	VERB
dpc-3672	136	14	the	the	DET
dpc-3672	136	15	production	production	NOUN
dpc-3672	136	16	of	of	ADP
dpc-3672	136	17	interferon	interferon	ADJ
dpc-3672	136	18	-	-	PUNCT
dpc-3672	136	19	γ	γ	X
dpc-3672	136	20	(	(	PUNCT
dpc-3672	136	21	ifn	ifn	PROPN
dpc-3672	136	22	-	-	PUNCT
dpc-3672	136	23	γ	γ	NOUN
dpc-3672	136	24	)	)	PUNCT
dpc-3672	136	25	from	from	ADP
dpc-3672	136	26	t	t	PROPN
dpc-3672	136	27	cells	cell	NOUN
dpc-3672	136	28	and	and	CCONJ
dpc-3672	136	29	natural	natural	ADJ
dpc-3672	136	30	killer	killer	NOUN
dpc-3672	136	31	cells	cell	NOUN
dpc-3672	136	32	(	(	PUNCT
dpc-3672	136	33	nk	nk	PROPN
dpc-3672	136	34	)	)	PUNCT
dpc-3672	136	35	,	,	PUNCT
dpc-3672	136	36	increases	increase	VERB
dpc-3672	136	37	adhesion	adhesion	NOUN
dpc-3672	136	38	molecules	molecule	NOUN
dpc-3672	136	39	on	on	ADP
dpc-3672	136	40	the	the	DET
dpc-3672	136	41	t	t	PROPN
dpc-3672	136	42	cell	cell	NOUN
dpc-3672	136	43	surface	surface	NOUN
dpc-3672	136	44	,	,	PUNCT
dpc-3672	136	45	and	and	CCONJ
dpc-3672	136	46	improves	improve	VERB
dpc-3672	136	47	the	the	DET
dpc-3672	136	48	function	function	NOUN
dpc-3672	136	49	of	of	ADP
dpc-3672	136	50	cd8	cd8	PROPN
dpc-3672	136	51	+	+	PROPN
dpc-3672	136	52	t	t	PROPN
dpc-3672	136	53	cells	cell	NOUN
dpc-3672	136	54	[	[	X
dpc-3672	136	55	21	21	NUM
dpc-3672	136	56	]	]	PUNCT
dpc-3672	136	57	.	.	PUNCT
dpc-3672	137	1	however	however	ADV
dpc-3672	137	2	,	,	PUNCT
dpc-3672	137	3	a	a	DET
dpc-3672	137	4	growing	grow	VERB
dpc-3672	137	5	number	number	NOUN
dpc-3672	137	6	of	of	ADP
dpc-3672	137	7	studies	study	NOUN
dpc-3672	137	8	have	have	AUX
dpc-3672	137	9	supported	support	VERB
dpc-3672	137	10	the	the	DET
dpc-3672	137	11	anti	anti	ADJ
dpc-3672	137	12	-	-	ADJ
dpc-3672	137	13	inflammatory	inflammatory	ADJ
dpc-3672	137	14	properties	property	NOUN
dpc-3672	137	15	of	of	ADP
dpc-3672	137	16	il-27	il-27	NUM
dpc-3672	137	17	in	in	ADP
dpc-3672	137	18	recent	recent	ADJ
dpc-3672	137	19	years	year	NOUN
dpc-3672	137	20	.	.	PUNCT
dpc-3672	138	1	il-27	il-27	PROPN
dpc-3672	138	2	shows	show	VERB
dpc-3672	138	3	a	a	DET
dpc-3672	138	4	suppressive	suppressive	ADJ
dpc-3672	138	5	effect	effect	NOUN
dpc-3672	138	6	by	by	ADP
dpc-3672	138	7	stimulating	stimulate	VERB
dpc-3672	138	8	the	the	DET
dpc-3672	138	9	production	production	NOUN
dpc-3672	138	10	of	of	ADP
dpc-3672	138	11	il-10	il-10	PRON
dpc-3672	138	12	,	,	PUNCT
dpc-3672	138	13	supporting	support	VERB
dpc-3672	138	14	the	the	DET
dpc-3672	138	15	growth	growth	NOUN
dpc-3672	138	16	and	and	CCONJ
dpc-3672	138	17	survival	survival	NOUN
dpc-3672	138	18	of	of	ADP
dpc-3672	138	19	treg	treg	PROPN
dpc-3672	138	20	cells	cell	NOUN
dpc-3672	138	21	,	,	PUNCT
dpc-3672	138	22	stimulating	stimulate	VERB
dpc-3672	138	23	the	the	DET
dpc-3672	138	24	expression	expression	NOUN
dpc-3672	138	25	of	of	ADP
dpc-3672	138	26	inhibitory	inhibitory	NOUN
dpc-3672	138	27	additionally	additionally	ADV
dpc-3672	138	28	,	,	PUNCT
dpc-3672	138	29	il-12	il-12	PRON
dpc-3672	138	30	helps	help	VERB
dpc-3672	138	31	the	the	DET
dpc-3672	138	32	differentiation	differentiation	NOUN
dpc-3672	138	33	of	of	ADP
dpc-3672	138	34	naive	naive	ADJ
dpc-3672	138	35	cd4	cd4	PROPN
dpc-3672	138	36	+	+	PROPN
dpc-3672	138	37	t	t	NOUN
dpc-3672	138	38	cells	cell	NOUN
dpc-3672	138	39	into	into	ADP
dpc-3672	138	40	interferon	interferon	NOUN
dpc-3672	138	41	(	(	PUNCT
dpc-3672	138	42	ifn)-γ	ifn)-γ	NOUN
dpc-3672	138	43	producing	produce	VERB
dpc-3672	138	44	type	type	NOUN
dpc-3672	138	45	1	1	NUM
dpc-3672	138	46	t	t	NOUN
dpc-3672	138	47	helper	helper	NOUN
dpc-3672	138	48	(	(	PUNCT
dpc-3672	138	49	th1	th1	NOUN
dpc-3672	138	50	)	)	PUNCT
dpc-3672	138	51	cells	cell	NOUN
dpc-3672	138	52	and	and	CCONJ
dpc-3672	138	53	stimulates	stimulate	VERB
dpc-3672	138	54	ifn	ifn	PROPN
dpc-3672	138	55	-	-	PUNCT
dpc-3672	138	56	γ	γ	NOUN
dpc-3672	138	57	production	production	NOUN
dpc-3672	138	58	from	from	ADP
dpc-3672	138	59	natural	natural	ADJ
dpc-3672	138	60	killer	killer	NOUN
dpc-3672	138	61	(	(	PUNCT
dpc-3672	138	62	nk	nk	PROPN
dpc-3672	138	63	)	)	PUNCT
dpc-3672	138	64	cells	cell	NOUN
dpc-3672	139	1	[	[	X
dpc-3672	139	2	5	5	NUM
dpc-3672	139	3	]	]	PUNCT
dpc-3672	139	4	.	.	PUNCT
dpc-3672	140	1	the	the	DET
dpc-3672	140	2	role	role	NOUN
dpc-3672	140	3	of	of	ADP
dpc-3672	140	4	ifn	ifn	PROPN
dpc-3672	140	5	-	-	PUNCT
dpc-3672	140	6	γ	γ	NOUN
dpc-3672	140	7	in	in	ADP
dpc-3672	140	8	the	the	DET
dpc-3672	140	9	pathogenesis	pathogenesis	NOUN
dpc-3672	140	10	of	of	ADP
dpc-3672	140	11	vitiligo	vitiligo	NOUN
dpc-3672	140	12	is	be	AUX
dpc-3672	140	13	known	know	VERB
dpc-3672	140	14	well	well	ADV
dpc-3672	140	15	.	.	PUNCT
dpc-3672	141	1	ifn	ifn	PROPN
dpc-3672	141	2	-	-	PUNCT
dpc-3672	141	3	γ	γ	NOUN
dpc-3672	141	4	increase	increase	VERB
dpc-3672	141	5	the	the	DET
dpc-3672	141	6	expression	expression	NOUN
dpc-3672	141	7	cxcl9	cxcl9	NOUN
dpc-3672	141	8	,	,	PUNCT
dpc-3672	141	9	cxcl10	cxcl10	NOUN
dpc-3672	141	10	and	and	CCONJ
dpc-3672	141	11	their	their	PRON
dpc-3672	141	12	receptor	receptor	NOUN
dpc-3672	141	13	cxcr3	cxcr3	NOUN
dpc-3672	141	14	which	which	PRON
dpc-3672	141	15	results	result	VERB
dpc-3672	141	16	in	in	ADP
dpc-3672	141	17	recruitment	recruitment	NOUN
dpc-3672	141	18	and	and	CCONJ
dpc-3672	141	19	localization	localization	NOUN
dpc-3672	141	20	of	of	ADP
dpc-3672	141	21	melanocyte	melanocyte	NOUN
dpc-3672	141	22	-	-	PUNCT
dpc-3672	141	23	specific	specific	ADJ
dpc-3672	141	24	autoreactive	autoreactive	ADJ
dpc-3672	141	25	t	t	NOUN
dpc-3672	141	26	cells	cell	NOUN
dpc-3672	141	27	within	within	ADP
dpc-3672	141	28	epidermis	epidermis	NOUN
dpc-3672	141	29	as	as	ADV
dpc-3672	141	30	well	well	ADV
dpc-3672	141	31	as	as	ADP
dpc-3672	141	32	stimulation	stimulation	NOUN
dpc-3672	141	33	of	of	ADP
dpc-3672	141	34	melanocyte	melanocyte	NOUN
dpc-3672	141	35	apoptosis	apoptosis	NOUN
dpc-3672	141	36	[	[	X
dpc-3672	141	37	3	3	NUM
dpc-3672	141	38	]	]	PUNCT
dpc-3672	141	39	.	.	PUNCT
dpc-3672	142	1	vitiligo	vitiligo	VERB
dpc-3672	142	2	-	-	PUNCT
dpc-3672	142	3	like	like	ADJ
dpc-3672	142	4	depigmented	depigmented	ADJ
dpc-3672	142	5	patches	patch	NOUN
dpc-3672	142	6	in	in	ADP
dpc-3672	142	7	mice	mouse	NOUN
dpc-3672	142	8	in	in	ADP
dpc-3672	142	9	studies	study	NOUN
dpc-3672	142	10	investigating	investigate	VERB
dpc-3672	142	11	the	the	DET
dpc-3672	142	12	effects	effect	NOUN
dpc-3672	142	13	of	of	ADP
dpc-3672	142	14	il-12	il-12	NOUN
dpc-3672	142	15	on	on	ADP
dpc-3672	142	16	melanoma	melanoma	NOUN
dpc-3672	142	17	cells	cell	NOUN
dpc-3672	142	18	also	also	ADV
dpc-3672	142	19	suggested	suggest	VERB
dpc-3672	142	20	that	that	SCONJ
dpc-3672	142	21	il-12	il-12	NOUN
dpc-3672	142	22	may	may	AUX
dpc-3672	142	23	play	play	VERB
dpc-3672	142	24	a	a	DET
dpc-3672	142	25	role	role	NOUN
dpc-3672	142	26	in	in	ADP
dpc-3672	142	27	the	the	DET
dpc-3672	142	28	pathogenesis	pathogenesis	NOUN
dpc-3672	142	29	of	of	ADP
dpc-3672	142	30	vitiligo	vitiligo	NOUN
dpc-3672	142	31	.	.	PUNCT
dpc-3672	143	1	in	in	ADP
dpc-3672	143	2	a	a	DET
dpc-3672	143	3	study	study	NOUN
dpc-3672	143	4	conducted	conduct	VERB
dpc-3672	143	5	by	by	ADP
dpc-3672	143	6	nagai	nagai	PROPN
dpc-3672	143	7	et	et	PROPN
dpc-3672	143	8	al	al	PROPN
dpc-3672	143	9	.	.	PROPN
dpc-3672	143	10	,	,	PUNCT
dpc-3672	143	11	mice	mouse	NOUN
dpc-3672	143	12	were	be	AUX
dpc-3672	143	13	inoculated	inoculate	VERB
dpc-3672	143	14	with	with	ADP
dpc-3672	143	15	locally	locally	ADV
dpc-3672	143	16	il-12	il-12	NOUN
dpc-3672	143	17	-	-	PUNCT
dpc-3672	143	18	producing	produce	VERB
dpc-3672	143	19	transfected	transfecte	VERB
dpc-3672	143	20	melanoma	melanoma	NOUN
dpc-3672	143	21	cells	cell	NOUN
dpc-3672	143	22	,	,	PUNCT
dpc-3672	143	23	vitiligo	vitiligo	PROPN
dpc-3672	143	24	was	be	AUX
dpc-3672	143	25	observed	observe	VERB
dpc-3672	143	26	in	in	ADP
dpc-3672	143	27	half	half	NOUN
dpc-3672	143	28	of	of	ADP
dpc-3672	143	29	the	the	DET
dpc-3672	143	30	mice	mouse	NOUN
dpc-3672	143	31	whose	whose	DET
dpc-3672	143	32	cd4	cd4	PROPN
dpc-3672	143	33	+	+	PROPN
dpc-3672	143	34	t	t	NOUN
dpc-3672	143	35	cells	cell	NOUN
dpc-3672	143	36	depleted	deplete	VERB
dpc-3672	144	1	[	[	X
dpc-3672	144	2	12	12	NUM
dpc-3672	144	3	]	]	PUNCT
dpc-3672	144	4	.	.	PUNCT
dpc-3672	145	1	in	in	ADP
dpc-3672	145	2	further	further	ADJ
dpc-3672	145	3	analyses	analysis	NOUN
dpc-3672	145	4	where	where	SCONJ
dpc-3672	145	5	the	the	DET
dpc-3672	145	6	cause	cause	NOUN
dpc-3672	145	7	of	of	ADP
dpc-3672	145	8	vitiligo	vitiligo	NOUN
dpc-3672	145	9	was	be	AUX
dpc-3672	145	10	investigated	investigate	VERB
dpc-3672	145	11	,	,	PUNCT
dpc-3672	145	12	it	it	PRON
dpc-3672	145	13	was	be	AUX
dpc-3672	145	14	reported	report	VERB
dpc-3672	145	15	that	that	SCONJ
dpc-3672	145	16	the	the	DET
dpc-3672	145	17	th1	th1	PROPN
dpc-3672	145	18	/	/	SYM
dpc-3672	145	19	th2	th2	PROPN
dpc-3672	145	20	cytokine	cytokine	NOUN
dpc-3672	145	21	profile	profile	NOUN
dpc-3672	145	22	shifted	shift	VERB
dpc-3672	145	23	in	in	ADP
dpc-3672	145	24	the	the	DET
dpc-3672	145	25	th1	th1	NOUN
dpc-3672	145	26	direction	direction	NOUN
dpc-3672	145	27	and	and	CCONJ
dpc-3672	145	28	that	that	SCONJ
dpc-3672	145	29	cd8	cd8	PROPN
dpc-3672	145	30	+	+	PROPN
dpc-3672	145	31	t	t	PROPN
dpc-3672	145	32	lymphocyte	lymphocyte	ADJ
dpc-3672	145	33	accumulations	accumulation	NOUN
dpc-3672	145	34	were	be	AUX
dpc-3672	145	35	observed	observe	VERB
dpc-3672	145	36	around	around	ADP
dpc-3672	145	37	the	the	DET
dpc-3672	145	38	hair	hair	NOUN
dpc-3672	145	39	follicles	follicle	VERB
dpc-3672	145	40	in	in	ADP
dpc-3672	145	41	lesions	lesion	NOUN
dpc-3672	145	42	with	with	ADP
dpc-3672	145	43	vitiligo	vitiligo	NOUN
dpc-3672	145	44	.	.	PUNCT
dpc-3672	146	1	even	even	ADV
dpc-3672	146	2	though	though	SCONJ
dpc-3672	146	3	il-12	il-12	NOUN
dpc-3672	146	4	is	be	AUX
dpc-3672	146	5	known	know	VERB
dpc-3672	146	6	to	to	PART
dpc-3672	146	7	trigger	trigger	VERB
dpc-3672	146	8	a	a	DET
dpc-3672	146	9	th1	th1	NOUN
dpc-3672	146	10	response	response	NOUN
dpc-3672	146	11	,	,	PUNCT
dpc-3672	146	12	observation	observation	NOUN
dpc-3672	146	13	of	of	ADP
dpc-3672	146	14	vitiligo	vitiligo	NOUN
dpc-3672	146	15	in	in	ADP
dpc-3672	146	16	mice	mouse	NOUN
dpc-3672	146	17	with	with	ADP
dpc-3672	146	18	depleted	depleted	ADJ
dpc-3672	146	19	cd4	cd4	PROPN
dpc-3672	146	20	+	+	PROPN
dpc-3672	146	21	t	t	NOUN
dpc-3672	146	22	cells	cell	NOUN
dpc-3672	146	23	raised	raise	VERB
dpc-3672	146	24	the	the	DET
dpc-3672	146	25	question	question	NOUN
dpc-3672	146	26	of	of	ADP
dpc-3672	146	27	whether	whether	SCONJ
dpc-3672	146	28	il-12	il-12	NOUN
dpc-3672	146	29	alone	alone	ADV
dpc-3672	146	30	is	be	AUX
dpc-3672	146	31	enough	enough	ADJ
dpc-3672	146	32	for	for	ADP
dpc-3672	146	33	the	the	DET
dpc-3672	146	34	development	development	NOUN
dpc-3672	146	35	of	of	ADP
dpc-3672	146	36	vitiligo	vitiligo	NOUN
dpc-3672	146	37	and	and	CCONJ
dpc-3672	146	38	whether	whether	SCONJ
dpc-3672	146	39	additional	additional	ADJ
dpc-3672	146	40	pathways	pathway	NOUN
dpc-3672	146	41	are	be	AUX
dpc-3672	146	42	needed	need	VERB
dpc-3672	146	43	for	for	ADP
dpc-3672	146	44	the	the	DET
dpc-3672	146	45	development	development	NOUN
dpc-3672	146	46	of	of	ADP
dpc-3672	146	47	vitiligo	vitiligo	NOUN
dpc-3672	146	48	[	[	X
dpc-3672	146	49	12	12	NUM
dpc-3672	146	50	]	]	PUNCT
dpc-3672	146	51	.	.	PUNCT
dpc-3672	147	1	in	in	ADP
dpc-3672	147	2	our	our	PRON
dpc-3672	147	3	study	study	NOUN
dpc-3672	147	4	,	,	PUNCT
dpc-3672	147	5	patient	patient	ADJ
dpc-3672	147	6	and	and	CCONJ
dpc-3672	147	7	control	control	NOUN
dpc-3672	147	8	groups	group	NOUN
dpc-3672	147	9	had	have	VERB
dpc-3672	147	10	similar	similar	ADJ
dpc-3672	147	11	serum	serum	NOUN
dpc-3672	147	12	il-23	il-23	NOUN
dpc-3672	147	13	levels	level	NOUN
dpc-3672	147	14	but	but	CCONJ
dpc-3672	147	15	there	there	PRON
dpc-3672	147	16	was	be	VERB
dpc-3672	147	17	a	a	DET
dpc-3672	147	18	significant	significant	ADJ
dpc-3672	147	19	correlation	correlation	NOUN
dpc-3672	147	20	between	between	ADP
dpc-3672	147	21	il-23	il-23	NOUN
dpc-3672	147	22	levels	level	NOUN
dpc-3672	147	23	and	and	CCONJ
dpc-3672	147	24	disease	disease	NOUN
dpc-3672	147	25	severity	severity	NOUN
dpc-3672	147	26	.	.	PUNCT
dpc-3672	148	1	only	only	ADV
dpc-3672	148	2	a	a	DET
dpc-3672	148	3	limited	limited	ADJ
dpc-3672	148	4	number	number	NOUN
dpc-3672	148	5	of	of	ADP
dpc-3672	148	6	studies	study	NOUN
dpc-3672	148	7	examine	examine	VERB
dpc-3672	148	8	serum	serum	NOUN
dpc-3672	148	9	il-23	il-23	NOUN
dpc-3672	148	10	levels	level	NOUN
dpc-3672	148	11	and	and	CCONJ
dpc-3672	148	12	their	their	PRON
dpc-3672	148	13	relations	relation	NOUN
dpc-3672	148	14	with	with	ADP
dpc-3672	148	15	disease	disease	NOUN
dpc-3672	148	16	characteristics	characteristic	NOUN
dpc-3672	148	17	.	.	PUNCT
dpc-3672	149	1	in	in	ADP
dpc-3672	149	2	two	two	NUM
dpc-3672	149	3	different	different	ADJ
dpc-3672	149	4	studies	study	NOUN
dpc-3672	149	5	conducted	conduct	VERB
dpc-3672	149	6	by	by	ADP
dpc-3672	149	7	vaccaro	vaccaro	PROPN
dpc-3672	149	8	et	et	PROPN
dpc-3672	149	9	al	al	PROPN
dpc-3672	149	10	.	.	PROPN
dpc-3672	149	11	and	and	CCONJ
dpc-3672	149	12	nieradko	nieradko	PROPN
dpc-3672	149	13	-	-	PUNCT
dpc-3672	149	14	iwanicka	iwanicka	PROPN
dpc-3672	149	15	et	et	PROPN
dpc-3672	149	16	al	al	PROPN
dpc-3672	149	17	,	,	PUNCT
dpc-3672	149	18	vitiligo	vitiligo	NOUN
dpc-3672	149	19	patients	patient	NOUN
dpc-3672	149	20	had	have	VERB
dpc-3672	149	21	higher	high	ADJ
dpc-3672	149	22	serum	serum	NOUN
dpc-3672	149	23	il-23	il-23	NOUN
dpc-3672	149	24	levels	level	NOUN
dpc-3672	149	25	than	than	ADP
dpc-3672	149	26	the	the	DET
dpc-3672	149	27	control	control	NOUN
dpc-3672	149	28	group	group	NOUN
dpc-3672	149	29	[	[	X
dpc-3672	149	30	13	13	NUM
dpc-3672	149	31	,	,	PUNCT
dpc-3672	149	32	14	14	NUM
dpc-3672	149	33	]	]	PUNCT
dpc-3672	149	34	.	.	PUNCT
dpc-3672	150	1	on	on	ADP
dpc-3672	150	2	the	the	DET
dpc-3672	150	3	other	other	ADJ
dpc-3672	150	4	hand	hand	NOUN
dpc-3672	150	5	,	,	PUNCT
dpc-3672	150	6	osman	osman	PROPN
dpc-3672	150	7	et	et	PROPN
dpc-3672	150	8	al	al	PROPN
dpc-3672	150	9	.	.	PROPN
dpc-3672	150	10	found	find	VERB
dpc-3672	150	11	in	in	ADP
dpc-3672	150	12	a	a	DET
dpc-3672	150	13	study	study	NOUN
dpc-3672	150	14	comparing	compare	VERB
dpc-3672	150	15	42	42	NUM
dpc-3672	150	16	adult	adult	NOUN
dpc-3672	150	17	vitiligo	vitiligo	NOUN
dpc-3672	150	18	patients	patient	NOUN
dpc-3672	150	19	and	and	CCONJ
dpc-3672	150	20	43	43	NUM
dpc-3672	150	21	healthy	healthy	ADJ
dpc-3672	150	22	controls	control	NOUN
dpc-3672	150	23	that	that	SCONJ
dpc-3672	150	24	the	the	DET
dpc-3672	150	25	patient	patient	ADJ
dpc-3672	150	26	and	and	CCONJ
dpc-3672	150	27	control	control	NOUN
dpc-3672	150	28	groups	group	NOUN
dpc-3672	150	29	did	do	AUX
dpc-3672	150	30	not	not	PART
dpc-3672	150	31	have	have	VERB
dpc-3672	150	32	any	any	DET
dpc-3672	150	33	significant	significant	ADJ
dpc-3672	150	34	difference	difference	NOUN
dpc-3672	150	35	in	in	ADP
dpc-3672	150	36	terms	term	NOUN
dpc-3672	150	37	of	of	ADP
dpc-3672	150	38	il-23	il-23	NOUN
dpc-3672	150	39	levels	level	NOUN
dpc-3672	150	40	,	,	PUNCT
dpc-3672	150	41	which	which	PRON
dpc-3672	150	42	was	be	AUX
dpc-3672	150	43	consistent	consistent	ADJ
dpc-3672	150	44	with	with	ADP
dpc-3672	150	45	our	our	PRON
dpc-3672	150	46	study	study	NOUN
dpc-3672	150	47	[	[	X
dpc-3672	150	48	15	15	NUM
dpc-3672	150	49	]	]	PUNCT
dpc-3672	150	50	.	.	PUNCT
dpc-3672	151	1	studies	study	NOUN
dpc-3672	151	2	also	also	ADV
dpc-3672	151	3	differ	differ	VERB
dpc-3672	151	4	greatly	greatly	ADV
dpc-3672	151	5	in	in	ADP
dpc-3672	151	6	terms	term	NOUN
dpc-3672	151	7	of	of	ADP
dpc-3672	151	8	the	the	DET
dpc-3672	151	9	relationship	relationship	NOUN
dpc-3672	151	10	between	between	ADP
dpc-3672	151	11	serum	serum	NOUN
dpc-3672	151	12	il-23	il-23	NOUN
dpc-3672	151	13	levels	level	NOUN
dpc-3672	151	14	and	and	CCONJ
dpc-3672	151	15	disease	disease	NOUN
dpc-3672	151	16	characteristics	characteristic	NOUN
dpc-3672	151	17	.	.	PUNCT
dpc-3672	152	1	while	while	SCONJ
dpc-3672	152	2	vaccaro	vaccaro	PROPN
dpc-3672	152	3	et	et	PROPN
dpc-3672	152	4	al	al	PROPN
dpc-3672	152	5	.	.	PROPN
dpc-3672	152	6	reported	report	VERB
dpc-3672	152	7	a	a	DET
dpc-3672	152	8	positive	positive	ADJ
dpc-3672	152	9	correlation	correlation	NOUN
dpc-3672	152	10	between	between	ADP
dpc-3672	152	11	serum	serum	NOUN
dpc-3672	152	12	il-23	il-23	NOUN
dpc-3672	152	13	levels	level	NOUN
dpc-3672	152	14	and	and	CCONJ
dpc-3672	152	15	disease	disease	NOUN
dpc-3672	152	16	duration	duration	NOUN
dpc-3672	152	17	,	,	PUNCT
dpc-3672	152	18	extent	extent	NOUN
dpc-3672	152	19	of	of	ADP
dpc-3672	152	20	vitiligo	vitiligo	NOUN
dpc-3672	152	21	and	and	CCONJ
dpc-3672	152	22	severity	severity	NOUN
dpc-3672	152	23	of	of	ADP
dpc-3672	152	24	the	the	DET
dpc-3672	152	25	disease	disease	NOUN
dpc-3672	152	26	,	,	PUNCT
dpc-3672	152	27	osman	osman	PROPN
dpc-3672	152	28	et	et	PROPN
dpc-3672	152	29	al	al	PROPN
dpc-3672	152	30	.	.	PROPN
dpc-3672	152	31	did	do	AUX
dpc-3672	152	32	not	not	PART
dpc-3672	152	33	find	find	VERB
dpc-3672	152	34	a	a	DET
dpc-3672	152	35	correlation	correlation	NOUN
dpc-3672	152	36	between	between	ADP
dpc-3672	152	37	il-23	il-23	NOUN
dpc-3672	152	38	and	and	CCONJ
dpc-3672	152	39	disease	disease	NOUN
dpc-3672	152	40	duration	duration	NOUN
dpc-3672	152	41	[	[	X
dpc-3672	152	42	13,15	13,15	NUM
dpc-3672	152	43	]	]	PUNCT
dpc-3672	152	44	.	.	PUNCT
dpc-3672	153	1	nieradko	nieradko	PROPN
dpc-3672	153	2	-	-	PUNCT
dpc-3672	153	3	iwanicka	iwanicka	PROPN
dpc-3672	153	4	et	et	PROPN
dpc-3672	153	5	al	al	PROPN
dpc-3672	153	6	.	.	PROPN
dpc-3672	153	7	investigated	investigate	VERB
dpc-3672	153	8	the	the	DET
dpc-3672	153	9	association	association	NOUN
dpc-3672	153	10	between	between	ADP
dpc-3672	153	11	il-23	il-23	NOUN
dpc-3672	153	12	and	and	CCONJ
dpc-3672	153	13	diseases	disease	VERB
dpc-3672	153	14	severity	severity	NOUN
dpc-3672	153	15	and	and	CCONJ
dpc-3672	153	16	reported	report	VERB
dpc-3672	153	17	that	that	SCONJ
dpc-3672	153	18	patients	patient	NOUN
dpc-3672	153	19	with	with	ADP
dpc-3672	153	20	an	an	DET
dpc-3672	153	21	involved	involved	ADJ
dpc-3672	153	22	body	body	NOUN
dpc-3672	153	23	surface	surface	NOUN
dpc-3672	153	24	area	area	NOUN
dpc-3672	153	25	<	<	X
dpc-3672	153	26	10	10	NUM
dpc-3672	153	27	%	%	NOUN
dpc-3672	153	28	and	and	CCONJ
dpc-3672	153	29	>	>	SYM
dpc-3672	153	30	10	10	NUM
dpc-3672	153	31	%	%	NOUN
dpc-3672	153	32	were	be	AUX
dpc-3672	153	33	similar	similar	ADJ
dpc-3672	153	34	in	in	ADP
dpc-3672	153	35	terms	term	NOUN
dpc-3672	153	36	of	of	ADP
dpc-3672	153	37	serum	serum	NOUN
dpc-3672	153	38	il-23	il-23	NOUN
dpc-3672	153	39	levels	level	NOUN
dpc-3672	153	40	[	[	X
dpc-3672	153	41	14	14	NUM
dpc-3672	153	42	]	]	PUNCT
dpc-3672	153	43	.	.	PUNCT
dpc-3672	154	1	il-23	il-23	NOUN
dpc-3672	154	2	(	(	PUNCT
dpc-3672	154	3	comprised	comprise	VERB
dpc-3672	154	4	of	of	ADP
dpc-3672	154	5	p40	p40	NOUN
dpc-3672	154	6	and	and	CCONJ
dpc-3672	154	7	p19	p19	NOUN
dpc-3672	154	8	subunits	subunit	NOUN
dpc-3672	154	9	)	)	PUNCT
dpc-3672	154	10	exerts	exert	VERB
dpc-3672	154	11	its	its	PRON
dpc-3672	154	12	effect	effect	NOUN
dpc-3672	154	13	by	by	ADP
dpc-3672	154	14	binding	bind	VERB
dpc-3672	154	15	to	to	ADP
dpc-3672	154	16	the	the	DET
dpc-3672	154	17	heterodimeric	heterodimeric	ADJ
dpc-3672	154	18	receptors	receptor	NOUN
dpc-3672	154	19	that	that	PRON
dpc-3672	154	20	are	be	AUX
dpc-3672	154	21	made	make	VERB
dpc-3672	154	22	up	up	ADP
dpc-3672	154	23	of	of	ADP
dpc-3672	154	24	the	the	DET
dpc-3672	154	25	il-12rβ1	il-12rβ1	PROPN
dpc-3672	154	26	and	and	CCONJ
dpc-3672	154	27	il-23r	il-23r	NOUN
dpc-3672	154	28	subunits	subunit	NOUN
dpc-3672	154	29	.	.	PUNCT
dpc-3672	155	1	once	once	ADV
dpc-3672	155	2	il-23	il-23	NOUN
dpc-3672	155	3	binds	bind	VERB
dpc-3672	155	4	to	to	ADP
dpc-3672	155	5	the	the	DET
dpc-3672	155	6	receptor	receptor	NOUN
dpc-3672	155	7	,	,	PUNCT
dpc-3672	155	8	jak2	jak2	PROPN
dpc-3672	155	9	and	and	CCONJ
dpc-3672	155	10	tyk2	tyk2	NOUN
dpc-3672	155	11	are	be	AUX
dpc-3672	155	12	activated	activate	VERB
dpc-3672	155	13	.	.	PUNCT
dpc-3672	156	1	activated	activate	VERB
dpc-3672	156	2	jak2	jak2	PROPN
dpc-3672	156	3	and	and	CCONJ
dpc-3672	156	4	tyk2	tyk2	NOUN
dpc-3672	156	5	than	than	SCONJ
dpc-3672	156	6	phosphorylate	phosphorylate	VERB
dpc-3672	156	7	stat3	stat3	NOUN
dpc-3672	156	8	and	and	CCONJ
dpc-3672	156	9	stat4	stat4	NOUN
dpc-3672	156	10	accomplishing	accomplish	VERB
dpc-3672	156	11	its	its	PRON
dpc-3672	156	12	biological	biological	ADJ
dpc-3672	156	13	effects	effect	NOUN
dpc-3672	157	1	[	[	X
dpc-3672	157	2	9	9	NUM
dpc-3672	157	3	]	]	PUNCT
dpc-3672	157	4	.	.	PUNCT
dpc-3672	158	1	the	the	DET
dpc-3672	158	2	biological	biological	ADJ
dpc-3672	158	3	activity	activity	NOUN
dpc-3672	158	4	original	original	ADJ
dpc-3672	158	5	article	article	NOUN
dpc-3672	158	6	|	|	ADV
dpc-3672	158	7	dermatol	dermatol	ADJ
dpc-3672	158	8	pract	pract	NOUN
dpc-3672	158	9	concept	concept	NOUN
dpc-3672	158	10	.	.	PUNCT
dpc-3672	159	1	2024;14(2):e2024069	2024;14(2):e2024069	NUM
dpc-3672	159	2	7	7	NUM
dpc-3672	159	3	the	the	DET
dpc-3672	159	4	maximal	maximal	ADJ
dpc-3672	159	5	effects	effect	NOUN
dpc-3672	159	6	of	of	ADP
dpc-3672	159	7	pro	pro	ADJ
dpc-3672	159	8	-	-	ADJ
dpc-3672	159	9	inflammatory	inflammatory	ADJ
dpc-3672	159	10	cytokines	cytokine	NOUN
dpc-3672	159	11	as	as	SCONJ
dpc-3672	159	12	is	be	AUX
dpc-3672	159	13	the	the	DET
dpc-3672	159	14	case	case	NOUN
dpc-3672	159	15	with	with	ADP
dpc-3672	159	16	lupus	lupus	NOUN
dpc-3672	159	17	and	and	CCONJ
dpc-3672	159	18	primary	primary	ADJ
dpc-3672	159	19	sjögren	sjögren	PROPN
dpc-3672	159	20	disease	disease	NOUN
dpc-3672	159	21	.	.	PUNCT
dpc-3672	160	1	levels	level	NOUN
dpc-3672	160	2	of	of	ADP
dpc-3672	160	3	il-12	il-12	NOUN
dpc-3672	160	4	,	,	PUNCT
dpc-3672	160	5	il-27	il-27	ADV
dpc-3672	160	6	and	and	CCONJ
dpc-3672	160	7	il-35	il-35	ADP
dpc-3672	160	8	from	from	ADP
dpc-3672	160	9	the	the	DET
dpc-3672	160	10	il-12	il-12	NOUN
dpc-3672	160	11	cytokine	cytokine	ADJ
dpc-3672	160	12	family	family	NOUN
dpc-3672	160	13	were	be	AUX
dpc-3672	160	14	not	not	PART
dpc-3672	160	15	similar	similar	ADJ
dpc-3672	160	16	for	for	ADP
dpc-3672	160	17	vitiligo	vitiligo	ADJ
dpc-3672	160	18	patients	patient	NOUN
dpc-3672	160	19	and	and	CCONJ
dpc-3672	160	20	healthy	healthy	ADJ
dpc-3672	160	21	volunteers	volunteer	NOUN
dpc-3672	160	22	.	.	PUNCT
dpc-3672	161	1	vitiligo	vitiligo	NOUN
dpc-3672	161	2	patients	patient	NOUN
dpc-3672	161	3	had	have	VERB
dpc-3672	161	4	higher	high	ADJ
dpc-3672	161	5	levels	level	NOUN
dpc-3672	161	6	of	of	ADP
dpc-3672	161	7	il-12	il-12	NOUN
dpc-3672	161	8	and	and	CCONJ
dpc-3672	161	9	il-35	il-35	ADP
dpc-3672	161	10	,	,	PUNCT
dpc-3672	161	11	and	and	CCONJ
dpc-3672	161	12	lower	low	ADJ
dpc-3672	161	13	levels	level	NOUN
dpc-3672	161	14	of	of	ADP
dpc-3672	161	15	il-27	il-27	NUM
dpc-3672	161	16	.	.	PUNCT
dpc-3672	162	1	also	also	ADV
dpc-3672	162	2	,	,	PUNCT
dpc-3672	162	3	lower	low	ADJ
dpc-3672	162	4	levels	level	NOUN
dpc-3672	162	5	of	of	ADP
dpc-3672	162	6	il-27	il-27	PROPN
dpc-3672	162	7	were	be	AUX
dpc-3672	162	8	clearer	clear	ADJ
dpc-3672	162	9	in	in	ADP
dpc-3672	162	10	patients	patient	NOUN
dpc-3672	162	11	with	with	ADP
dpc-3672	162	12	a	a	DET
dpc-3672	162	13	higher	high	ADJ
dpc-3672	162	14	disease	disease	NOUN
dpc-3672	162	15	activity	activity	NOUN
dpc-3672	162	16	and	and	CCONJ
dpc-3672	162	17	a	a	DET
dpc-3672	162	18	shorter	short	ADJ
dpc-3672	162	19	duration	duration	NOUN
dpc-3672	162	20	of	of	ADP
dpc-3672	162	21	vitiligo	vitiligo	NOUN
dpc-3672	162	22	.	.	PUNCT
dpc-3672	163	1	il-23	il-23	NOUN
dpc-3672	163	2	,	,	PUNCT
dpc-3672	163	3	which	which	PRON
dpc-3672	163	4	had	have	VERB
dpc-3672	163	5	similar	similar	ADJ
dpc-3672	163	6	serum	serum	NOUN
dpc-3672	163	7	levels	level	NOUN
dpc-3672	163	8	in	in	ADP
dpc-3672	163	9	the	the	DET
dpc-3672	163	10	patient	patient	ADJ
dpc-3672	163	11	and	and	CCONJ
dpc-3672	163	12	control	control	NOUN
dpc-3672	163	13	groups	group	NOUN
dpc-3672	163	14	,	,	PUNCT
dpc-3672	163	15	was	be	AUX
dpc-3672	163	16	correlated	correlate	VERB
dpc-3672	163	17	with	with	ADP
dpc-3672	163	18	vasi	vasi	PROPN
dpc-3672	163	19	.	.	PUNCT
dpc-3672	164	1	this	this	DET
dpc-3672	164	2	study	study	NOUN
dpc-3672	164	3	showed	show	VERB
dpc-3672	164	4	that	that	SCONJ
dpc-3672	164	5	in	in	ADP
dpc-3672	164	6	addition	addition	NOUN
dpc-3672	164	7	to	to	ADP
dpc-3672	164	8	previously	previously	ADV
dpc-3672	164	9	studied	study	VERB
dpc-3672	164	10	il-12	il-12	ADP
dpc-3672	164	11	cytokines	cytokine	NOUN
dpc-3672	164	12	(	(	PUNCT
dpc-3672	164	13	il-12	il-12	NOUN
dpc-3672	164	14	,	,	PUNCT
dpc-3672	164	15	il-23	il-23	NOUN
dpc-3672	164	16	,	,	PUNCT
dpc-3672	164	17	il-27	il-27	NUM
dpc-3672	164	18	)	)	PUNCT
dpc-3672	164	19	,	,	PUNCT
dpc-3672	164	20	il-35	il-35	ADP
dpc-3672	164	21	,	,	PUNCT
dpc-3672	164	22	one	one	NUM
dpc-3672	164	23	of	of	ADP
dpc-3672	164	24	the	the	DET
dpc-3672	164	25	newest	new	ADJ
dpc-3672	164	26	members	member	NOUN
dpc-3672	164	27	of	of	ADP
dpc-3672	164	28	il-12	il-12	DET
dpc-3672	164	29	family	family	NOUN
dpc-3672	164	30	,	,	PUNCT
dpc-3672	164	31	may	may	AUX
dpc-3672	164	32	also	also	ADV
dpc-3672	164	33	play	play	VERB
dpc-3672	164	34	a	a	DET
dpc-3672	164	35	role	role	NOUN
dpc-3672	164	36	in	in	ADP
dpc-3672	164	37	the	the	DET
dpc-3672	164	38	pathogenesis	pathogenesis	NOUN
dpc-3672	164	39	of	of	ADP
dpc-3672	164	40	vitiligo	vitiligo	NOUN
dpc-3672	164	41	.	.	PUNCT
dpc-3672	165	1	references	reference	NOUN
dpc-3672	165	2	1	1	NUM
dpc-3672	165	3	.	.	PUNCT
dpc-3672	166	1	alikhan	alikhan	PROPN
dpc-3672	166	2	a	a	DET
dpc-3672	166	3	,	,	PUNCT
dpc-3672	166	4	felsten	felsten	ADJ
dpc-3672	166	5	lm	lm	PROPN
dpc-3672	166	6	,	,	PUNCT
dpc-3672	166	7	daly	daly	PROPN
dpc-3672	166	8	m	m	PROPN
dpc-3672	166	9	,	,	PUNCT
dpc-3672	166	10	petronic	petronic	ADJ
dpc-3672	166	11	-	-	PUNCT
dpc-3672	166	12	rosic	rosic	NOUN
dpc-3672	166	13	v.	v.	ADP
dpc-3672	166	14	vitiligo	vitiligo	NOUN
dpc-3672	166	15	:	:	PUNCT
dpc-3672	166	16	a	a	DET
dpc-3672	166	17	comprehensive	comprehensive	ADJ
dpc-3672	166	18	overview	overview	NOUN
dpc-3672	166	19	part	part	NOUN
dpc-3672	166	20	i.	i.	NOUN
dpc-3672	166	21	introduction	introduction	NOUN
dpc-3672	166	22	,	,	PUNCT
dpc-3672	166	23	epidemiology	epidemiology	NOUN
dpc-3672	166	24	,	,	PUNCT
dpc-3672	166	25	quality	quality	NOUN
dpc-3672	166	26	of	of	ADP
dpc-3672	166	27	life	life	NOUN
dpc-3672	166	28	,	,	PUNCT
dpc-3672	166	29	diagnosis	diagnosis	NOUN
dpc-3672	166	30	,	,	PUNCT
dpc-3672	166	31	differential	differential	ADJ
dpc-3672	166	32	diagnosis	diagnosis	NOUN
dpc-3672	166	33	,	,	PUNCT
dpc-3672	166	34	associations	association	NOUN
dpc-3672	166	35	,	,	PUNCT
dpc-3672	166	36	histopathology	histopathology	NOUN
dpc-3672	166	37	,	,	PUNCT
dpc-3672	166	38	etiology	etiology	NOUN
dpc-3672	166	39	,	,	PUNCT
dpc-3672	166	40	and	and	CCONJ
dpc-3672	166	41	work	work	NOUN
dpc-3672	166	42	-	-	PUNCT
dpc-3672	166	43	up	up	NOUN
dpc-3672	166	44	.	.	PUNCT
dpc-3672	167	1	j	j	PROPN
dpc-3672	167	2	am	be	AUX
dpc-3672	167	3	acad	acad	ADJ
dpc-3672	167	4	dermatol	dermatol	NOUN
dpc-3672	167	5	.	.	PUNCT
dpc-3672	168	1	2011;65(3):473	2011;65(3):473	NUM
dpc-3672	168	2	-	-	SYM
dpc-3672	168	3	491	491	NUM
dpc-3672	168	4	.	.	PUNCT
dpc-3672	169	1	doi	doi	NOUN
dpc-3672	169	2	:	:	PUNCT
dpc-3672	169	3	10.1016	10.1016	NUM
dpc-3672	169	4	/	/	SYM
dpc-3672	169	5	j.jaad.2010.11.061	j.jaad.2010.11.061	PROPN
dpc-3672	169	6	.	.	PUNCT
dpc-3672	170	1	pmid	pmid	NOUN
dpc-3672	170	2	:	:	PUNCT
dpc-3672	170	3	21839315	21839315	NUM
dpc-3672	170	4	.	.	PUNCT
dpc-3672	171	1	2	2	X
dpc-3672	171	2	.	.	X
dpc-3672	171	3	e	e	PROPN
dpc-3672	171	4	ezzedine	ezzedine	PROPN
dpc-3672	171	5	k	k	PROPN
dpc-3672	171	6	,	,	PUNCT
dpc-3672	171	7	eleftheriadou	eleftheriadou	NOUN
dpc-3672	171	8	v	v	PROPN
dpc-3672	171	9	,	,	PUNCT
dpc-3672	171	10	jones	jones	PROPN
dpc-3672	171	11	h	h	PROPN
dpc-3672	171	12	,	,	PUNCT
dpc-3672	171	13	et	et	PROPN
dpc-3672	171	14	al	al	PROPN
dpc-3672	171	15	.	.	PUNCT
dpc-3672	172	1	psychosocial	psychosocial	ADJ
dpc-3672	172	2	effects	effect	NOUN
dpc-3672	172	3	of	of	ADP
dpc-3672	172	4	vitiligo	vitiligo	NOUN
dpc-3672	172	5	:	:	PUNCT
dpc-3672	172	6	a	a	DET
dpc-3672	172	7	systematic	systematic	ADJ
dpc-3672	172	8	literature	literature	PROPN
dpc-3672	172	9	review	review	NOUN
dpc-3672	172	10	.	.	PUNCT
dpc-3672	173	1	am	be	AUX
dpc-3672	173	2	j	j	PROPN
dpc-3672	173	3	clin	clin	PROPN
dpc-3672	173	4	dermatol	dermatol	NOUN
dpc-3672	173	5	.	.	PUNCT
dpc-3672	174	1	2021;22(6):757	2021;22(6):757	NOUN
dpc-3672	174	2	-	-	SYM
dpc-3672	174	3	774	774	NUM
dpc-3672	174	4	.	.	PUNCT
dpc-3672	175	1	doi	doi	NOUN
dpc-3672	175	2	:	:	PUNCT
dpc-3672	175	3	10.1007	10.1007	NUM
dpc-3672	175	4	/	/	SYM
dpc-3672	175	5	s40257	s40257	NOUN
dpc-3672	175	6	-	-	PUNCT
dpc-3672	175	7	021	021	NUM
dpc-3672	175	8	-	-	PUNCT
dpc-3672	175	9	00631	00631	NUM
dpc-3672	175	10	-	-	PUNCT
dpc-3672	175	11	6	6	NUM
dpc-3672	175	12	.	.	PUNCT
dpc-3672	176	1	pmid	pmid	NOUN
dpc-3672	176	2	:	:	PUNCT
dpc-3672	176	3	34554406	34554406	NUM
dpc-3672	176	4	.	.	PUNCT
dpc-3672	177	1	pmcid	pmcid	NOUN
dpc-3672	177	2	:	:	PUNCT
dpc-3672	177	3	pmc8566637	pmc8566637	ADV
dpc-3672	177	4	.	.	PUNCT
dpc-3672	178	1	3	3	X
dpc-3672	178	2	.	.	X
dpc-3672	178	3	bergqvist	bergqvist	PROPN
dpc-3672	178	4	c	c	PROPN
dpc-3672	178	5	,	,	PUNCT
dpc-3672	178	6	ezzedine	ezzedine	PROPN
dpc-3672	178	7	k.	k.	PROPN
dpc-3672	178	8	vitiligo	vitiligo	PROPN
dpc-3672	178	9	:	:	PUNCT
dpc-3672	178	10	a	a	DET
dpc-3672	178	11	focus	focus	NOUN
dpc-3672	178	12	on	on	ADP
dpc-3672	178	13	pathogenesis	pathogenesis	NOUN
dpc-3672	178	14	and	and	CCONJ
dpc-3672	178	15	its	its	PRON
dpc-3672	178	16	therapeutic	therapeutic	ADJ
dpc-3672	178	17	implications	implication	NOUN
dpc-3672	178	18	.	.	PUNCT
dpc-3672	179	1	j	j	PROPN
dpc-3672	179	2	dermatol	dermatol	NOUN
dpc-3672	179	3	.	.	PUNCT
dpc-3672	180	1	2021;48(3):252	2021;48(3):252	NUM
dpc-3672	180	2	-	-	SYM
dpc-3672	180	3	270	270	NUM
dpc-3672	180	4	.	.	PUNCT
dpc-3672	181	1	doi	doi	NOUN
dpc-3672	181	2	:	:	PUNCT
dpc-3672	181	3	10.1111/1346	10.1111/1346	NUM
dpc-3672	181	4	-	-	SYM
dpc-3672	181	5	8138.15743	8138.15743	NUM
dpc-3672	181	6	.	.	PUNCT
dpc-3672	182	1	pmid	pmid	NOUN
dpc-3672	182	2	:	:	PUNCT
dpc-3672	182	3	33404102	33404102	NUM
dpc-3672	182	4	.	.	PUNCT
dpc-3672	183	1	4	4	X
dpc-3672	183	2	.	.	NUM
dpc-3672	183	3	gomes	gomes	PROPN
dpc-3672	183	4	ia	ia	PROPN
dpc-3672	183	5	,	,	PUNCT
dpc-3672	183	6	de	de	PROPN
dpc-3672	183	7	carvalho	carvalho	NOUN
dpc-3672	183	8	fo	fo	PROPN
dpc-3672	183	9	,	,	PUNCT
dpc-3672	183	10	de	de	PROPN
dpc-3672	183	11	menezes	menezes	PROPN
dpc-3672	183	12	af	af	PROPN
dpc-3672	183	13	,	,	PUNCT
dpc-3672	183	14	et	et	PROPN
dpc-3672	183	15	al	al	PROPN
dpc-3672	183	16	.	.	PUNCT
dpc-3672	184	1	the	the	DET
dpc-3672	184	2	role	role	NOUN
dpc-3672	184	3	of	of	ADP
dpc-3672	184	4	interleukins	interleukin	NOUN
dpc-3672	184	5	in	in	ADP
dpc-3672	184	6	vitiligo	vitiligo	NOUN
dpc-3672	184	7	:	:	PUNCT
dpc-3672	184	8	a	a	DET
dpc-3672	184	9	systematic	systematic	ADJ
dpc-3672	184	10	review	review	NOUN
dpc-3672	184	11	.	.	PUNCT
dpc-3672	185	1	j	j	PROPN
dpc-3672	185	2	eur	eur	PROPN
dpc-3672	185	3	acad	acad	PROPN
dpc-3672	185	4	dermatol	dermatol	NOUN
dpc-3672	185	5	venereol	venereol	NOUN
dpc-3672	185	6	.	.	PUNCT
dpc-3672	186	1	2018;32(12):2097	2018;32(12):2097	NUM
dpc-3672	186	2	-	-	SYM
dpc-3672	186	3	2111	2111	NUM
dpc-3672	186	4	.	.	PUNCT
dpc-3672	187	1	doi	doi	NOUN
dpc-3672	187	2	:	:	PUNCT
dpc-3672	187	3	10.1111	10.1111	NUM
dpc-3672	187	4	/	/	SYM
dpc-3672	187	5	jdv.15016	jdv.15016	PROPN
dpc-3672	187	6	.	.	PUNCT
dpc-3672	188	1	pmid	pmid	NOUN
dpc-3672	188	2	:	:	PUNCT
dpc-3672	188	3	29704266	29704266	NUM
dpc-3672	188	4	.	.	PUNCT
dpc-3672	189	1	5	5	X
dpc-3672	189	2	.	.	X
dpc-3672	189	3	vignali	vignali	PROPN
dpc-3672	189	4	da	da	PROPN
dpc-3672	189	5	,	,	PUNCT
dpc-3672	189	6	kuchroo	kuchroo	PROPN
dpc-3672	189	7	vk	vk	PROPN
dpc-3672	189	8	.	.	PROPN
dpc-3672	190	1	il-12	il-12	VERB
dpc-3672	190	2	family	family	NOUN
dpc-3672	190	3	cytokines	cytokine	VERB
dpc-3672	190	4	:	:	PUNCT
dpc-3672	190	5	immunological	immunological	ADJ
dpc-3672	190	6	playmakers	playmaker	NOUN
dpc-3672	190	7	.	.	PUNCT
dpc-3672	191	1	nat	nat	PROPN
dpc-3672	191	2	immunol	immunol	NOUN
dpc-3672	191	3	.	.	PUNCT
dpc-3672	192	1	2012;13(8):722	2012;13(8):722	NUM
dpc-3672	192	2	-	-	PUNCT
dpc-3672	192	3	728	728	NUM
dpc-3672	192	4	.	.	PUNCT
dpc-3672	193	1	doi	doi	NOUN
dpc-3672	193	2	:	:	PUNCT
dpc-3672	193	3	10.1038	10.1038	NUM
dpc-3672	193	4	/ni.2366	/ni.2366	X
dpc-3672	193	5	.	.	PUNCT
dpc-3672	194	1	pmid	pmid	NOUN
dpc-3672	194	2	:	:	PUNCT
dpc-3672	194	3	22814351	22814351	NUM
dpc-3672	194	4	.	.	PUNCT
dpc-3672	195	1	pmcid	pmcid	ADJ
dpc-3672	195	2	:	:	PUNCT
dpc-3672	195	3	pmc4158817	pmc4158817	NOUN
dpc-3672	195	4	.	.	PUNCT
dpc-3672	196	1	6	6	X
dpc-3672	196	2	.	.	X
dpc-3672	196	3	ringkowski	ringkowski	PROPN
dpc-3672	196	4	s	s	PROPN
dpc-3672	196	5	,	,	PUNCT
dpc-3672	196	6	thomas	thomas	PROPN
dpc-3672	196	7	ps	ps	PROPN
dpc-3672	196	8	,	,	PUNCT
dpc-3672	196	9	herbert	herbert	PROPN
dpc-3672	196	10	c.	c.	PROPN
dpc-3672	196	11	interleukin-12	interleukin-12	PROPN
dpc-3672	196	12	family	family	NOUN
dpc-3672	196	13	cytokines	cytokine	NOUN
dpc-3672	196	14	and	and	CCONJ
dpc-3672	196	15	sarcoidosis	sarcoidosis	NOUN
dpc-3672	196	16	.	.	PUNCT
dpc-3672	197	1	front	front	ADJ
dpc-3672	197	2	pharmacol	pharmacol	PROPN
dpc-3672	197	3	.	.	PUNCT
dpc-3672	198	1	2014;5:233	2014;5:233	X
dpc-3672	198	2	.	.	PUNCT
dpc-3672	199	1	doi	doi	NOUN
dpc-3672	199	2	:	:	PUNCT
dpc-3672	199	3	10.3389	10.3389	NUM
dpc-3672	199	4	/	/	SYM
dpc-3672	199	5	fphar.2014.00233	fphar.2014.00233	NOUN
dpc-3672	199	6	.	.	PUNCT
dpc-3672	200	1	pmid	pmid	NOUN
dpc-3672	200	2	:	:	PUNCT
dpc-3672	200	3	25386143	25386143	NUM
dpc-3672	200	4	.	.	PUNCT
dpc-3672	201	1	pmcid	pmcid	NOUN
dpc-3672	201	2	:	:	PUNCT
dpc-3672	201	3	pmc4209812	pmc4209812	NOUN
dpc-3672	201	4	.	.	PUNCT
dpc-3672	202	1	7	7	X
dpc-3672	202	2	.	.	X
dpc-3672	202	3	singh	singh	PROPN
dpc-3672	202	4	a	a	PROPN
dpc-3672	202	5	,	,	PUNCT
dpc-3672	202	6	das	das	PROPN
dpc-3672	202	7	d	d	PROPN
dpc-3672	202	8	,	,	PUNCT
dpc-3672	202	9	kurra	kurra	PROPN
dpc-3672	202	10	s	s	PROPN
dpc-3672	202	11	,	,	PUNCT
dpc-3672	202	12	arava	arava	PROPN
dpc-3672	202	13	s	s	PROPN
dpc-3672	202	14	,	,	PUNCT
dpc-3672	202	15	gupta	gupta	PROPN
dpc-3672	202	16	s	s	PART
dpc-3672	202	17	,	,	PUNCT
dpc-3672	202	18	sharma	sharma	PROPN
dpc-3672	202	19	a.	a.	PROPN
dpc-3672	202	20	dendritic	dendritic	PROPN
dpc-3672	202	21	cells	cell	NOUN
dpc-3672	202	22	and	and	CCONJ
dpc-3672	202	23	their	their	PRON
dpc-3672	202	24	associated	associated	ADJ
dpc-3672	202	25	pro	pro	ADJ
dpc-3672	202	26	-	-	ADJ
dpc-3672	202	27	inflammatory	inflammatory	ADJ
dpc-3672	202	28	cytokines	cytokine	NOUN
dpc-3672	202	29	augment	augment	VERB
dpc-3672	202	30	to	to	ADP
dpc-3672	202	31	the	the	DET
dpc-3672	202	32	inflammatory	inflammatory	ADJ
dpc-3672	202	33	milieu	milieu	NOUN
dpc-3672	202	34	in	in	ADP
dpc-3672	202	35	vitiligo	vitiligo	NOUN
dpc-3672	202	36	skin	skin	NOUN
dpc-3672	202	37	.	.	PUNCT
dpc-3672	203	1	cytokine	cytokine	NOUN
dpc-3672	203	2	.	.	PUNCT
dpc-3672	204	1	2021;148:155598	2021;148:155598	NUM
dpc-3672	204	2	.	.	PUNCT
dpc-3672	205	1	doi	doi	NOUN
dpc-3672	205	2	:	:	PUNCT
dpc-3672	205	3	10.1016	10.1016	NUM
dpc-3672	205	4	/	/	SYM
dpc-3672	205	5	j.cyto.2021.155598	j.cyto.2021.155598	NOUN
dpc-3672	205	6	.	.	PUNCT
dpc-3672	206	1	pmid	pmid	NOUN
dpc-3672	206	2	:	:	PUNCT
dpc-3672	206	3	34103210	34103210	NUM
dpc-3672	206	4	.	.	PUNCT
dpc-3672	207	1	8	8	X
dpc-3672	207	2	.	.	X
dpc-3672	207	3	njoo	njoo	PROPN
dpc-3672	207	4	md	md	PROPN
dpc-3672	207	5	,	,	PUNCT
dpc-3672	207	6	das	das	PROPN
dpc-3672	207	7	pk	pk	PROPN
dpc-3672	207	8	,	,	PUNCT
dpc-3672	207	9	bos	bos	PROPN
dpc-3672	207	10	jd	jd	PROPN
dpc-3672	207	11	,	,	PUNCT
dpc-3672	207	12	westerhof	westerhof	PROPN
dpc-3672	207	13	w.	w.	PROPN
dpc-3672	207	14	association	association	PROPN
dpc-3672	207	15	of	of	ADP
dpc-3672	207	16	the	the	DET
dpc-3672	207	17	köbner	köbner	PROPN
dpc-3672	207	18	phenomenon	phenomenon	NOUN
dpc-3672	207	19	with	with	ADP
dpc-3672	207	20	disease	disease	NOUN
dpc-3672	207	21	activity	activity	NOUN
dpc-3672	207	22	and	and	CCONJ
dpc-3672	207	23	therapeutic	therapeutic	ADJ
dpc-3672	207	24	responsiveness	responsiveness	NOUN
dpc-3672	207	25	in	in	ADP
dpc-3672	207	26	vitiligo	vitiligo	NOUN
dpc-3672	207	27	vulgaris	vulgaris	NOUN
dpc-3672	207	28	.	.	PUNCT
dpc-3672	208	1	arch	arch	ADJ
dpc-3672	208	2	dermatol	dermatol	NOUN
dpc-3672	208	3	.	.	PUNCT
dpc-3672	209	1	1999;135(4):407	1999;135(4):407	NUM
dpc-3672	209	2	-	-	SYM
dpc-3672	209	3	413	413	NUM
dpc-3672	209	4	.	.	PUNCT
dpc-3672	210	1	doi	doi	NOUN
dpc-3672	210	2	:	:	PUNCT
dpc-3672	210	3	10.1001	10.1001	NUM
dpc-3672	210	4	/	/	SYM
dpc-3672	210	5	archderm.135.4.407	archderm.135.4.407	PROPN
dpc-3672	210	6	.	.	PUNCT
dpc-3672	211	1	pmid	pmid	NOUN
dpc-3672	211	2	:	:	PUNCT
dpc-3672	211	3	10206047	10206047	NUM
dpc-3672	211	4	.	.	PUNCT
dpc-3672	212	1	9	9	X
dpc-3672	212	2	.	.	X
dpc-3672	213	1	teng	teng	PROPN
dpc-3672	213	2	mw	mw	PROPN
dpc-3672	213	3	,	,	PUNCT
dpc-3672	213	4	bowman	bowman	PROPN
dpc-3672	213	5	ep	ep	PROPN
dpc-3672	213	6	,	,	PUNCT
dpc-3672	213	7	mcelwee	mcelwee	PROPN
dpc-3672	213	8	jj	jj	PROPN
dpc-3672	213	9	,	,	PUNCT
dpc-3672	213	10	et	et	PROPN
dpc-3672	213	11	al	al	PROPN
dpc-3672	213	12	.	.	PROPN
dpc-3672	213	13	il-12	il-12	NOUN
dpc-3672	213	14	and	and	CCONJ
dpc-3672	213	15	il-23	il-23	NOUN
dpc-3672	213	16	cytokines	cytokine	NOUN
dpc-3672	213	17	:	:	PUNCT
dpc-3672	213	18	from	from	ADP
dpc-3672	213	19	discovery	discovery	NOUN
dpc-3672	213	20	to	to	ADP
dpc-3672	213	21	targeted	target	VERB
dpc-3672	213	22	therapies	therapy	NOUN
dpc-3672	213	23	for	for	ADP
dpc-3672	213	24	immune	immune	NOUN
dpc-3672	213	25	-	-	PUNCT
dpc-3672	213	26	mediated	mediate	VERB
dpc-3672	213	27	inflammatory	inflammatory	ADJ
dpc-3672	213	28	diseases	disease	NOUN
dpc-3672	213	29	.	.	PUNCT
dpc-3672	214	1	nat	nat	PROPN
dpc-3672	214	2	med	med	PROPN
dpc-3672	214	3	.	.	PUNCT
dpc-3672	215	1	2015;21(7):719	2015;21(7):719	NUM
dpc-3672	215	2	-	-	SYM
dpc-3672	215	3	729	729	NUM
dpc-3672	215	4	.	.	PUNCT
dpc-3672	216	1	doi	doi	NOUN
dpc-3672	216	2	:	:	PUNCT
dpc-3672	216	3	10.1038	10.1038	NUM
dpc-3672	216	4	/	/	SYM
dpc-3672	216	5	nm.3895	nm.3895	PROPN
dpc-3672	216	6	.	.	PUNCT
dpc-3672	217	1	pmid	pmid	PROPN
dpc-3672	217	2	:	:	PUNCT
dpc-3672	217	3	26121196	26121196	NUM
dpc-3672	217	4	.	.	PUNCT
dpc-3672	218	1	10	10	NUM
dpc-3672	218	2	.	.	X
dpc-3672	218	3	chyuan	chyuan	PROPN
dpc-3672	218	4	it	it	PRON
dpc-3672	218	5	,	,	PUNCT
dpc-3672	218	6	lai	lai	PROPN
dpc-3672	218	7	jh	jh	PROPN
dpc-3672	218	8	.	.	PUNCT
dpc-3672	219	1	new	new	ADJ
dpc-3672	219	2	insights	insight	NOUN
dpc-3672	219	3	into	into	ADP
dpc-3672	219	4	the	the	DET
dpc-3672	219	5	il-12	il-12	NOUN
dpc-3672	219	6	and	and	CCONJ
dpc-3672	219	7	il-23	il-23	NOUN
dpc-3672	219	8	:	:	PUNCT
dpc-3672	219	9	from	from	ADP
dpc-3672	219	10	a	a	DET
dpc-3672	219	11	molecular	molecular	ADJ
dpc-3672	219	12	basis	basis	NOUN
dpc-3672	219	13	to	to	ADP
dpc-3672	219	14	clinical	clinical	ADJ
dpc-3672	219	15	application	application	NOUN
dpc-3672	219	16	in	in	ADP
dpc-3672	219	17	immune	immune	NOUN
dpc-3672	219	18	-	-	PUNCT
dpc-3672	219	19	mediated	mediate	VERB
dpc-3672	219	20	inflammation	inflammation	NOUN
dpc-3672	219	21	and	and	CCONJ
dpc-3672	219	22	cancers	cancer	NOUN
dpc-3672	219	23	.	.	PUNCT
dpc-3672	220	1	biochem	biochem	PROPN
dpc-3672	220	2	pharmacol	pharmacol	PROPN
dpc-3672	220	3	.	.	PUNCT
dpc-3672	221	1	2020;175:113928	2020;175:113928	NUM
dpc-3672	221	2	.	.	PUNCT
dpc-3672	222	1	doi	doi	NOUN
dpc-3672	222	2	:	:	PUNCT
dpc-3672	222	3	10.1016	10.1016	NUM
dpc-3672	222	4	/	/	SYM
dpc-3672	222	5	j.bcp.2020.113928	j.bcp.2020.113928	PROPN
dpc-3672	222	6	.	.	PUNCT
dpc-3672	223	1	pmid	pmid	NOUN
dpc-3672	223	2	:	:	PUNCT
dpc-3672	223	3	32217101	32217101	NUM
dpc-3672	223	4	.	.	PUNCT
dpc-3672	224	1	receptors	receptor	NOUN
dpc-3672	224	2	on	on	ADP
dpc-3672	224	3	the	the	DET
dpc-3672	224	4	t	t	PROPN
dpc-3672	224	5	cell	cell	NOUN
dpc-3672	224	6	surface	surface	NOUN
dpc-3672	224	7	,	,	PUNCT
dpc-3672	224	8	and	and	CCONJ
dpc-3672	224	9	suppressing	suppress	VERB
dpc-3672	224	10	dendritic	dendritic	ADJ
dpc-3672	224	11	cells	cell	NOUN
dpc-3672	224	12	[	[	X
dpc-3672	224	13	21	21	NUM
dpc-3672	224	14	]	]	PUNCT
dpc-3672	224	15	.	.	PUNCT
dpc-3672	225	1	vitiligo	vitiligo	NOUN
dpc-3672	225	2	patients	patient	NOUN
dpc-3672	225	3	having	have	VERB
dpc-3672	225	4	lower	low	ADJ
dpc-3672	225	5	levels	level	NOUN
dpc-3672	225	6	of	of	ADP
dpc-3672	225	7	il-27	il-27	NUM
dpc-3672	225	8	than	than	ADP
dpc-3672	225	9	controls	control	NOUN
dpc-3672	225	10	suggests	suggest	VERB
dpc-3672	225	11	that	that	SCONJ
dpc-3672	225	12	il-27	il-27	ADV
dpc-3672	225	13	may	may	AUX
dpc-3672	225	14	play	play	VERB
dpc-3672	225	15	an	an	DET
dpc-3672	225	16	immunosuppressive	immunosuppressive	ADJ
dpc-3672	225	17	role	role	NOUN
dpc-3672	225	18	in	in	ADP
dpc-3672	225	19	vitiligo	vitiligo	NOUN
dpc-3672	225	20	.	.	PUNCT
dpc-3672	226	1	although	although	SCONJ
dpc-3672	226	2	serum	serum	NOUN
dpc-3672	226	3	levels	level	NOUN
dpc-3672	226	4	of	of	ADP
dpc-3672	226	5	il-12	il-12	NOUN
dpc-3672	226	6	,	,	PUNCT
dpc-3672	226	7	il-23	il-23	NOUN
dpc-3672	226	8	and	and	CCONJ
dpc-3672	226	9	il-27	il-27	ADV
dpc-3672	226	10	have	have	AUX
dpc-3672	226	11	been	be	AUX
dpc-3672	226	12	studied	study	VERB
dpc-3672	226	13	in	in	ADP
dpc-3672	226	14	vitiligo	vitiligo	NOUN
dpc-3672	226	15	,	,	PUNCT
dpc-3672	226	16	the	the	DET
dpc-3672	226	17	effect	effect	NOUN
dpc-3672	226	18	of	of	ADP
dpc-3672	226	19	il-35	il-35	NOUN
dpc-3672	226	20	in	in	ADP
dpc-3672	226	21	vitiligo	vitiligo	NOUN
dpc-3672	226	22	is	be	AUX
dpc-3672	226	23	yet	yet	ADV
dpc-3672	226	24	to	to	PART
dpc-3672	226	25	be	be	AUX
dpc-3672	226	26	identified	identify	VERB
dpc-3672	226	27	.	.	PUNCT
dpc-3672	227	1	serum	serum	NOUN
dpc-3672	227	2	il-35	il-35	ADP
dpc-3672	227	3	levels	level	NOUN
dpc-3672	227	4	were	be	AUX
dpc-3672	227	5	also	also	ADV
dpc-3672	227	6	higher	high	ADJ
dpc-3672	227	7	in	in	ADP
dpc-3672	227	8	vitiligo	vitiligo	ADJ
dpc-3672	227	9	patients	patient	NOUN
dpc-3672	227	10	compared	compare	VERB
dpc-3672	227	11	to	to	ADP
dpc-3672	227	12	controls	control	NOUN
dpc-3672	227	13	in	in	ADP
dpc-3672	227	14	our	our	PRON
dpc-3672	227	15	study	study	NOUN
dpc-3672	227	16	.	.	PUNCT
dpc-3672	228	1	il-35	il-35	ADP
dpc-3672	228	2	is	be	AUX
dpc-3672	228	3	mainly	mainly	ADV
dpc-3672	228	4	produced	produce	VERB
dpc-3672	228	5	by	by	ADP
dpc-3672	228	6	regulatory	regulatory	ADJ
dpc-3672	228	7	t	t	NOUN
dpc-3672	228	8	cells	cell	NOUN
dpc-3672	228	9	(	(	PUNCT
dpc-3672	228	10	treg	treg	PROPN
dpc-3672	228	11	)	)	PUNCT
dpc-3672	228	12	,	,	PUNCT
dpc-3672	228	13	active	active	ADJ
dpc-3672	228	14	macrophages	macrophage	NOUN
dpc-3672	228	15	and	and	CCONJ
dpc-3672	228	16	b	b	NOUN
dpc-3672	228	17	cells	cell	NOUN
dpc-3672	228	18	.	.	PUNCT
dpc-3672	229	1	comprised	comprise	VERB
dpc-3672	229	2	of	of	ADP
dpc-3672	229	3	ebi3	ebi3	PROPN
dpc-3672	229	4	and	and	CCONJ
dpc-3672	229	5	p35	p35	NOUN
dpc-3672	229	6	subunits	subunit	NOUN
dpc-3672	229	7	,	,	PUNCT
dpc-3672	229	8	il-35	il-35	ADP
dpc-3672	229	9	operates	operate	VERB
dpc-3672	229	10	by	by	ADP
dpc-3672	229	11	binding	bind	VERB
dpc-3672	229	12	to	to	ADP
dpc-3672	229	13	its	its	PRON
dpc-3672	229	14	heterodimeric	heterodimeric	ADJ
dpc-3672	229	15	receptor	receptor	NOUN
dpc-3672	229	16	(	(	PUNCT
dpc-3672	229	17	gp130	gp130	PROPN
dpc-3672	229	18	–	–	PUNCT
dpc-3672	229	19	gp130	gp130	PROPN
dpc-3672	229	20	,	,	PUNCT
dpc-3672	229	21	il12rb2	il12rb2	PROPN
dpc-3672	229	22	–	–	PUNCT
dpc-3672	229	23	il-12rb2	il-12rb2	PROPN
dpc-3672	229	24	,	,	PUNCT
dpc-3672	229	25	il-12rb2	il-12rb2	PROPN
dpc-3672	229	26	–	–	PUNCT
dpc-3672	229	27	gp130	gp130	PROPN
dpc-3672	229	28	,	,	PUNCT
dpc-3672	229	29	and	and	CCONJ
dpc-3672	229	30	gp130	gp130	PROPN
dpc-3672	229	31	-	-	PUNCT
dpc-3672	229	32	il-12rb1	il-12rb1	PROPN
dpc-3672	229	33	)	)	PUNCT
dpc-3672	229	34	.	.	PUNCT
dpc-3672	230	1	il-35	il-35	ADP
dpc-3672	230	2	binding	bind	VERB
dpc-3672	230	3	to	to	ADP
dpc-3672	230	4	the	the	DET
dpc-3672	230	5	receptor	receptor	NOUN
dpc-3672	230	6	activates	activate	VERB
dpc-3672	230	7	jak1	jak1	NOUN
dpc-3672	230	8	and	and	CCONJ
dpc-3672	230	9	jak2	jak2	PROPN
dpc-3672	230	10	.	.	PUNCT
dpc-3672	231	1	stat1	stat1	PROPN
dpc-3672	231	2	,	,	PUNCT
dpc-3672	231	3	stat3	stat3	NOUN
dpc-3672	231	4	,	,	PUNCT
dpc-3672	231	5	and	and	CCONJ
dpc-3672	231	6	stat4	stat4	NOUN
dpc-3672	231	7	are	be	AUX
dpc-3672	231	8	than	than	SCONJ
dpc-3672	231	9	phosphorylated	phosphorylate	VERB
dpc-3672	231	10	for	for	ADP
dpc-3672	231	11	biological	biological	ADJ
dpc-3672	231	12	effect	effect	NOUN
dpc-3672	231	13	[	[	X
dpc-3672	231	14	22	22	NUM
dpc-3672	231	15	]	]	PUNCT
dpc-3672	231	16	.	.	PUNCT
dpc-3672	232	1	different	different	ADJ
dpc-3672	232	2	receptors	receptor	NOUN
dpc-3672	232	3	on	on	ADP
dpc-3672	232	4	the	the	DET
dpc-3672	232	5	surfaces	surface	NOUN
dpc-3672	232	6	of	of	ADP
dpc-3672	232	7	cells	cell	NOUN
dpc-3672	232	8	may	may	AUX
dpc-3672	232	9	have	have	VERB
dpc-3672	232	10	different	different	ADJ
dpc-3672	232	11	biological	biological	ADJ
dpc-3672	232	12	effects	effect	NOUN
dpc-3672	232	13	by	by	ADP
dpc-3672	232	14	activating	activate	VERB
dpc-3672	232	15	different	different	ADJ
dpc-3672	232	16	jak	jak	PROPN
dpc-3672	232	17	/	/	SYM
dpc-3672	232	18	stat	stat	PROPN
dpc-3672	232	19	pathways	pathway	NOUN
dpc-3672	232	20	.	.	PUNCT
dpc-3672	233	1	il-35	il-35	ADP
dpc-3672	233	2	receptors	receptor	NOUN
dpc-3672	233	3	on	on	ADP
dpc-3672	233	4	treg	treg	PROPN
dpc-3672	233	5	cells	cells	PROPN
dpc-3672	233	6	and	and	CCONJ
dpc-3672	233	7	breg	breg	PROPN
dpc-3672	233	8	cells	cell	NOUN
dpc-3672	233	9	enable	enable	VERB
dpc-3672	233	10	il-35	il-35	PART
dpc-3672	233	11	to	to	PART
dpc-3672	233	12	stimulate	stimulate	VERB
dpc-3672	233	13	expansion	expansion	NOUN
dpc-3672	233	14	in	in	ADP
dpc-3672	233	15	treg	treg	PROPN
dpc-3672	233	16	and	and	CCONJ
dpc-3672	233	17	breg	breg	PROPN
dpc-3672	233	18	cells	cell	NOUN
dpc-3672	233	19	,	,	PUNCT
dpc-3672	233	20	creating	create	VERB
dpc-3672	233	21	immunosuppressive	immunosuppressive	ADJ
dpc-3672	233	22	effects	effect	NOUN
dpc-3672	233	23	[	[	X
dpc-3672	233	24	23	23	NUM
dpc-3672	233	25	]	]	PUNCT
dpc-3672	233	26	.	.	PUNCT
dpc-3672	234	1	il-35	il-35	ADP
dpc-3672	234	2	serum	serum	NOUN
dpc-3672	234	3	levels	level	NOUN
dpc-3672	234	4	have	have	AUX
dpc-3672	234	5	been	be	AUX
dpc-3672	234	6	previously	previously	ADV
dpc-3672	234	7	studied	study	VERB
dpc-3672	234	8	in	in	ADP
dpc-3672	234	9	many	many	ADJ
dpc-3672	234	10	autoimmune	autoimmune	ADJ
dpc-3672	234	11	and	and	CCONJ
dpc-3672	234	12	inflammatory	inflammatory	ADJ
dpc-3672	234	13	diseases	disease	NOUN
dpc-3672	234	14	and	and	CCONJ
dpc-3672	234	15	different	different	ADJ
dpc-3672	234	16	outcomes	outcome	NOUN
dpc-3672	234	17	reported	report	VERB
dpc-3672	234	18	.	.	PUNCT
dpc-3672	235	1	compared	compare	VERB
dpc-3672	235	2	to	to	ADP
dpc-3672	235	3	healthy	healthy	ADJ
dpc-3672	235	4	controls	control	NOUN
dpc-3672	235	5	lower	low	ADJ
dpc-3672	235	6	serum	serum	NOUN
dpc-3672	235	7	il-35	il-35	ADP
dpc-3672	235	8	levels	level	NOUN
dpc-3672	235	9	were	be	AUX
dpc-3672	235	10	reported	report	VERB
dpc-3672	235	11	in	in	ADP
dpc-3672	235	12	patients	patient	NOUN
dpc-3672	235	13	with	with	ADP
dpc-3672	235	14	systemic	systemic	ADJ
dpc-3672	235	15	lupus	lupus	NOUN
dpc-3672	235	16	erythematosus	erythematosus	NOUN
dpc-3672	235	17	and	and	CCONJ
dpc-3672	235	18	rheumatoid	rheumatoid	VERB
dpc-3672	235	19	arthritis	arthritis	NOUN
dpc-3672	235	20	,	,	PUNCT
dpc-3672	235	21	whereas	whereas	SCONJ
dpc-3672	235	22	higher	high	ADJ
dpc-3672	235	23	levels	level	NOUN
dpc-3672	235	24	of	of	ADP
dpc-3672	235	25	il-35	il-35	NOUN
dpc-3672	235	26	were	be	AUX
dpc-3672	235	27	seen	see	VERB
dpc-3672	235	28	in	in	ADP
dpc-3672	235	29	patients	patient	NOUN
dpc-3672	235	30	with	with	ADP
dpc-3672	235	31	systemic	systemic	ADJ
dpc-3672	235	32	sclerosis	sclerosis	NOUN
dpc-3672	236	1	[	[	X
dpc-3672	236	2	23,24	23,24	NOUN
dpc-3672	236	3	]	]	PUNCT
dpc-3672	236	4	.	.	PUNCT
dpc-3672	237	1	even	even	ADV
dpc-3672	237	2	though	though	SCONJ
dpc-3672	237	3	the	the	DET
dpc-3672	237	4	reason	reason	NOUN
dpc-3672	237	5	for	for	ADP
dpc-3672	237	6	the	the	DET
dpc-3672	237	7	increased	increase	VERB
dpc-3672	237	8	levels	level	NOUN
dpc-3672	237	9	of	of	ADP
dpc-3672	237	10	il-35	il-35	ADP
dpc-3672	237	11	,	,	PUNCT
dpc-3672	237	12	which	which	PRON
dpc-3672	237	13	has	have	VERB
dpc-3672	237	14	an	an	DET
dpc-3672	237	15	anti	anti	ADJ
dpc-3672	237	16	-	-	ADJ
dpc-3672	237	17	inflammatory	inflammatory	ADJ
dpc-3672	237	18	and	and	CCONJ
dpc-3672	237	19	immunosuppressive	immunosuppressive	ADJ
dpc-3672	237	20	cytokine	cytokine	NOUN
dpc-3672	237	21	,	,	PUNCT
dpc-3672	237	22	in	in	ADP
dpc-3672	237	23	autoimmune	autoimmune	ADJ
dpc-3672	237	24	/	/	SYM
dpc-3672	237	25	inflammatory	inflammatory	ADJ
dpc-3672	237	26	diseases	disease	NOUN
dpc-3672	237	27	is	be	AUX
dpc-3672	237	28	not	not	PART
dpc-3672	237	29	fully	fully	ADV
dpc-3672	237	30	known	know	VERB
dpc-3672	237	31	,	,	PUNCT
dpc-3672	237	32	several	several	ADJ
dpc-3672	237	33	studies	study	NOUN
dpc-3672	237	34	have	have	AUX
dpc-3672	237	35	attempted	attempt	VERB
dpc-3672	237	36	to	to	PART
dpc-3672	237	37	explain	explain	VERB
dpc-3672	237	38	this	this	DET
dpc-3672	237	39	contradiction	contradiction	NOUN
dpc-3672	237	40	.	.	PUNCT
dpc-3672	238	1	in	in	ADP
dpc-3672	238	2	a	a	DET
dpc-3672	238	3	study	study	NOUN
dpc-3672	238	4	investigating	investigate	VERB
dpc-3672	238	5	whether	whether	SCONJ
dpc-3672	238	6	il-35	il-35	NOUN
dpc-3672	238	7	has	have	VERB
dpc-3672	238	8	different	different	ADJ
dpc-3672	238	9	properties	property	NOUN
dpc-3672	238	10	from	from	ADP
dpc-3672	238	11	il-10	il-10	PRON
dpc-3672	238	12	,	,	PUNCT
dpc-3672	238	13	transforming	transform	VERB
dpc-3672	238	14	growth	growth	NOUN
dpc-3672	238	15	factor	factor	NOUN
dpc-3672	238	16	(	(	PUNCT
dpc-3672	238	17	tgf)-β	tgf)-β	NOUN
dpc-3672	238	18	or	or	CCONJ
dpc-3672	238	19	similar	similar	ADJ
dpc-3672	238	20	other	other	ADJ
dpc-3672	238	21	anti	anti	ADJ
dpc-3672	238	22	-	-	ADJ
dpc-3672	238	23	inflammatory	inflammatory	ADJ
dpc-3672	238	24	cytokines	cytokine	NOUN
dpc-3672	238	25	,	,	PUNCT
dpc-3672	238	26	li	li	PROPN
dpc-3672	238	27	et	et	PROPN
dpc-3672	238	28	 	 	SPACE
dpc-3672	238	29	al	al	PROPN
dpc-3672	238	30	.	.	PROPN
dpc-3672	238	31	showed	show	VERB
dpc-3672	238	32	that	that	SCONJ
dpc-3672	238	33	il-35	il-35	ADP
dpc-3672	238	34	was	be	AUX
dpc-3672	238	35	a	a	DET
dpc-3672	238	36	stimulable	stimulable	ADJ
dpc-3672	238	37	anti	anti	ADJ
dpc-3672	238	38	-	-	ADJ
dpc-3672	238	39	inflammatory	inflammatory	ADJ
dpc-3672	238	40	cytokine	cytokine	NOUN
dpc-3672	238	41	unlike	unlike	ADP
dpc-3672	238	42	other	other	ADJ
dpc-3672	238	43	anti	anti	ADJ
dpc-3672	238	44	-	-	ADJ
dpc-3672	238	45	inflammatory	inflammatory	ADJ
dpc-3672	238	46	cytokines	cytokine	NOUN
dpc-3672	238	47	[	[	X
dpc-3672	238	48	25	25	NUM
dpc-3672	238	49	]	]	PUNCT
dpc-3672	238	50	.	.	PUNCT
dpc-3672	239	1	il-35	il-35	PROPN
dpc-3672	239	2	prevents	prevent	VERB
dpc-3672	239	3	inflammation	inflammation	NOUN
dpc-3672	239	4	from	from	ADP
dpc-3672	239	5	reaching	reach	VERB
dpc-3672	239	6	its	its	PRON
dpc-3672	239	7	maximum	maximum	ADJ
dpc-3672	239	8	impact	impact	NOUN
dpc-3672	239	9	rather	rather	ADV
dpc-3672	239	10	than	than	ADP
dpc-3672	239	11	preventing	prevent	VERB
dpc-3672	239	12	inflammation	inflammation	NOUN
dpc-3672	239	13	from	from	ADP
dpc-3672	239	14	forming	form	VERB
dpc-3672	239	15	by	by	ADP
dpc-3672	239	16	being	be	AUX
dpc-3672	239	17	expressed	express	VERB
dpc-3672	239	18	in	in	ADP
dpc-3672	239	19	response	response	NOUN
dpc-3672	239	20	to	to	ADP
dpc-3672	239	21	inflammatory	inflammatory	ADJ
dpc-3672	239	22	stimuli	stimulus	NOUN
dpc-3672	239	23	[	[	X
dpc-3672	239	24	25	25	NUM
dpc-3672	239	25	]	]	PUNCT
dpc-3672	239	26	.	.	PUNCT
dpc-3672	240	1	qiu	qiu	PROPN
dpc-3672	240	2	et	et	PROPN
dpc-3672	240	3	al	al	PROPN
dpc-3672	240	4	.	.	PROPN
dpc-3672	240	5	found	find	VERB
dpc-3672	240	6	higher	high	ADJ
dpc-3672	240	7	levels	level	NOUN
dpc-3672	240	8	of	of	ADP
dpc-3672	240	9	serum	serum	NOUN
dpc-3672	240	10	il-35	il-35	ADP
dpc-3672	240	11	in	in	ADP
dpc-3672	240	12	patients	patient	NOUN
dpc-3672	240	13	with	with	ADP
dpc-3672	240	14	active	active	ADJ
dpc-3672	240	15	lupus	lupus	NOUN
dpc-3672	240	16	compared	compare	VERB
dpc-3672	240	17	to	to	ADP
dpc-3672	240	18	controls	control	NOUN
dpc-3672	240	19	,	,	PUNCT
dpc-3672	240	20	and	and	CCONJ
dpc-3672	240	21	observed	observe	VERB
dpc-3672	240	22	a	a	DET
dpc-3672	240	23	reduction	reduction	NOUN
dpc-3672	240	24	in	in	ADP
dpc-3672	240	25	il-35	il-35	ADP
dpc-3672	240	26	levels	level	NOUN
dpc-3672	240	27	after	after	ADP
dpc-3672	240	28	treatment	treatment	NOUN
dpc-3672	240	29	.	.	PUNCT
dpc-3672	241	1	the	the	DET
dpc-3672	241	2	authors	author	NOUN
dpc-3672	241	3	argued	argue	VERB
dpc-3672	241	4	that	that	SCONJ
dpc-3672	241	5	il-35	il-35	ADP
dpc-3672	241	6	was	be	AUX
dpc-3672	241	7	an	an	DET
dpc-3672	241	8	anti	anti	ADJ
dpc-3672	241	9	-	-	ADJ
dpc-3672	241	10	inflammatory	inflammatory	ADJ
dpc-3672	241	11	factor	factor	NOUN
dpc-3672	241	12	that	that	PRON
dpc-3672	241	13	increased	increase	VERB
dpc-3672	241	14	to	to	PART
dpc-3672	241	15	antagonize	antagonize	VERB
dpc-3672	241	16	the	the	DET
dpc-3672	241	17	negative	negative	ADJ
dpc-3672	241	18	impact	impact	NOUN
dpc-3672	241	19	of	of	ADP
dpc-3672	241	20	the	the	DET
dpc-3672	241	21	pathological	pathological	ADJ
dpc-3672	241	22	inflammation	inflammation	NOUN
dpc-3672	241	23	to	to	ADP
dpc-3672	241	24	a	a	DET
dpc-3672	241	25	certain	certain	ADJ
dpc-3672	241	26	extent	extent	NOUN
dpc-3672	241	27	[	[	X
dpc-3672	241	28	26	26	NUM
dpc-3672	241	29	]	]	PUNCT
dpc-3672	241	30	.	.	PUNCT
dpc-3672	242	1	correlation	correlation	NOUN
dpc-3672	242	2	of	of	ADP
dpc-3672	242	3	il-35	il-35	NOUN
dpc-3672	242	4	with	with	ADP
dpc-3672	242	5	sedimentation	sedimentation	NOUN
dpc-3672	242	6	levels	level	NOUN
dpc-3672	242	7	in	in	ADP
dpc-3672	242	8	patients	patient	NOUN
dpc-3672	242	9	with	with	ADP
dpc-3672	242	10	primary	primary	ADJ
dpc-3672	242	11	sjögren	sjögren	PROPN
dpc-3672	242	12	syndrome	syndrome	NOUN
dpc-3672	242	13	backs	back	VERB
dpc-3672	242	14	the	the	DET
dpc-3672	242	15	arguments	argument	NOUN
dpc-3672	242	16	that	that	PRON
dpc-3672	242	17	il-35	il-35	ADP
dpc-3672	242	18	is	be	AUX
dpc-3672	242	19	an	an	DET
dpc-3672	242	20	anti	anti	ADJ
dpc-3672	242	21	-	-	ADJ
dpc-3672	242	22	inflammatory	inflammatory	ADJ
dpc-3672	242	23	cytokine	cytokine	NOUN
dpc-3672	242	24	that	that	PRON
dpc-3672	242	25	is	be	AUX
dpc-3672	242	26	secreted	secrete	VERB
dpc-3672	242	27	secondarily	secondarily	ADV
dpc-3672	242	28	to	to	ADP
dpc-3672	242	29	inflammatory	inflammatory	ADJ
dpc-3672	242	30	stimuli	stimulus	NOUN
dpc-3672	242	31	to	to	PART
dpc-3672	242	32	antagonize	antagonize	VERB
dpc-3672	242	33	the	the	DET
dpc-3672	242	34	effects	effect	NOUN
dpc-3672	242	35	of	of	ADP
dpc-3672	242	36	maximal	maximal	ADJ
dpc-3672	242	37	inflammation	inflammation	NOUN
dpc-3672	242	38	[	[	X
dpc-3672	242	39	24	24	NUM
dpc-3672	242	40	]	]	PUNCT
dpc-3672	242	41	.	.	PUNCT
dpc-3672	243	1	although	although	SCONJ
dpc-3672	243	2	vitiligo	vitiligo	NOUN
dpc-3672	243	3	patients	patient	NOUN
dpc-3672	243	4	had	have	VERB
dpc-3672	243	5	higher	high	ADJ
dpc-3672	243	6	levels	level	NOUN
dpc-3672	243	7	of	of	ADP
dpc-3672	243	8	il-35	il-35	ADP
dpc-3672	243	9	than	than	ADP
dpc-3672	243	10	healthy	healthy	ADJ
dpc-3672	243	11	controls	control	NOUN
dpc-3672	243	12	,	,	PUNCT
dpc-3672	243	13	there	there	PRON
dpc-3672	243	14	was	be	VERB
dpc-3672	243	15	not	not	PART
dpc-3672	243	16	any	any	DET
dpc-3672	243	17	significant	significant	ADJ
dpc-3672	243	18	correlation	correlation	NOUN
dpc-3672	243	19	between	between	ADP
dpc-3672	243	20	serum	serum	NOUN
dpc-3672	243	21	il-35	il-35	ADP
dpc-3672	243	22	levels	level	NOUN
dpc-3672	243	23	and	and	CCONJ
dpc-3672	243	24	the	the	DET
dpc-3672	243	25	extensiveness	extensiveness	NOUN
dpc-3672	243	26	or	or	CCONJ
dpc-3672	243	27	activity	activity	NOUN
dpc-3672	243	28	of	of	ADP
dpc-3672	243	29	the	the	DET
dpc-3672	243	30	disease	disease	NOUN
dpc-3672	243	31	.	.	PUNCT
dpc-3672	244	1	in	in	ADP
dpc-3672	244	2	vitiligo	vitiligo	PROPN
dpc-3672	244	3	il-35	il-35	X
dpc-3672	244	4	may	may	AUX
dpc-3672	244	5	be	be	AUX
dpc-3672	244	6	expressed	express	VERB
dpc-3672	244	7	to	to	PART
dpc-3672	244	8	antagonize	antagonize	VERB
dpc-3672	244	9	8	8	NUM
dpc-3672	244	10	original	original	ADJ
dpc-3672	244	11	article	article	NOUN
dpc-3672	244	12	|	|	ADV
dpc-3672	244	13	dermatol	dermatol	ADJ
dpc-3672	244	14	pract	pract	NOUN
dpc-3672	244	15	concept	concept	NOUN
dpc-3672	244	16	.	.	PUNCT
dpc-3672	245	1	2024;14(2):e2024069	2024;14(2):e2024069	NUM
dpc-3672	245	2	19	19	NUM
dpc-3672	245	3	.	.	PUNCT
dpc-3672	245	4	elkady	elkady	PROPN
dpc-3672	245	5	a	a	PRON
dpc-3672	245	6	,	,	PUNCT
dpc-3672	245	7	bonomo	bonomo	NOUN
dpc-3672	245	8	l	l	NOUN
dpc-3672	245	9	,	,	PUNCT
dpc-3672	245	10	amir	amir	PROPN
dpc-3672	245	11	y	y	PROPN
dpc-3672	245	12	,	,	PUNCT
dpc-3672	245	13	vekaria	vekaria	NOUN
dpc-3672	245	14	as	as	ADP
dpc-3672	245	15	,	,	PUNCT
dpc-3672	245	16	guttman	guttman	ADJ
dpc-3672	245	17	-	-	PUNCT
dpc-3672	245	18	yassky	yassky	NOUN
dpc-3672	245	19	e.	e.	PROPN
dpc-3672	245	20	effective	effective	ADJ
dpc-3672	245	21	use	use	NOUN
dpc-3672	245	22	of	of	ADP
dpc-3672	245	23	ustekinumab	ustekinumab	NOUN
dpc-3672	245	24	in	in	ADP
dpc-3672	245	25	a	a	DET
dpc-3672	245	26	patient	patient	NOUN
dpc-3672	245	27	with	with	ADP
dpc-3672	245	28	concomitant	concomitant	ADJ
dpc-3672	245	29	psoriasis	psoriasis	NOUN
dpc-3672	245	30	,	,	PUNCT
dpc-3672	245	31	vitiligo	vitiligo	VERB
dpc-3672	245	32	,	,	PUNCT
dpc-3672	245	33	and	and	CCONJ
dpc-3672	245	34	alopecia	alopecia	NOUN
dpc-3672	245	35	areata	areata	ADJ
dpc-3672	245	36	.	.	PUNCT
dpc-3672	246	1	jaad	jaad	NOUN
dpc-3672	246	2	case	case	NOUN
dpc-3672	246	3	rep	rep	PROPN
dpc-3672	246	4	.	.	PROPN
dpc-3672	246	5	2017;3(6):477	2017;3(6):477	NOUN
dpc-3672	246	6	-	-	PUNCT
dpc-3672	246	7	479	479	NUM
dpc-3672	246	8	.	.	PUNCT
dpc-3672	247	1	doi	doi	NOUN
dpc-3672	247	2	:	:	PUNCT
dpc-3672	247	3	10.1016	10.1016	NUM
dpc-3672	247	4	/	/	SYM
dpc-3672	247	5	j.jdcr.2017.07.009	j.jdcr.2017.07.009	PROPN
dpc-3672	247	6	.	.	PUNCT
dpc-3672	248	1	pmid	pmid	NOUN
dpc-3672	248	2	:	:	PUNCT
dpc-3672	248	3	28971137	28971137	NUM
dpc-3672	248	4	.	.	PUNCT
dpc-3672	249	1	pmcid	pmcid	NOUN
dpc-3672	249	2	:	:	PUNCT
dpc-3672	249	3	pmc5614637	pmc5614637	ADJ
dpc-3672	249	4	.	.	PUNCT
dpc-3672	250	1	20	20	NUM
dpc-3672	250	2	.	.	PUNCT
dpc-3672	251	1	hosseini	hosseini	PROPN
dpc-3672	251	2	sm	sm	PROPN
dpc-3672	251	3	,	,	PUNCT
dpc-3672	251	4	gholijani	gholijani	PROPN
dpc-3672	251	5	n	n	CCONJ
dpc-3672	251	6	,	,	PUNCT
dpc-3672	251	7	chenari	chenari	ADJ
dpc-3672	251	8	n	n	CCONJ
dpc-3672	251	9	,	,	PUNCT
dpc-3672	251	10	kalantar	kalantar	PROPN
dpc-3672	251	11	k.	k.	PROPN
dpc-3672	251	12	decreased	decrease	VERB
dpc-3672	251	13	levels	level	NOUN
dpc-3672	251	14	of	of	ADP
dpc-3672	251	15	interleukin	interleukin	NOUN
dpc-3672	251	16	27	27	NUM
dpc-3672	251	17	in	in	ADP
dpc-3672	251	18	the	the	DET
dpc-3672	251	19	serum	serum	NOUN
dpc-3672	251	20	of	of	ADP
dpc-3672	251	21	vitiligo	vitiligo	ADJ
dpc-3672	251	22	patients	patient	NOUN
dpc-3672	251	23	.	.	PUNCT
dpc-3672	252	1	an	an	DET
dpc-3672	252	2	bras	bras	NOUN
dpc-3672	252	3	dermatol	dermatol	NOUN
dpc-3672	252	4	.	.	PUNCT
dpc-3672	253	1	2020;95(5):570	2020;95(5):570	NUM
dpc-3672	253	2	-	-	SYM
dpc-3672	253	3	574	574	NUM
dpc-3672	253	4	.	.	PUNCT
dpc-3672	254	1	doi	doi	NOUN
dpc-3672	254	2	:	:	PUNCT
dpc-3672	254	3	10.1016	10.1016	NUM
dpc-3672	254	4	/	/	SYM
dpc-3672	254	5	j	j	PROPN
dpc-3672	254	6	.abd.2020.02.005	.abd.2020.02.005	PROPN
dpc-3672	254	7	.	.	PUNCT
dpc-3672	255	1	pmid	pmid	NOUN
dpc-3672	255	2	:	:	PUNCT
dpc-3672	255	3	32616337	32616337	NUM
dpc-3672	255	4	.	.	PUNCT
dpc-3672	256	1	pmcid	pmcid	NOUN
dpc-3672	256	2	:	:	PUNCT
dpc-3672	256	3	pmc7563000	pmc7563000	PROPN
dpc-3672	256	4	.	.	PUNCT
dpc-3672	257	1	21	21	NUM
dpc-3672	257	2	.	.	PUNCT
dpc-3672	258	1	yoshida	yoshida	PROPN
dpc-3672	258	2	h	h	PROPN
dpc-3672	258	3	,	,	PUNCT
dpc-3672	258	4	hunter	hunter	NOUN
dpc-3672	258	5	ca	ca	NOUN
dpc-3672	258	6	.	.	PUNCT
dpc-3672	259	1	the	the	DET
dpc-3672	259	2	immunobiology	immunobiology	NOUN
dpc-3672	259	3	of	of	ADP
dpc-3672	259	4	interleukin-27	interleukin-27	PROPN
dpc-3672	259	5	.	.	PUNCT
dpc-3672	259	6	annu	annu	PROPN
dpc-3672	259	7	rev	rev	VERB
dpc-3672	259	8	immunol	immunol	NOUN
dpc-3672	259	9	.	.	PUNCT
dpc-3672	260	1	2015;33:417	2015;33:417	NOUN
dpc-3672	260	2	-	-	SYM
dpc-3672	260	3	443	443	NUM
dpc-3672	260	4	.	.	PUNCT
dpc-3672	261	1	doi	doi	NOUN
dpc-3672	261	2	:	:	PUNCT
dpc-3672	261	3	10.1146/	10.1146/	NUM
dpc-3672	261	4	annurev	annurev	PROPN
dpc-3672	261	5	-immunol-032414	-immunol-032414	PROPN
dpc-3672	261	6	-	-	PUNCT
dpc-3672	261	7	112134	112134	NUM
dpc-3672	261	8	.	.	PUNCT
dpc-3672	262	1	pmid	pmid	NOUN
dpc-3672	262	2	:	:	PUNCT
dpc-3672	262	3	25861977	25861977	NUM
dpc-3672	262	4	.	.	PUNCT
dpc-3672	263	1	22	22	NUM
dpc-3672	263	2	.	.	PUNCT
dpc-3672	264	1	zhang	zhang	PROPN
dpc-3672	264	2	j	j	PROPN
dpc-3672	264	3	,	,	PUNCT
dpc-3672	264	4	zhang	zhang	PROPN
dpc-3672	264	5	y	y	PROPN
dpc-3672	264	6	,	,	PUNCT
dpc-3672	264	7	wang	wang	PROPN
dpc-3672	264	8	q	q	PROPN
dpc-3672	264	9	,	,	PUNCT
dpc-3672	264	10	et	et	PROPN
dpc-3672	264	11	al	al	PROPN
dpc-3672	264	12	.	.	PROPN
dpc-3672	264	13	interleukin-35	interleukin-35	PROPN
dpc-3672	264	14	in	in	ADP
dpc-3672	264	15	immune	immune	NOUN
dpc-3672	264	16	-	-	PUNCT
dpc-3672	264	17	related	relate	VERB
dpc-3672	264	18	diseases	disease	NOUN
dpc-3672	264	19	:	:	PUNCT
dpc-3672	264	20	protection	protection	NOUN
dpc-3672	264	21	or	or	CCONJ
dpc-3672	264	22	destruction	destruction	NOUN
dpc-3672	264	23	.	.	PUNCT
dpc-3672	265	1	immunology	immunology	NOUN
dpc-3672	265	2	.	.	PUNCT
dpc-3672	266	1	2019;157(1):13	2019;157(1):13	VERB
dpc-3672	266	2	-	-	SYM
dpc-3672	266	3	20	20	NUM
dpc-3672	266	4	.	.	PUNCT
dpc-3672	267	1	doi	doi	NOUN
dpc-3672	267	2	:	:	PUNCT
dpc-3672	267	3	10.1111	10.1111	NUM
dpc-3672	267	4	/	/	SYM
dpc-3672	267	5	imm.13044	imm.13044	X
dpc-3672	267	6	.	.	PUNCT
dpc-3672	268	1	pmid	pmid	NOUN
dpc-3672	268	2	:	:	PUNCT
dpc-3672	268	3	30681737	30681737	NUM
dpc-3672	268	4	.	.	PUNCT
dpc-3672	269	1	pmcid	pmcid	NOUN
dpc-3672	269	2	:	:	PUNCT
dpc-3672	269	3	pmc6459776	pmc6459776	NOUN
dpc-3672	269	4	.	.	PUNCT
dpc-3672	270	1	23	23	NUM
dpc-3672	270	2	.	.	PUNCT
dpc-3672	270	3	sakkas	sakkas	PROPN
dpc-3672	270	4	li	li	PROPN
dpc-3672	270	5	,	,	PUNCT
dpc-3672	270	6	mavropoulos	mavropoulo	NOUN
dpc-3672	270	7	a	a	PROPN
dpc-3672	270	8	,	,	PUNCT
dpc-3672	270	9	perricone	perricone	PROPN
dpc-3672	270	10	c	c	PROPN
dpc-3672	270	11	,	,	PUNCT
dpc-3672	270	12	bogdanos	bogdanos	PROPN
dpc-3672	270	13	dp	dp	PROPN
dpc-3672	270	14	.	.	PROPN
dpc-3672	270	15	il-35	il-35	ADP
dpc-3672	270	16	:	:	PUNCT
dpc-3672	270	17	a	a	DET
dpc-3672	270	18	new	new	ADJ
dpc-3672	270	19	immunomodulator	immunomodulator	NOUN
dpc-3672	270	20	in	in	ADP
dpc-3672	270	21	autoimmune	autoimmune	ADJ
dpc-3672	270	22	rheumatic	rheumatic	ADJ
dpc-3672	270	23	diseases	disease	NOUN
dpc-3672	270	24	.	.	PUNCT
dpc-3672	271	1	immunol	immunol	NOUN
dpc-3672	271	2	res	re	NOUN
dpc-3672	271	3	.	.	PUNCT
dpc-3672	272	1	2018;66(3):305	2018;66(3):305	NUM
dpc-3672	272	2	-	-	PUNCT
dpc-3672	272	3	312	312	NUM
dpc-3672	272	4	.	.	PUNCT
dpc-3672	272	5	doi	doi	NOUN
dpc-3672	272	6	:	:	PUNCT
dpc-3672	272	7	10.1007	10.1007	NUM
dpc-3672	272	8	/	/	SYM
dpc-3672	272	9	s12026	s12026	ADJ
dpc-3672	272	10	-	-	PUNCT
dpc-3672	272	11	018	018	NUM
dpc-3672	272	12	-8998	-8998	NUM
dpc-3672	272	13	-	-	PUNCT
dpc-3672	272	14	3	3	NUM
dpc-3672	272	15	.	.	PUNCT
dpc-3672	273	1	pmid	pmid	NOUN
dpc-3672	273	2	:	:	PUNCT
dpc-3672	273	3	29749583	29749583	NUM
dpc-3672	273	4	.	.	PUNCT
dpc-3672	274	1	24	24	NUM
dpc-3672	274	2	.	.	PUNCT
dpc-3672	274	3	han	han	PROPN
dpc-3672	274	4	m	m	PROPN
dpc-3672	274	5	,	,	PUNCT
dpc-3672	274	6	li	li	PROPN
dpc-3672	274	7	y	y	PROPN
dpc-3672	274	8	,	,	PUNCT
dpc-3672	274	9	liu	liu	PROPN
dpc-3672	274	10	s	s	PROPN
dpc-3672	274	11	,	,	PUNCT
dpc-3672	274	12	jiang	jiang	PROPN
dpc-3672	274	13	s	s	PROPN
dpc-3672	274	14	,	,	PUNCT
dpc-3672	274	15	yuan	yuan	PROPN
dpc-3672	274	16	l	l	PROPN
dpc-3672	274	17	,	,	PUNCT
dpc-3672	274	18	xia	xia	PROPN
dpc-3672	274	19	l	l	PROPN
dpc-3672	274	20	,	,	PUNCT
dpc-3672	274	21	shen	shen	PROPN
dpc-3672	274	22	h	h	PROPN
dpc-3672	274	23	,	,	PUNCT
dpc-3672	274	24	lu	lu	PROPN
dpc-3672	274	25	j.	j.	PROPN
dpc-3672	274	26	elevation	elevation	PROPN
dpc-3672	274	27	of	of	ADP
dpc-3672	274	28	serum	serum	NOUN
dpc-3672	274	29	il-35	il-35	ADP
dpc-3672	274	30	in	in	ADP
dpc-3672	274	31	patients	patient	NOUN
dpc-3672	274	32	with	with	ADP
dpc-3672	274	33	primary	primary	ADJ
dpc-3672	274	34	sjögren	sjögren	PROPN
dpc-3672	274	35	’s	’s	PART
dpc-3672	274	36	syndrome	syndrome	NOUN
dpc-3672	274	37	.	.	PUNCT
dpc-3672	275	1	j	j	PROPN
dpc-3672	275	2	interferon	interferon	PROPN
dpc-3672	275	3	cytokine	cytokine	NOUN
dpc-3672	275	4	res	re	NOUN
dpc-3672	275	5	.	.	PUNCT
dpc-3672	276	1	2018;38(10):452	2018;38(10):452	PROPN
dpc-3672	276	2	-	-	SYM
dpc-3672	276	3	456	456	NUM
dpc-3672	276	4	.	.	PUNCT
dpc-3672	277	1	doi	doi	NOUN
dpc-3672	277	2	:	:	PUNCT
dpc-3672	277	3	10.1089	10.1089	NUM
dpc-3672	277	4	/	/	SYM
dpc-3672	277	5	jir.2018.0059	jir.2018.0059	PROPN
dpc-3672	277	6	.	.	PUNCT
dpc-3672	278	1	pmid	pmid	NOUN
dpc-3672	278	2	:	:	PUNCT
dpc-3672	278	3	30256702	30256702	NUM
dpc-3672	278	4	.	.	PUNCT
dpc-3672	279	1	25	25	NUM
dpc-3672	279	2	.	.	PUNCT
dpc-3672	279	3	li	li	PROPN
dpc-3672	279	4	x	x	PROPN
dpc-3672	279	5	,	,	PUNCT
dpc-3672	279	6	mai	mai	PROPN
dpc-3672	279	7	j	j	PROPN
dpc-3672	279	8	,	,	PUNCT
dpc-3672	279	9	virtue	virtue	VERB
dpc-3672	279	10	a	a	PRON
dpc-3672	279	11	,	,	PUNCT
dpc-3672	279	12	yin	yin	PROPN
dpc-3672	279	13	y	y	PROPN
dpc-3672	279	14	,	,	PUNCT
dpc-3672	279	15	gong	gong	NOUN
dpc-3672	279	16	r	r	PROPN
dpc-3672	279	17	,	,	PUNCT
dpc-3672	279	18	sha	sha	PROPN
dpc-3672	279	19	x	x	PROPN
dpc-3672	279	20	,	,	PUNCT
dpc-3672	279	21	gutchigian	gutchigian	PROPN
dpc-3672	279	22	s	s	PROPN
dpc-3672	279	23	,	,	PUNCT
dpc-3672	279	24	frisch	frisch	VERB
dpc-3672	279	25	a	a	PRON
dpc-3672	279	26	,	,	PUNCT
dpc-3672	279	27	hodge	hodge	PROPN
dpc-3672	279	28	i	i	PROPN
dpc-3672	279	29	,	,	PUNCT
dpc-3672	279	30	jiang	jiang	PROPN
dpc-3672	279	31	x	x	PROPN
dpc-3672	279	32	,	,	PUNCT
dpc-3672	279	33	wang	wang	PROPN
dpc-3672	279	34	h	h	PROPN
dpc-3672	279	35	,	,	PUNCT
dpc-3672	279	36	yang	yang	PROPN
dpc-3672	279	37	xf	xf	PROPN
dpc-3672	279	38	.	.	PROPN
dpc-3672	279	39	il-35	il-35	PROPN
dpc-3672	279	40	is	be	AUX
dpc-3672	279	41	a	a	DET
dpc-3672	279	42	novel	novel	NOUN
dpc-3672	279	43	responsive	responsive	ADJ
dpc-3672	279	44	anti	anti	ADJ
dpc-3672	279	45	-	-	ADJ
dpc-3672	279	46	inflammatory	inflammatory	ADJ
dpc-3672	279	47	cytokine	cytokine	NOUN
dpc-3672	279	48	--	--	PUNCT
dpc-3672	279	49	a	a	DET
dpc-3672	279	50	new	new	ADJ
dpc-3672	279	51	system	system	NOUN
dpc-3672	279	52	of	of	ADP
dpc-3672	279	53	categorizing	categorize	VERB
dpc-3672	279	54	anti	anti	ADJ
dpc-3672	279	55	-	-	ADJ
dpc-3672	279	56	inflammatory	inflammatory	ADJ
dpc-3672	279	57	cytokines	cytokine	NOUN
dpc-3672	279	58	.	.	PUNCT
dpc-3672	280	1	plos	plos	PROPN
dpc-3672	280	2	one	one	NUM
dpc-3672	280	3	.	.	PUNCT
dpc-3672	281	1	2012;7(3):e33628	2012;7(3):e33628	X
dpc-3672	281	2	.	.	PUNCT
dpc-3672	282	1	doi	doi	NOUN
dpc-3672	282	2	:	:	PUNCT
dpc-3672	282	3	10.1371	10.1371	NUM
dpc-3672	282	4	/	/	SYM
dpc-3672	282	5	journal.pone.0033628	journal.pone.0033628	PROPN
dpc-3672	282	6	.	.	PUNCT
dpc-3672	283	1	pmid	pmid	NOUN
dpc-3672	283	2	:	:	PUNCT
dpc-3672	283	3	22438968	22438968	NUM
dpc-3672	283	4	.	.	PUNCT
dpc-3672	284	1	pmcid	pmcid	NOUN
dpc-3672	284	2	:	:	PUNCT
dpc-3672	284	3	pmc3306427	pmc3306427	NOUN
dpc-3672	284	4	.	.	PUNCT
dpc-3672	285	1	26	26	NUM
dpc-3672	285	2	.	.	PUNCT
dpc-3672	286	1	qiu	qiu	PROPN
dpc-3672	286	2	f	f	PROPN
dpc-3672	286	3	,	,	PUNCT
dpc-3672	286	4	song	song	PROPN
dpc-3672	286	5	l	l	PROPN
dpc-3672	286	6	,	,	PUNCT
dpc-3672	286	7	yang	yang	PROPN
dpc-3672	286	8	n	n	PROPN
dpc-3672	286	9	,	,	PUNCT
dpc-3672	286	10	li	li	PROPN
dpc-3672	286	11	x.	x.	PROPN
dpc-3672	286	12	glucocorticoid	glucocorticoid	PROPN
dpc-3672	286	13	downregulates	downregulate	NOUN
dpc-3672	286	14	expression	expression	NOUN
dpc-3672	286	15	of	of	ADP
dpc-3672	286	16	il-12	il-12	DET
dpc-3672	286	17	family	family	NOUN
dpc-3672	286	18	cytokines	cytokine	NOUN
dpc-3672	286	19	in	in	ADP
dpc-3672	286	20	systemic	systemic	ADJ
dpc-3672	286	21	lupus	lupus	NOUN
dpc-3672	286	22	erythematosus	erythematosus	PROPN
dpc-3672	286	23	patients	patient	NOUN
dpc-3672	286	24	.	.	PUNCT
dpc-3672	287	1	lupus	lupus	NOUN
dpc-3672	287	2	.	.	PUNCT
dpc-3672	288	1	2013;22(10):1011	2013;22(10):1011	NUM
dpc-3672	288	2	-	-	SYM
dpc-3672	288	3	1016	1016	NUM
dpc-3672	288	4	.	.	PUNCT
dpc-3672	289	1	doi	doi	NOUN
dpc-3672	289	2	:	:	PUNCT
dpc-3672	289	3	10.1177/0961203313498799	10.1177/0961203313498799	NUM
dpc-3672	289	4	.	.	PUNCT
dpc-3672	290	1	pmid	pmid	NOUN
dpc-3672	290	2	:	:	PUNCT
dpc-3672	290	3	23884985	23884985	NUM
dpc-3672	290	4	.	.	PUNCT
dpc-3672	291	1	11	11	NUM
dpc-3672	291	2	.	.	PUNCT
dpc-3672	292	1	gholijani	gholijani	PROPN
dpc-3672	292	2	n	n	CCONJ
dpc-3672	292	3	,	,	PUNCT
dpc-3672	292	4	yazdani	yazdani	PROPN
dpc-3672	292	5	mr	mr	PROPN
dpc-3672	292	6	,	,	PUNCT
dpc-3672	292	7	dastgheib	dastgheib	PROPN
dpc-3672	292	8	l.	l.	PROPN
dpc-3672	292	9	predominant	predominant	ADJ
dpc-3672	292	10	role	role	NOUN
dpc-3672	292	11	of	of	ADP
dpc-3672	292	12	innate	innate	ADJ
dpc-3672	292	13	pro	pro	ADJ
dpc-3672	292	14	-	-	ADJ
dpc-3672	292	15	inflammatory	inflammatory	ADJ
dpc-3672	292	16	cytokines	cytokine	NOUN
dpc-3672	292	17	in	in	ADP
dpc-3672	292	18	vitiligo	vitiligo	NOUN
dpc-3672	292	19	disease	disease	NOUN
dpc-3672	292	20	.	.	PUNCT
dpc-3672	293	1	arch	arch	ADJ
dpc-3672	293	2	dermatol	dermatol	NOUN
dpc-3672	293	3	res	re	NOUN
dpc-3672	293	4	.	.	PUNCT
dpc-3672	294	1	2020;312(2):123	2020;312(2):123	NUM
dpc-3672	294	2	-	-	SYM
dpc-3672	294	3	131	131	NUM
dpc-3672	294	4	.	.	PUNCT
dpc-3672	295	1	doi	doi	NOUN
dpc-3672	295	2	:	:	PUNCT
dpc-3672	295	3	10.1007	10.1007	NUM
dpc-3672	295	4	/	/	SYM
dpc-3672	295	5	s00403	s00403	AUX
dpc-3672	295	6	-	-	PUNCT
dpc-3672	295	7	019	019	NUM
dpc-3672	295	8	-01996	-01996	NOUN
dpc-3672	295	9	-	-	PUNCT
dpc-3672	295	10	9	9	NUM
dpc-3672	295	11	.	.	PUNCT
dpc-3672	296	1	pmid	pmid	NOUN
dpc-3672	296	2	:	:	PUNCT
dpc-3672	296	3	31620869	31620869	NUM
dpc-3672	296	4	.	.	PUNCT
dpc-3672	297	1	12	12	NUM
dpc-3672	297	2	.	.	PUNCT
dpc-3672	298	1	nagai	nagai	PROPN
dpc-3672	298	2	h	h	PROPN
dpc-3672	298	3	,	,	PUNCT
dpc-3672	298	4	hara	hara	PROPN
dpc-3672	298	5	i	i	PROPN
dpc-3672	298	6	,	,	PUNCT
dpc-3672	298	7	horikawa	horikawa	PROPN
dpc-3672	298	8	t	t	PROPN
dpc-3672	298	9	,	,	PUNCT
dpc-3672	298	10	oka	oka	PROPN
dpc-3672	298	11	m	m	PROPN
dpc-3672	298	12	,	,	PUNCT
dpc-3672	298	13	kamidono	kamidono	PROPN
dpc-3672	298	14	s	s	PROPN
dpc-3672	298	15	,	,	PUNCT
dpc-3672	298	16	ichihashi	ichihashi	PROPN
dpc-3672	298	17	m.	m.	NOUN
dpc-3672	298	18	elimination	elimination	NOUN
dpc-3672	298	19	of	of	ADP
dpc-3672	298	20	cd4(+	cd4(+	NOUN
dpc-3672	298	21	)	)	PUNCT
dpc-3672	298	22	t	t	NOUN
dpc-3672	298	23	cells	cell	NOUN
dpc-3672	298	24	enhances	enhance	VERB
dpc-3672	298	25	anti	anti	ADJ
dpc-3672	298	26	-	-	ADJ
dpc-3672	298	27	tumor	tumor	ADJ
dpc-3672	298	28	effect	effect	NOUN
dpc-3672	298	29	of	of	ADP
dpc-3672	298	30	locally	locally	ADV
dpc-3672	298	31	secreted	secrete	VERB
dpc-3672	298	32	interleukin-12	interleukin-12	NOUN
dpc-3672	298	33	on	on	ADP
dpc-3672	298	34	b16	b16	PROPN
dpc-3672	298	35	mouse	mouse	NOUN
dpc-3672	298	36	melanoma	melanoma	NOUN
dpc-3672	298	37	and	and	CCONJ
dpc-3672	298	38	induces	induce	VERB
dpc-3672	298	39	vitiligo	vitiligo	ADJ
dpc-3672	298	40	-	-	PUNCT
dpc-3672	298	41	like	like	ADJ
dpc-3672	298	42	coat	coat	NOUN
dpc-3672	298	43	color	color	NOUN
dpc-3672	298	44	alteration	alteration	NOUN
dpc-3672	298	45	.	.	PUNCT
dpc-3672	299	1	j	j	PROPN
dpc-3672	299	2	invest	invest	VERB
dpc-3672	299	3	dermatol	dermatol	NOUN
dpc-3672	299	4	.	.	PUNCT
dpc-3672	300	1	2000;115(6):1059	2000;115(6):1059	NUM
dpc-3672	300	2	-	-	SYM
dpc-3672	300	3	1064	1064	NUM
dpc-3672	300	4	.	.	PUNCT
dpc-3672	301	1	doi	doi	NOUN
dpc-3672	301	2	:	:	PUNCT
dpc-3672	301	3	10.1046	10.1046	NUM
dpc-3672	301	4	/	/	SYM
dpc-3672	301	5	j.1523	j.1523	NOUN
dpc-3672	301	6	-	-	SYM
dpc-3672	301	7	1747	1747	NUM
dpc-3672	301	8	.2000.00156.x	.2000.00156.x	SYM
dpc-3672	301	9	.	.	PUNCT
dpc-3672	302	1	pmid	pmid	NOUN
dpc-3672	302	2	:	:	PUNCT
dpc-3672	302	3	11121142	11121142	NUM
dpc-3672	302	4	.	.	PUNCT
dpc-3672	303	1	13	13	NUM
dpc-3672	303	2	.	.	PUNCT
dpc-3672	303	3	vaccaro	vaccaro	PROPN
dpc-3672	303	4	m	m	PROPN
dpc-3672	303	5	,	,	PUNCT
dpc-3672	303	6	cannavò	cannavò	VERB
dpc-3672	303	7	sp	sp	NOUN
dpc-3672	303	8	,	,	PUNCT
dpc-3672	303	9	imbesi	imbesi	NOUN
dpc-3672	303	10	s	s	PROPN
dpc-3672	303	11	,	,	PUNCT
dpc-3672	304	1	et	et	PROPN
dpc-3672	304	2	al	al	PROPN
dpc-3672	304	3	.	.	PROPN
dpc-3672	304	4	increased	increase	VERB
dpc-3672	304	5	serum	serum	NOUN
dpc-3672	304	6	levels	level	NOUN
dpc-3672	304	7	of	of	ADP
dpc-3672	304	8	interleukin-23	interleukin-23	PROPN
dpc-3672	304	9	circulating	circulate	VERB
dpc-3672	304	10	in	in	ADP
dpc-3672	304	11	patients	patient	NOUN
dpc-3672	304	12	with	with	ADP
dpc-3672	304	13	non	non	ADJ
dpc-3672	304	14	-	-	ADJ
dpc-3672	304	15	segmental	segmental	ADJ
dpc-3672	304	16	generalized	generalized	ADJ
dpc-3672	304	17	vitiligo	vitiligo	NOUN
dpc-3672	304	18	.	.	PUNCT
dpc-3672	305	1	int	int	NOUN
dpc-3672	305	2	j	j	PROPN
dpc-3672	305	3	dermatol	dermatol	NOUN
dpc-3672	305	4	.	.	PUNCT
dpc-3672	306	1	2015;54(6):672	2015;54(6):672	NUM
dpc-3672	306	2	-	-	PUNCT
dpc-3672	306	3	674	674	NUM
dpc-3672	306	4	.	.	PUNCT
dpc-3672	307	1	doi	doi	NOUN
dpc-3672	307	2	:	:	PUNCT
dpc-3672	307	3	10.1111	10.1111	NUM
dpc-3672	307	4	/	/	SYM
dpc-3672	307	5	ijd.12392	ijd.12392	NOUN
dpc-3672	307	6	.	.	PUNCT
dpc-3672	308	1	pmid	pmid	NOUN
dpc-3672	308	2	:	:	PUNCT
dpc-3672	308	3	25427848	25427848	NUM
dpc-3672	308	4	.	.	PUNCT
dpc-3672	309	1	14	14	NUM
dpc-3672	309	2	.	.	PUNCT
dpc-3672	310	1	nieradko	nieradko	NOUN
dpc-3672	310	2	-	-	PUNCT
dpc-3672	310	3	iwanicka	iwanicka	PROPN
dpc-3672	310	4	b	b	PROPN
dpc-3672	310	5	,	,	PUNCT
dpc-3672	310	6	przybylska	przybylska	ADJ
dpc-3672	310	7	d	d	NOUN
dpc-3672	310	8	,	,	PUNCT
dpc-3672	310	9	borzęcki	borzęcki	NOUN
dpc-3672	310	10	a.	a.	NOUN
dpc-3672	310	11	a	a	DET
dpc-3672	310	12	case	case	NOUN
dpc-3672	310	13	control	control	NOUN
dpc-3672	310	14	study	study	NOUN
dpc-3672	310	15	on	on	ADP
dpc-3672	310	16	immunologic	immunologic	ADJ
dpc-3672	310	17	markers	marker	NOUN
dpc-3672	310	18	of	of	ADP
dpc-3672	310	19	patients	patient	NOUN
dpc-3672	310	20	with	with	ADP
dpc-3672	310	21	vitiligo	vitiligo	PROPN
dpc-3672	310	22	.	.	PUNCT
dpc-3672	310	23	biomed	biome	VERB
dpc-3672	310	24	pharmacother	pharmacother	ADJ
dpc-3672	310	25	.	.	PUNCT
dpc-3672	311	1	2022;156:113785	2022;156:113785	X
dpc-3672	311	2	.	.	PUNCT
dpc-3672	312	1	doi	doi	NOUN
dpc-3672	312	2	:	:	PUNCT
dpc-3672	312	3	10.1016	10.1016	NUM
dpc-3672	312	4	/	/	SYM
dpc-3672	312	5	j	j	PROPN
dpc-3672	312	6	.biopha.2022.113785	.biopha.2022.113785	PROPN
dpc-3672	312	7	.	.	PUNCT
dpc-3672	313	1	pmid	pmid	NOUN
dpc-3672	313	2	:	:	PUNCT
dpc-3672	313	3	36244264	36244264	NUM
dpc-3672	313	4	.	.	PUNCT
dpc-3672	314	1	15	15	NUM
dpc-3672	314	2	.	.	X
dpc-3672	315	1	osman	osman	PROPN
dpc-3672	315	2	am	am	PROPN
dpc-3672	315	3	,	,	PUNCT
dpc-3672	315	4	mukhtar	mukhtar	PROPN
dpc-3672	315	5	mm	mm	PROPN
dpc-3672	315	6	,	,	PUNCT
dpc-3672	315	7	bakheit	bakheit	PROPN
dpc-3672	315	8	kh	kh	PROPN
dpc-3672	315	9	,	,	PUNCT
dpc-3672	315	10	hamdan	hamdan	PROPN
dpc-3672	315	11	hz	hz	PROPN
dpc-3672	315	12	.	.	PROPN
dpc-3672	315	13	plasma	plasma	NOUN
dpc-3672	315	14	levels	level	NOUN
dpc-3672	315	15	of	of	ADP
dpc-3672	315	16	interleukin-17	interleukin-17	PROPN
dpc-3672	315	17	,	,	PUNCT
dpc-3672	315	18	interleukin-23	interleukin-23	PROPN
dpc-3672	315	19	,	,	PUNCT
dpc-3672	315	20	and	and	CCONJ
dpc-3672	315	21	transforming	transform	VERB
dpc-3672	315	22	growth	growth	NOUN
dpc-3672	315	23	factor	factor	NOUN
dpc-3672	315	24	-	-	PUNCT
dpc-3672	315	25	β	β	NOUN
dpc-3672	315	26	in	in	ADP
dpc-3672	315	27	sudanese	sudanese	ADJ
dpc-3672	315	28	patients	patient	NOUN
dpc-3672	315	29	with	with	ADP
dpc-3672	315	30	vitiligo	vitiligo	NOUN
dpc-3672	315	31	:	:	PUNCT
dpc-3672	315	32	a	a	DET
dpc-3672	315	33	case	case	NOUN
dpc-3672	315	34	-	-	PUNCT
dpc-3672	315	35	control	control	NOUN
dpc-3672	315	36	study	study	NOUN
dpc-3672	315	37	.	.	PUNCT
dpc-3672	316	1	indian	indian	PROPN
dpc-3672	316	2	j	j	PROPN
dpc-3672	316	3	dermatol	dermatol	NOUN
dpc-3672	316	4	.	.	PUNCT
dpc-3672	317	1	2015c;60(6):635	2015c;60(6):635	PROPN
dpc-3672	317	2	.	.	PUNCT
dpc-3672	318	1	doi	doi	PROPN
dpc-3672	318	2	:	:	PUNCT
dpc-3672	318	3	10.4103/0019	10.4103/0019	NUM
dpc-3672	318	4	-	-	PUNCT
dpc-3672	318	5	5154.169136	5154.169136	NOUN
dpc-3672	318	6	.	.	PUNCT
dpc-3672	319	1	pmid	pmid	NOUN
dpc-3672	319	2	:	:	PUNCT
dpc-3672	319	3	26677292	26677292	NUM
dpc-3672	319	4	.	.	PUNCT
dpc-3672	320	1	pmcid	pmcid	ADJ
dpc-3672	320	2	:	:	PUNCT
dpc-3672	320	3	pmc4681218	pmc4681218	NOUN
dpc-3672	320	4	.	.	PUNCT
dpc-3672	321	1	16	16	NUM
dpc-3672	321	2	.	.	PUNCT
dpc-3672	322	1	kotobuki	kotobuki	PROPN
dpc-3672	322	2	y	y	PROPN
dpc-3672	322	3	,	,	PUNCT
dpc-3672	322	4	tanemura	tanemura	NOUN
dpc-3672	322	5	a	a	NOUN
dpc-3672	322	6	,	,	PUNCT
dpc-3672	322	7	yang	yang	PROPN
dpc-3672	322	8	l	l	PROPN
dpc-3672	322	9	,	,	PUNCT
dpc-3672	322	10	et	et	PROPN
dpc-3672	322	11	al	al	PROPN
dpc-3672	322	12	.	.	PROPN
dpc-3672	322	13	dysregulation	dysregulation	NOUN
dpc-3672	322	14	of	of	ADP
dpc-3672	322	15	melanocyte	melanocyte	NOUN
dpc-3672	322	16	function	function	NOUN
dpc-3672	322	17	by	by	ADP
dpc-3672	322	18	th17	th17	NOUN
dpc-3672	322	19	-	-	PUNCT
dpc-3672	322	20	related	relate	VERB
dpc-3672	322	21	cytokines	cytokine	NOUN
dpc-3672	322	22	:	:	PUNCT
dpc-3672	322	23	significance	significance	NOUN
dpc-3672	322	24	of	of	ADP
dpc-3672	322	25	th17	th17	PROPN
dpc-3672	322	26	cell	cell	NOUN
dpc-3672	322	27	infiltration	infiltration	NOUN
dpc-3672	322	28	in	in	ADP
dpc-3672	322	29	autoimmune	autoimmune	ADJ
dpc-3672	322	30	vitiligo	vitiligo	NOUN
dpc-3672	322	31	vulgaris	vulgaris	NOUN
dpc-3672	322	32	.	.	PUNCT
dpc-3672	323	1	pigment	pigment	ADJ
dpc-3672	323	2	cell	cell	NOUN
dpc-3672	323	3	melanoma	melanoma	NOUN
dpc-3672	323	4	res	re	NOUN
dpc-3672	323	5	.	.	PUNCT
dpc-3672	324	1	2012;25(2):219	2012;25(2):219	NUM
dpc-3672	324	2	-	-	SYM
dpc-3672	324	3	230	230	NUM
dpc-3672	324	4	.	.	PUNCT
dpc-3672	325	1	doi	doi	NOUN
dpc-3672	325	2	:	:	PUNCT
dpc-3672	325	3	10.1111	10.1111	NUM
dpc-3672	325	4	/	/	SYM
dpc-3672	325	5	j.1755	j.1755	PROPN
dpc-3672	325	6	-148x.2011.00945.x	-148x.2011.00945.x	NOUN
dpc-3672	325	7	.	.	PUNCT
dpc-3672	326	1	pmid	pmid	NOUN
dpc-3672	326	2	:	:	PUNCT
dpc-3672	326	3	22136309	22136309	NUM
dpc-3672	326	4	.	.	PUNCT
dpc-3672	327	1	17	17	NUM
dpc-3672	327	2	.	.	PUNCT
dpc-3672	328	1	singh	singh	PROPN
dpc-3672	328	2	rk	rk	PROPN
dpc-3672	328	3	,	,	PUNCT
dpc-3672	328	4	lee	lee	PROPN
dpc-3672	328	5	km	km	PROPN
dpc-3672	328	6	,	,	PUNCT
dpc-3672	328	7	vujkovic	vujkovic	ADJ
dpc-3672	328	8	-	-	PUNCT
dpc-3672	328	9	cvijin	cvijin	NOUN
dpc-3672	328	10	i	i	PRON
dpc-3672	328	11	,	,	PUNCT
dpc-3672	328	12	et	et	PROPN
dpc-3672	328	13	al	al	PROPN
dpc-3672	328	14	.	.	PUNCT
dpc-3672	329	1	the	the	DET
dpc-3672	329	2	role	role	NOUN
dpc-3672	329	3	of	of	ADP
dpc-3672	329	4	il-17	il-17	X
dpc-3672	329	5	in	in	ADP
dpc-3672	329	6	vitiligo	vitiligo	NOUN
dpc-3672	329	7	:	:	PUNCT
dpc-3672	329	8	a	a	DET
dpc-3672	329	9	review	review	NOUN
dpc-3672	329	10	.	.	PUNCT
dpc-3672	330	1	autoimmun	autoimmun	PROPN
dpc-3672	330	2	rev	rev	PROPN
dpc-3672	330	3	.	.	PUNCT
dpc-3672	331	1	2016;15(4):397	2016;15(4):397	PROPN
dpc-3672	331	2	-	-	SYM
dpc-3672	331	3	404	404	NUM
dpc-3672	331	4	.	.	PUNCT
dpc-3672	332	1	doi	doi	NOUN
dpc-3672	332	2	:	:	PUNCT
dpc-3672	332	3	10.1016	10.1016	NUM
dpc-3672	332	4	/	/	SYM
dpc-3672	332	5	j.autrev.2016.01.004	j.autrev.2016.01.004	PROPN
dpc-3672	332	6	.	.	PUNCT
dpc-3672	333	1	pmid	pmid	NOUN
dpc-3672	333	2	:	:	PUNCT
dpc-3672	333	3	26804758	26804758	NUM
dpc-3672	333	4	.	.	PUNCT
dpc-3672	334	1	pmcid	pmcid	NOUN
dpc-3672	334	2	:	:	PUNCT
dpc-3672	334	3	pmc4769658	pmc4769658	NOUN
dpc-3672	334	4	.	.	PUNCT
dpc-3672	335	1	18	18	NUM
dpc-3672	335	2	.	.	PUNCT
dpc-3672	335	3	méry	méry	NOUN
dpc-3672	335	4	-	-	PUNCT
dpc-3672	335	5	bossard	bossard	NOUN
dpc-3672	335	6	l	l	NOUN
dpc-3672	335	7	,	,	PUNCT
dpc-3672	335	8	bagny	bagny	PROPN
dpc-3672	335	9	k	k	NOUN
dpc-3672	335	10	,	,	PUNCT
dpc-3672	335	11	chaby	chaby	NOUN
dpc-3672	335	12	g	g	NOUN
dpc-3672	335	13	,	,	PUNCT
dpc-3672	335	14	et	et	PROPN
dpc-3672	335	15	al	al	PROPN
dpc-3672	335	16	.	.	PUNCT
dpc-3672	336	1	new	new	ADJ
dpc-3672	336	2	-	-	PUNCT
dpc-3672	336	3	onset	onset	NOUN
dpc-3672	336	4	vitiligo	vitiligo	NOUN
dpc-3672	336	5	and	and	CCONJ
dpc-3672	336	6	progression	progression	NOUN
dpc-3672	336	7	of	of	ADP
dpc-3672	336	8	pre	pre	ADJ
dpc-3672	336	9	-	-	ADJ
dpc-3672	336	10	existing	exist	VERB
dpc-3672	336	11	vitiligo	vitiligo	NOUN
dpc-3672	336	12	during	during	ADP
dpc-3672	336	13	treatment	treatment	NOUN
dpc-3672	336	14	with	with	ADP
dpc-3672	336	15	biological	biological	ADJ
dpc-3672	336	16	agents	agent	NOUN
dpc-3672	336	17	in	in	ADP
dpc-3672	336	18	chronic	chronic	ADJ
dpc-3672	336	19	inflammatory	inflammatory	ADJ
dpc-3672	336	20	diseases	disease	NOUN
dpc-3672	336	21	.	.	PUNCT
dpc-3672	337	1	j	j	PROPN
dpc-3672	337	2	eur	eur	PROPN
dpc-3672	337	3	acad	acad	PROPN
dpc-3672	337	4	dermatol	dermatol	NOUN
dpc-3672	337	5	venereol	venereol	NOUN
dpc-3672	337	6	.	.	PUNCT
dpc-3672	338	1	2017;31(1):181	2017;31(1):181	NUM
dpc-3672	338	2	-	-	SYM
dpc-3672	338	3	186	186	NUM
dpc-3672	338	4	.	.	PUNCT
dpc-3672	339	1	doi	doi	NOUN
dpc-3672	339	2	:	:	PUNCT
dpc-3672	339	3	10.1111	10.1111	NUM
dpc-3672	339	4	/	/	SYM
dpc-3672	339	5	jdv.13759	jdv.13759	NUM
dpc-3672	339	6	.	.	PUNCT
dpc-3672	340	1	pmid	pmid	NOUN
dpc-3672	340	2	:	:	PUNCT
dpc-3672	340	3	27291924	27291924	NUM
dpc-3672	340	4	.	.	PUNCT